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l I-1. Summary:  
Prematurity leads to many handicaps, some of them are only recognized later in life and may 
impact the individuals for the rest of their life. The delivery date compared to the full term 
delivery time will be a measure of “indication of risks” of post-natal handicap risk, but this is 
only one of the many measurements that can be looked at. Many studies have investigated 
development of premature infants, based on different criteria at entry in the considered study. 
Our investigations are only a limited contribution to the investigation of premature infants. We 
included infants born as young as 24 weeks of gestational-age [GA] but none of the infants had 
major neurological syndromes recognized at birth. “Normal infants” defined as infants with 
more than 37 weeks of GA, birth-weight >2500g and absence of any indication of health 
problems born in the same hospital maternity at same time as premature infants were also 
recruited to serve as normal controls. 
As most newborn infants spend a large amount of time asleep, all the presented studies include 
investigation of sleep, and once sleep-time occurred mostly during the nocturnal period, it 
focused on the polygraphic monitoring of the nocturnal sleep.  
The premature cohort study was a longitudinal study and parents who signed informed consent 
approved by the Chang Gung Hospital and Medical College Ethic Committee, were asked to 
come back on a yearly basis for at least 5 years. This is an on-going study and not every child 
has been followed for such time. Furthermore, as in any longitudinal study, loss of patients 
occurred as parents did not bring children back. At entry 400 parents signed the informed 
consent, currently at 5 years follow-up 150 children have ended the follow-up period and about 
215 at 4 years. The sample is a non-random convenience sample of children selected based on 
the parents` willingness to participate in the protocol and obtained with the help of neonatologist 
physicians in our NICUs. 
Most of the studies presented in the thesis come-out of this longitudinal study. The studies asked 
specific questions, particularly looking at development of abnormal obstructive breathing during 
sleep. But some of our studies looked also at children of older age as some of the findings that 
we observed in our premature cohort needed a different investigative approach, and prior 
validation on older children-premature and in non-premature infants. 
We have included these studies in our narrative as they become part of our research, and they 
are part of a general research program on “sleep- breathing-and-cognition” in children. 
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The thesis has the following organization: 
1. Summary in English and Portuguese 
The preamble explains major sleep problems of premature infants and the work done 
2. Introduction with background and objectives as follows: 
(1) the understanding of the development of abnormal upper airway in premature 
infants and abnormal breathing during sleep. 
(2) the understanding the craniofacial development and impact on occurrence of 
pediatric SDB. 
(3) to evaluate the differences in development between premature and full-term 
infants. 
(4) finally investigating, from our cohort-data, the relationship between the SDB 
and the developmental problems that we could observed in our premature 
infants.  
 
To perform these tasks she had to:  
(1) Develop an “infant sleep questionnaires” in Chinese version to use through 
our studies 
(2) Develop pediatric obstructive sleep apnea questionnaires in Chinese version 
to use in our study. 
(3) To investigate the possible actions of pediatric SDB on neurocognitive 
dysfunctions in our children and is behind the protocols presented in our 
studies.  
(4) To develop the biomarkers for diagnosis and selection for treatment of 
pediatric SDB  
(5) To improve treatments of pediatric OSA. 
 
3. Literature review including Sleep disordered breathing in infants and children, the 
problem of obesity, the issues related to craniofacial development, type of breathing, 
facial configuration and the lingual frenulum, the pro inflammatory cytokines, 
neurodevelopmental and neurocognitive dysfunctions of SDB in infants and children. 
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4. The methodology used which includes the set-up of the Sleep Lab, the multidisciplinary 
team and the development of Chinese-version of Infant Sleep Questionnaire: “Brief 
Infant Sleep Questionnaire-Chinese version” 
5. The results which are based on the published articles 
6. The discussion in which she integrates the achieved results in the international literature. 
 
The following research projects were undertaken: 
 
Study #1The Chinese version of the obstructive-sleep-apnea questionnaire-18 
Our first study involved defining another tool for our research considering the parents’ 
reluctance to come back, year after year to the sleep-laboratory for follow-up investigation. Not 
to have too many “absence of data”, we had to validate another tool: a questionnaire that parents 
would be willing to fill- in, even at home if necessary. This validation involved monitoring of 
children during sleep. 
Our study validate the CBISQ, but it is also the first study targeting the difference between 
premature and full-term infants through a reliable and valid screening questionnaire. 
 
Study #2 - Sleep and Breathing in premature infants at 6 months post-natal age –  
Sleep  and sleep breathing disturbances were investigated in premature infants at 6 months of 
age. 
Premature infants are presenting with a more narrow and high-arched palate, more SDB-related 
sleep problems, and more neurodevelopmental deficits than normal full-term infants. 
Till 2 years of age, premature infants with narrow and high-arched palate have more SDB-
related sleep problems and more neurodevelopmental deficits than those without. 
These findings support our hypothesis that high and narrow-arched palate in premature infants 
plays a role in the development of sleep problems and neurodevelopmental delays.  
 
Study #3 - Early detection of minor neurodevelopmental dysfunctions at age 6 months in 
prematurely born neonates. 
The infants involved in our longitudinal studies were selected as free of clear neurological signs 
and symptoms. However, these children are considered to have clear neurological risks. We 
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investigated such possibility assessing subtle neuromotor dysfunctions, such as difficulties with 
gross motor skill, social contact, or learning. 
Premature neonates, even those born at 33 to 36 weeks, are found to have MNDs (Minor 
Neurodevelopmental Dysfunction) as early as 6 months corrected age by BSID-II and DDST, 
with risk increasing as gestation decreases.  
Moreover, we used multivariate logistic regression to evaluate the relationships between 
neonatal factors and the presence of MNDs. After multivariate logistic regression adjusted for 
GA and BBW (Birth Body Weight), MND was independently associated with postnatal 
corticosteroid use and cholestasis. Besides, neonates with BBW less than 1000g were 
significantly associated with MNDs when compared with those with BBW more than 2000g. 
 
Study#4   Pediatric Obstructive Sleep Apnea and the critical role of oral-facial growth (a 
review of our evidences placed in an historical context) 
We looked to the critical role of facial growth in the development of SDB. 
Currently at 4 years of age, 77% of our premature infants have OSA and a high and narrow hard 
palate. There is a relationship between gestational age(GA) at birth and presence of problems 
which increase with lower  GA at birth. But, this is not the only factor. As found, children with 
normal palate and AHI may progressively deteriorate during the first post-natal months. 
Preliminary data indicate that normal functioning of suction, swallowing, mastication and nasal 
breathing post-birth are key factors in the switch overtime to abnormal breathing and high and 
narrow hard palate. 
  
Study #5 Short nasal lingual frenulum, mouth breathing and abnormal oral facial growth. 
This study was performed to investigate the role of abnormal oral facial functioning in children 
and development of OSA. 
Short lingual frenulum may lead to abnormal orofacial growth early in life, a risk factor for 
development of SDB.  
Careful surveillance for abnormal breathing during sleep should occur in the presence of short 
lingual frenulum. 
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Study #6 Inflammation, cytokines and mouth breathing 
From of our longitudinal study on premature children we had found out that mouth breathing 
was frequent and that tonsils were not initially enlarged in children that developed OSA, but 
become enlarged. We had shown that children with enlarged tonsils and adenoids (T&A) treated 
with adenotonsillectomy present relapse of OSA within 3 years. We questioned if inflammatory 
factors could not play a role in the development of OSA and if persistence of inflammatory 
factors could not be involved in relapse of OSA. This study is only the first step in our 
investigation but it shows that specific inflammatory factors, currently very much looked at: ie 
interleukines(IL) 17 and 23 are clearly abnormal in OSA children, supporting our hypothesis 
and opening the field for further studies. We do not have post-surgery results as the study takes 
time to be completed, but we demonstrated the validity of our hypothesis and the need to pursue 
this line of research. 
By Regression analysis the following conclusions were achieved: significant relationships 
between pro-inflammatory cytokines and PSG scores with higher AHI score and OSA severity, 
such as HS-CRP (High Sensitivity- C Reactive Protein) (β=0.390, P<0.05) and IL-17(β=0. 329, 
P<0.05. Higher AI “influenced” serum levels of HS-CRP suggesting an impact of inflammatory 
cytokines on soft tissues hypertrophy. Higher serum levels of IL-23 (β=0.403, P<0.05) were 
“influenced” by higher AI. Lower mean SaO2 (O2 saturation) “influenced” IL-10 level (β= -
0.567, P<0.01), and higher serum levels of TNF-α (tumor necrosis factor alpha) and IL-1β were 
“influenced” by higher diastolic pressure (β=0.469 and 0.659, P<0.01). There was a significant 
relationship between lower performances of CPT test and pro-inflammatory cytokines. 
Significant Spearman’s correlation factors between pro-inflammatory cytokines and clinical 
findings such as asthma and IL-6 (ρ= 0.261, P=0.026*); allergic rhinitis and HS-CRP (ρ= 0.280, 
P=0.022*), IL-6(ρ= 0.299, P=0.01*) and IL-10(ρ= -0.265, P=0.023*) ; Tonsil hypertrophy and 
HS-CRP(ρ= 0.244, P=0.046*) ; Adenoid hypertrophy and IL-6 (ρ=0.232, P=0.048*) were 
observed. 
 
  
l Key words: prematurity, sleep, obstructive breathing, cognition 
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l I-2. Sumário:  
A prematuridade leva a muitas deficiências, algumas das quais são apenas reconhecidas mais 
tarde, podendo afetar os indivíduos para o resto das suas vidas. À data do parto, a comparação 
com o tempo de gestação duma criança prematura com o de uma criança de termo será uma 
medida de "indicação de riscos", nomeadamente de risco de deficiência pós-natal. Muitos 
estudos têm investigado o desenvolvimento do bebé prematuro, com base em critérios 
diferentes. As nossas investigações são apenas uma contribuição limitada à investigação de 
bebés prematuros. Incluímos bebês nascidos com apenas 24 semanas de idade gestacional (IG), 
mas nenhuma das crianças incluídas tinha síndromes neurológicas graves reconhecidas na altura 
do nascimento. As "Crianças normais" foram definidas como tendo mais de 37 semanas de IG, 
peso ao nascer > 2500g e ausência de qualquer indicação de problemas de saúde, e foram 
recrutadas para servir como controlos normais. 
Como a maioria dos recém-nascidos passa uma grande quantidade de tempo dormindo, todos 
os estudos apresentados incluem a investigação de sono durante o período noturno, 
designadamente registo poligráfico do sono noturno.  
O estudo de coorte de prematuros foi um estudo longitudinal e os pais que assinaram o 
consentimento livre e esclarecido aprovado pela Comissão de ética da Faculdade de Medicina e 
do Chang Gung Hospital, foram convidados a voltar anualmente, pelo menos durante 5 anos. 
Este é um estudo que continua a decorrer e nem todas as crianças foram seguidas por este 
período de tempo. Além disso, como em qualquer estudo longitudinal, a perda de pacientes 
ocorreu quando os pais não trouxeram as crianças para re-observação. Na entrada 400 pais 
assinaram o consentimento informado, atualmente há follow-up de 5 anos para 150 crianças e 
cerca de 215 têm follow-up aos 4 anos. A coorte resulta de uma amostra de conveniência não-
aleatória das crianças selecionadas com base na disponibilidade dos pais para participar do 
protocolo, os quais foram obtidos com a ajuda de médicos neonatologistas no nosso Hospital. 
A maioria dos estudos apresentados na tese resultam deste estudo longitudinal. Também foram 
feitos estudos com perguntas específicas, particularmente os que se referem ao desenvolvimento 
de disfunção respiratória de tipo obstrutivo durante o sono. Mas alguns dos estudos também 
olharam para as crianças de idade mais avançada, no sentido de validar algumas das conclusões 
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que observámos na nossa coorte prematura. Estes estudos são parte de um programa de 
investigação sobre "sono-respiração-e-cognição" em crianças. 
A tese tem a seguinte organização: 
1. Sumário em Inglês e Português 
2. Preâmbulo 
3. Introdução com justificativo e objetivos: 
(1) compreensão do desenvolvimento anormal das vias aéreas superiores em 
recém-nascidos prematuros e da respiração anormal durante o sono. 
(2) compreensão do desenvolvimento craniofacial e seu impacto na ocorrência de 
apneia pediátrica. 
(3) avaliação da diferença no desenvolvimento de recém-nascidos de termo e 
prematuros. 
(4) investigação, na coorte de dados, a relação entre a disfunção respiratória do 
sono e os problemas do desenvolvimento em prematuros. 
  
Para executar essas tarefas, teve que:  
(1) Desenvolver um "questionário de sono infantil" em versão chinesa  
(2) Desenvolver um questionário para apneia obstrutiva pediátrica do sono em 
versão chinesa. 
(3) Investigar os efeitos da apneia pediátrica em disfunções neurocognitivos  
(4) Identificar biomarcadores para diagnóstico e seleção do tratamento da SAOS 
(Síndrome da Apneia Obstrutiva do Sono) pediátrica 
(5) Melhorar os tratamentos de SAOS pediátrica. 
4. Revisão de literatura, incluindo disfunção respiratória do sono em bebês e crianças, o 
problema da obesidade, os problemas relacionados ao desenvolvimento craniofacial, 
tipo de respiração, configuração facial e o freio lingual, o citoquinas pro-inflamatórias, 
desenvolvimento neurológico e neurocognitivo, e disfunções da SAOS em bebês e 
crianças. 
5. A metodologia utilizada, incluiu a estruturação de um laboratório de sono, uma equipa 
multidisciplinar e a validação de questionários em chinês (Questionário Breve de Sono 
do Recém-nascido.  
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6. Os resultados que foram publicados em revistas indexadas 
7. A discussão que integra os resultados obtidos com os da literatura internacional. 
 
As investigações feitas foram as seguintes: 
 
Estudo # 1 - Versão chinesa do questionário---apneia obstrutiva 18 
Desenvolvemos uma ferramenta para nossa pesquisa. Considerando a relutância dos pais em 
voltar, ano após ano ao laboratório de sono, e para evitar a "ausência de dados", tivemos que 
validar uma outra ferramenta: um questionário que os pais estariam dispostos a preencher, 
mesmo em casa, se necessário. Esta validação implicava o acompanhamento das crianças 
durante o sono. 
O nosso estudo validou o CBISQ, (Chinese Brief Infant Sleep Questionnaire) e é o primeiro 
estudo que avalia a diferença entre crianças prematuras e de termo, através de um questionário 
de triagem fiável e válido. 
 
Estudo #2 - Sono e respiração em bebés prematuros com 6 meses de idade post-natal –  
O sono e os distúrbios respiratórios do sono foram investigados em recém-nascidos prematuros 
com 6 meses de idade. 
Os bebés prematuros que apresentam um palato mais estreito e mais arqueado, têm mais 
problemas de sono relacionados com a respiração e mais déficits de desenvolvimento 
neurológico do que os recém-nascidos de termo. 
Estes resultados suportam a nossa hipótese que o palato estreito e arqueado em bebés prematuros 
desempenha um papel no desenvolvimento de problemas de sono e atrasos de desenvolvimento 
neurológico. 
 
Estudo #3- Deteção precoce de disfunções minor do neurodesenvolvimento (DMND) aos 6 
meses de idade em recém-nascidos prematuros. 
As crianças envolvidas em nossos estudos longitudinais foram selecionadas como não tendo 
sinais e sintomas neurológicos na altura do nascimento. No entanto, estas crianças são 
consideradas ter riscos neurológicos claros. Nós investigámos esta possibilidade avaliando 
disfunções subtis, tais como motilidade fina, contato social, ou de aprendizagem. 
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Prematuros, mesmo aqueles que nasceram com 33 a 36 semanas, são encontrados para ter 
DMND logo aos 6 meses corrigidos idade; o risco aumenta com a diminuição da idade de 
gestação  
Usando a regressão logística multivariada para avaliar as relações entre fatores Neonatais e a 
presença de DMND, verificou-se, após ajustamento para IG e PN (Peso à Nascença), que a 
presença de DMND tinha uma associação independente com o uso de corticosteroides no 
período pós-natal e a presença de colestase. Além disso, recém-nascidos com PN inferior a 
1000g tiveram significativamente mais DMND quando comparados com aqueles com PN 
superior a 2000 g. 
  
Estudo #4 Papel crítico de crescimento oral-facial na apneia obstrutiva do sono pediátrica 
(uma revisão das nossas evidências num contexto histórico) 
Olhámos para o papel crítico de crescimento facial no desenvolvimento da SAOS  
Aos 4 anos de idade, 77% dos nossos bebés prematuros têm SAOS e um palato duro alto e 
estreito. Existe uma relação entre a idade gestacional e presença de problemas Crianças com o 
palato normal e IAH (Índice de Apneia Hipopneia) podem deteriorar progressivamente durante 
os primeiros meses pós-parto. Dados preliminares indicam que o normal funcionamento da 
sucção, deglutição, mastigação e respiração nasal são fatores-chave na prorrogação respiração 
anormal. 
 
Estudo n º 5 Freio lingual, respiração bucal e crescimento oro-facial anormal. Este estudo 
foi realizado para investigar o papel do funcionamento orofacial no desenvolvimento de SAOS 
Um freio lingual curto pode levar a um crescimento orofacial anormal no início da vida, sendo 
um fator de risco para o desenvolvimento de DRS (Distúrbio Respiratório do Sono). A vigilância 
cuidadosa da respiração durante o sono deve ocorrer nestas condições 
 
Estudo #6, Inflamação, citocinas e respiração oral 
A partir de nosso estudo longitudinal em crianças prematuras descobrimos que a respiração oral 
era frequente e que as amígdalas não estavam necessariamente aumentadas em crianças que 
desenvolveram SAOS. Crianças com hipertrofia das amígdalas e adenoides apresentavam 
recidivas de SAOS após adenoamigdalectomia ao fim de 3 anos. Questionámos se fatores 
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inflamatórios poderiam ter um papel no desenvolvimento da SAOS e se a persistência de fatores 
inflamatórios poderia estar envolvida na recaída. Este estudo é apenas o primeiro passo em nossa 
investigação, mas mostra que fatores inflamatórios específicos, as interleucinas 17 e 23 estão 
claramente anormais em crianças com SAOS. Não temos ainda resultados post cirurgia, mas 
demonstramos a validade da nossa hipótese e a necessidade de prosseguir nesta linha de pesquisa. 
Por análise de regressão, as conclusões foram: há uma relação significativa entre citocinas pró-
inflamatórias e valores da PSG, designadamente de IAH elevado e severidade da SAOS, tais 
como PCR-as (Proteína C reativa de alta sensibilidade) (β = 0.390, P < 0,05) e IL-17(β=0. 329, 
P<0.05). IA (Índice de Apneia) e níveis séricos de PCR mais elevados-sugerem um impacto de 
citocinas inflamatórias na hipertrofia de tecidos moles. Níveis séricos de IL-23 mais elevados 
(β = 0.403, P < 0,05) associaram-se a um IA mais elevado. SatO2 médias (Saturações médias de 
O2) baixas associaram-se a IL-10 (β =-0.567, P < 0,01), e níveis mais elevados de FNT-α (Fator 
de necrose tumoral alfa) e IL-1 β foram "associaram-se" a pressão diastólica mais elevada (β = 
0.469 e 0.659, P < 0,01). As citocinas pró-inflamatórias correlacionaram-se positivamente com 
dados clínicos tais como asma e IL-6 (ρ = 0,261, P = 0,026); rinite alérgica e PCR-as (ρ= 0.280, 
P=0.022*), IL-6(ρ= 0.299, P=0.01*) e IL-10(ρ=-0.265, P=0.023*); Hipertrofia de amígdalas e 
PCR-as (ρ= 0.244, P=0.046); Hipertrofia dos adenoides e IL-6 (ρ = 0.232, P = 0,048*). 
  
 
  
 
 
Palavras chave: prematuridade, sono, respiração obstrutiva, cognição 
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l II. Introduction  
Sleep is essential to human life and developmentally involves both physiologic and mental 
processes. During infancy, humans spend a majority of time asleep. Sleep is recognized not only 
as a resting state, but also as a state of intense brain development during which neurotransmitters, 
specific for each sleep stage, impact brain maturation. Therefore, we will discuss some 
important issues for pediatric sleep especially pediatric sleep-disordered breathing in the early 
years of life in our thesis. 
 
II-1. Background and Rationale 
 
Abnormal breathing during sleep in children may affect up to 7 to 10% of pre-pubertal 
children [1].  The consequences of sleep disordered breathing-SDB- are not only tiredness, 
fatigue, but the syndrome may also lead to cardio-vascular and metabolic changes. In children, 
behavioral problems are also common with daytime hyperactivity, inattention, difficulties in 
learning, aggressiveness against peers, and at night nocturnal disrupted sleep, parasomnias- 
more particularly night terrors and sleepwalking-, bruxism and even insomnia [2]. Persistence 
of obstructive sleep apnea-OSA- in children after adenotonsillectomy has been reported over 
the years by different groups [1-5].  In one of our studies [6], four factors were identified as 
significantly related to persistence of SDB after adenotonsillectomy: 1) enlarged nasal inferior 
turbinates; 2) nasal septal deviation; 3) retro-placement of the mandible; and 4) a Mallampati-
scale grade 3 or 4 airway [7].  Mallampati-scale scores of 3 and 4 are associated with risk for 
difficulty with intubation and may also indicate a narrow upper airway (see figure1).  
Anatomically small upper airway was similarly suggested as a cause for persistent SDB by 
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Tauman et al [2]. Studies have suggested that children with SDB and residual problems after 
adenotonsillectomy, had certain facial features that were hypothesized to play a role in the 
development of OSA in children. These facial features involve the nasomaxillary complex and 
the mandible [6,8].  Based on this hypothesis, some patients have undergone orthodontic-
treatments such as rapid maxillary expansion or bimandibular expansion that targeted widening 
of the maxilla and mandible respectively; these approaches have been successful to some degree 
in eliminating residual obstructive sleep apnea in children [8-12]. But the factors behind the 
findings of anatomical involvement in development of SDB are still very much unknown. It has 
been shown that SDB and OSA apnea may be seen in different family members and a genetic 
influence behind occurrence of these syndromes has been suggested [13-18].                                                                                 
Environmental factors are also suspected: experimental studies on new-born monkeys [19-
22] have shown that creation at birth of increase in nasal resistance by placing a ligature 
restricting the size of the nares results in concomitant mouth breathing, increased facial height, 
abnormal maxillary and mandibular development with mandibular retrusion and abnormal 
mandibular growth, and secondary small upper airway. In children, nasal allergies leading to 
nasal turbinate enlargement, deviated nasal septum, enlarged adeno-tonsils have similar effects 
emphasizing the role of environmental factors in the development of small upper airway leading 
to SDB [23,24]. A recent retrospective study performed at Stanford University on 400 children 
showed that 373 (93.3%) had craniofacial features considered to be risk-factors for SDB, 
including small mandible and/or high and narrow hard palate associated with a narrow 
nasomaxillary complex [25]. It seems also that premature infants are at greater risk to present 
these anatomical risks factors [25] and to develop SDB with its behavioral consequences. 
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Sleep is important for pediatric development: Premature neonates bear less mature organs and 
higher incidence of multiple morbidities, as well as poorer developmental outcomes later during 
their infancy and childhood. SDB encompasses varieties of respiratory disorders that occurs or 
are exacerbated exclusively during sleep; and the breathing event may be defined as central, 
obstructive, or mixed based on polysomnographic recording. Conditions that disrupt respiration 
and sleep in premature neonates and infants include apnea of prematurity, central apnea, 
bronchopulmonary dysplasia, etc.  
Obstructive SDB is characterized by partial or complete upper airway obstruction and 
includes a spectrum of conditions ranging from primary snoring (PS) to upper airway resistance 
syndrome (UARS) to evident apneas with repeated arousals and intermittent hypoxia, as seen 
in obstructive sleep apnea syndrome (OSAs). Since the first identification of sleep apnea in 
children by Guilleminault et al. in 1976 [26], SDB and OSA have been found to be associated 
with cardiovascular and metabolic (e.g., hypertension) [27], growth (e.g., failure to thrive) [28], 
neurocognitive (e.g., low academic performance) [29], and neurobehavioral (e.g., inattention, 
hyperactivity, impulsivity, aggressivity, and poor executive functions, communication, and 
adaptive skills) [30,31] morbidities during childhood or adolescence. Even primary snoring 
itself, without other symptoms or polysomnographic findings, has been shown to be associated 
with adverse neurocognitive and neurobehavioral outcomes as well as cardiovascular sequelae 
that are linked with systemic inflammation [31].  Recently, preterm birth has been recognized 
as a risk factor for both sleep disordered breathing (group-age 8 – 11) and obstructive sleep 
apnea (group-age 2.5 – 6) in prepubertal children [32,33].   
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Anatomical factors contributing to upper airway obstruction include: nasal septum deviation, 
allergic rhinitis and chronic nasal obstruction, craniofacial anomalies, adenotonsillar 
hypertrophy, obesity, cleft palate following pharyngeal flap surgery, etc.  
Adenotonsillar hypertrophy is the first-line treatment target for childhood SDB and OSA. 
However, craniofacial anomalies, instead of adenotonsillar hypertrophy, are important factors 
that caused of OSA in infants [33-35]. Craniofacial anomalies are hypoplasia or displacement 
of the maxilla or mandible, such as midface hypoplasia, micrognathia (small mandible), and 
glossoptosis (posterior tongue displacement), which commonly contribute to OSA in infants 
with Down syndrome [36] or Pierre Robin sequence [37] as examples. High and narrow-arched 
palate associated with narrow nasomaxillary complex is also an important craniofacial 
abnormality that gives rise to OSA [25,38], as seen in Apert syndrome [38] Reduced nasal 
breathing is accompanied by open mouthed breathing, which exposes the tonsils to abnormal 
stimulation and subsequently leads to their local inflammation and hypertrophy as hypothesized. 
Furthermore, mouth breathing and abnormal tongue positioning may give rise to impairment of 
maxillomandibular growth [38,39]. 
  The first 4 – 6 years of life are critical for maxillomandibular growth as 60% of the adult 
face is built during that period [39]. The consequent impairment of maxillomandibular growth 
further increases the risk of SDB.  
In 1998, Gozal first reported high prevalence of sleep disordered breathing (18.1%) among 
279 low performance (< 10 percentile) first-grade elementary school children [29]. To date, 
there is an abundant literature demonstrating the association of pediatric SDB and OSA with 
cognitive (mental) and behavioral problems [30,40-42]. But how sleep problems and early 
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developmental deficits interact in premature infants and young toddlers is still not extensively 
studied. We hypothesize that abnormal craniofacial development and narrow-high -arched 
palate in premature infants may play a major role in the development of SDB and may 
subsequently worsen any neurodevelopmental deficits. In this prospective study, we focused on 
the craniofacial development, presence of sleep problems, and neurodevelopment, trying to note 
the evolution of these three factors and their interaction during the post-natal growth of 
premature individuals. 
II-2. Study Purpose 
Our research aims at:  
1. Contributing to: 
(1) the understanding the development of abnormal upper airway in premature 
infants and abnormal breathing during sleep. 
(2) the understanding the craniofacial development and impact on occurrence of 
pediatric SDB. 
(3) evaluate the difference in development of full-term infants versus premature 
individuals. 
(4) finally investigating, from our cohort-data, the relationship between the 
SDB and the developmental problems that we could observe in our 
premature infants.  
2. To perform these tasks we had firstly to:  
(1) Develop an “infant sleep questionnaires” in Chinese version to use through 
our studies 
(2) Develop pediatric obstructive sleep apnea questionnaires in Chinese version 
to use in our study. 
(3) Our ultimate goal was to investigate the possible actions of pediatric SDB 
on neurocognitive dysfunctions in our children and is behind the protocols 
presented in our studies. Based on our findings we hope: 
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(4) To develop the biomarker for diagnosis and selection of treatment of 
pediatric SDB  
(5) To improve treatments of pediatric OSA. 
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l III. Literature Review 
 
III-1. Pediatric Sleep-Disordered-Breathing (SDB)  
Pediatric obstructive sleep apnea (OSA) was initially described in 1976 [26], and in 1981 
Guilleminault et al published a review of 50 pediatric patients [43] emphasizing that pediatric 
OSA was different from the clinical presentation reported in adults. The authors emphasized 
that these children had more disturbed nocturnal sleep than excessive daytime sleepiness, and 
presented more behavioral problems, particularly school problems related to attention deficit, 
poor school performance, hyperactivity, all symptoms classified as “attention-deficit-
hyperactivity syndrome”, nocturnal enuresis, sleep-terrors, sleep-walking, confusional arousals: 
symptoms classified as “NREM hypersomnias”, depression, insomnia and psychiatric problems. 
Cardiology-related symptoms were infrequent but tachybradycardia was regularly noted. 
Adenotonsillectomy (T&A) was performed and was successful in some but not all children, as 
shown well by follow-up studies; finally, a small group of children presented an abnormal 
weight increase post-T&A. These children presented apnea and hypopneas closely following 
the current polysomnographic definition.  
However, a year later, Guilleminault et al published a new report indicating that children may 
present the same chronic symptoms, but polysomnographic investigations performed with these 
children using esophageal pressure manometry showed absence of apnea and hypopnea, but 
presence of abnormal upper airway (UA) resistance with snoring of variable intensity [44]. In 
1982, many of the features presented today in reports on pediatric SDB were already clearly 
indicated but some of the raised issues still need further research, including recurrence post-
T&A, weight increase also post-T&A and the issue of having “sleep-disordered-breathing“ with 
similar complaints, symptoms and clinical findings at evaluation associated with and without 
snoring with very different patterns of abnormal breathing at the PSG evaluation. 
In the 1990s, the obesity epidemic started in the industrialized world and added a level of 
complexity. Two different syndromes were observed: a) obesity per se could lead to the same 
complaints and symptoms as OSA syndrome in a normal-weight child; b) obesity could lead to 
the development of OSA as a co-morbidity due to the deposit of fat in the tongue tissues and 
other UA muscles. The obese presentation could lead to a “chest-bellow syndrome” when supine, 
related to the abdominal fat deposit, and it could worsen the symptoms seen in a slim OSA child. 
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To attribute to obesity and OSA their respective responsibilities in the clinical presentation was 
difficult, particularly due to the fact that the children were often not seen early at time of 
development of the health problem but only after several years of evolution. 
 
III-2. Obesity and SDB 
Obesity is a complex disorder leading to worsening supine ventilation secondary to restrictive 
chest-bellows syndrome [45]. Obesity also leads to progressive fatty infiltration of the neck and 
UA. MRI studies have shown that a progressive fatty infiltration of the genio-hyoid and genio-
glossal muscles occurs along with dissociation of muscle fibers with fat cells [46]. Certain 
ethnicities, particularly African-American children, have a stronger association between obesity 
and SDB [47].  
Obesity is associated with a progressive dysfunction of the adipocytes. Pre-adipocytes 
differentiate into mature adipocytes and form adipose tissue in response to a positive energy 
balance. Adipose tissue not only stores energy, but also acts as a dynamic endocrine organ, vital 
for hormone and cytokine (adipokine) secretion. White adipose tissue (WAT), located in 
abdominal and subcutaneous deposits in mammals, performs the majority of energy storage and 
adipokine secretion [48]. Brown adipose tissue (BAT) mediates the non-shivering 
thermogenesis, well known to protect infants from cold exposure. Genetics play a role in the 
control and development of WAT and BAT. 
 Dysfunction of adipocytes leads to stimulation of adipokines, particularly TNF-alpha and 
interleukins 6 and 1. These defects lead to pivotal inflammatory responses, both local and 
general, in addition to abnormal secretion of peptides found not only in the adipocyte, but also 
in the gut and brain. Peptides such as leptin, adinopectin, obesin, etc., are involved, and 
dysfunction of the adipocytes leads to leptin resistance and ghrelin dysfunction. These two 
peptides are crucial to food intake, insulin resistance, and dysregulation of glucose and lipid 
control [48]. Overweight and obese individuals, with or without SDB, will develop these 
dysfunctions. The consequences of these abnormalities affect the cardiovascular, respiratory, 
metabolic, and cerebral systems. Sleep fragmentation, which occurs with abnormal breathing, 
will cause changes in metabolic controls in part through the process of epigenetics, by which 
environmental events trigger a genetic cascade that would not have otherwise occurred. Obesity 
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along with fatty infiltration of the UA will always lead to SDB from simple flow limitation to 
frank OSA. 
 
III-3. Non-overweight children and SDB: Why does the upper airway collapse during sleep 
in non-overweight children? 
The upper airway (UA) is a collapsible tube and the muscles that constitute its borders are 
inserted on bones that are part of the oral facial region. The muscles forming the limits of the 
UA are controlled by reflexes, and the reflex-loops call upon sensory receptors, sensory nerve-
fibers, brainstem neurons integrators, and a motor loop to act on these muscles. During sleep, it 
was shown that many of these reflexes are attenuated or even non-functional at times, 
particularly during Rapid-Eye-Movement (REM) sleep. This leads to an increase in the risk of 
collapse during sleep as compared to wakefulness. Studies looking at the laws of physics that 
govern the airflow in the UA have determined that fluid-dynamics-physic-laws can be applied 
to investigate the changes in UA airflow [49]. 
 One of the features impacting the UA is its dynamic airway collapsibility.  The abnormal 
collapsibility in both children and adults has been related to the different stages of sleep, which 
cause fundamental modifications to the pharyngeal muscle tone and reflex responses.  Other 
factors have also been considered, including one’s position during sleep.  
Given that sleep usually occurs in a recumbent position, both intrinsic and extrinsic factors 
affect its collapsibility: The upper airway (UA) has an intrinsic collapsibility that is studied via 
evaluation of the “critical pressure”, [50,51] while extrinsic factors may lead to increased overall 
collapsibility.  
Three external factors that impact the retropalatal and retroglossal space of the UA have been 
firmly established: (a) UA fat deposit, (b) non-fat related hypertrophy of UA tissues in which 
chronic inflammation is a participant, and (c) craniofacial features impacting UA size, and 
possibly related to genetic and environmental factors.  
 
l Monkey Experimental Investigation 
Historically, orthodontists performed fundamental experimental studies in the 1980s on new-
born Rhesus monkeys [20,22,52]. These experimenters placed a soft hollow cone silicon plug 
filling the nares and held in position by a silk ligature. The emphasis of the study was on the 
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orthodontic changes, and sleep was not monitored. However, it became evident that the great 
increase in nasal resistance had a dramatic impact on the naso-maxillary and mandibular 
skeleton leading to a halt in the growth and development of abnormal maxilla and mandible, 
and to adaptive changes in soft tissues that were associated with deviation in jaw posture and 
tongue activity. Systematic recording of orofacial muscles, including the genio-glossus and 
genio-hyoid muscles, demonstrated that such abnormal nasal resistance led to abnormal electro-
myographic (EMG) activity with induction of an abnormal rhythmic discharge pattern compared 
to control animals. This pattern was slowly reversible once the nasal resistance was eliminated. 
The experiment showed that in these growing monkeys, the nose is progressively occluded with 
increase in nasal resistance, and an adverse effect is seen on the morphology of maxilla and 
mandible. Moreover, this adverse effect is associated with changes in the EMG activity of 
orofacial muscles [20,22,52]. 
 
l Cranio-facial Growth 
The earliest form of the face appears in the fourth week of life of fetal development. Migration 
of cranial neural crest cells into developing facial prominences is an important step in fetal 
development and the family of Homeobox or HOX genes (n=39) play a major role in the 
development of the end tissue [38]. By the ninth week of fetal development, the initial 
cartilaginous facial skeleton is well established and by the twelfth week of fetal growth, areas 
of ossification appear and bone rapidly replace the cartilaginous template forming the early 
cranial base. At the same time, the bones of the cranial vault and of the mandible and maxilla 
develop through intramembranous ossification [53,54].  Post-natal development is rapid. The 
head that represent nearly a quarter of the child’s length at birth decreases to about 12% at 
adulthood. 60% of the adult face is developed by 6 years of age, with maximum growth between 
birth and 2 years of age.  
During infancy and early childhood, the cranial base increases in length through endochondral 
ossification that occurs at important growth sites called synchondroses (growth centers). Two 
of these growth centers, the” intermaxillary synchondrosis” and “alveolo-dental ligament”, are 
active until close to the end of puberty. The growth of the cranial-base is the initial engine of 
the facial growth through enchondral ossification. The maxilla and mandible are pulled down 
and forward by the soft tissues on which they are attached. However, if the maxilla benefits 
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from growth at the mid-palatal suture and from growth of the alveolar process that accompanies 
tooth eruption, the mandible lacks an open suture and grows mostly through enchondral 
ossification at the condyles. The dental-alveolar structure develops with eruption of the teeth, 
and the maintenance of the occlusal contact is an important element related to vertical ramus 
growth [55-57]. 
 
l Nasal Breathing and Mouth Breathing 
At birth, an infant is an obligatory nose breather. Beginning in the 1960s, important attention 
was given to the development of nasal breathing early in life. Planas [58] indicated that the 
normal airflow through the nose can be considered a “praxia” that develops very early in life. 
That is, nasal ventilation provides direct feedback on the thoracic ventilatory movements. The 
nasal airflow-thoracic-ventilatory movements involved a complex series of reflexes with 
engraving in the motor cortex. The lack of normal nasal breathing coupled with thoraco-
abdominal ventilation leads to deficiencies in the development of normal breathing and lack of 
learning to adjust between the amplitude of the thoraco-abdominal ventilatory movements and 
the nasal resistance.  It was found that normal nasal ventilation is critical for the normal 
development of the sinuses. But investigation of a deviated septum or presence of enlarged 
adenoids close from birth showed that nasal breathing has an impact on skeletal oral-facial 
development [59-63]. This is particularly important because, as mentioned above, the face 
grows extensively between birth and 2 years of age.  
The skeletal changes noted involved the anterior part of the nasal fossae. In this anterior portion, 
a slight elevation of the floor of the nasal cavity was found to be related to normative bone 
resorption and an abnormal narrowness to the transversal lower part of the pyriform aperture, 
which impacts the anterior part of the maxilla. This impact on the maxilla, in turn, leads to a 
malposition of the superior incisive, and such malposition has a negative feedback on the growth 
of the anterior part of the maxilla and the nasal fossae. Abnormal nasal flow also leads to a 
dysfunction of the deciduous canine that may lead to a malposition of the permanent canines. 
The skeletal changes also involve the posterior part of the nasal fossae. The impairment of the 
nasal flow impacts the normal periosteum resorption and this absence of resorption limits the 
normal lowering of the inferior part of the nasal fossae. Finally, abnormal nasal flow also leads 
to a narrowness of the transversal section of the nasal fossae and to an abnormal sagittal growth 
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of the maxilla (i.e., an inconstant impairment of the development and expansion of the maxillary 
sinuses). The narrowness of this transversal section may have an impact on the normal 
development of the 3rd molar later on [59-63]. 
Abnormal nasal airflow was shown to affect the palate and its maxillary-alveolo-dental 
development [59,62,63]. The development of the palate is impacted in 3 dimensions: 
 First, there is an abnormal vertical development with appearance of a high, ogival vault. 
Secondly, a narrowness occurs whereby the palate forms an extreme V-shape and the 
narrowness involves both the part of the palate at the level of the nasal fossae and the lower part 
located under the sinus. It was noted that if the nasal obstruction is predominant on one side, 
there is an asymmetry of the palate vault with deviation of the ogival arch toward the hypoplastic 
nasal fossa. Such changes have an impact on teeth orientation: with an oblique teeth direction 
on one side with the least impairment and a vertical development on the other side [59]. 
 Finally, there is a sagittal impact leading to development of a small maxilla. Such changes 
interfere, as mentioned above, with the maxillary dental arch growth, which will disturb the 
mandibular dental arch development secondarily. In particular, the changes lead to the 
disappearance of the diastasis (or interspace) between the deciduous incisive teeth, which in turn 
interferes with the placement of the permanent teeth. 
 
l Other early-in-life functions involving the oral cavity  
Nasal breathing is not the only function that has a very important role on the oral-facial 
development.  Coordination between nasal breathing and sucking must also develop very early 
in life. This is very apparent with breastfeeding, but also necessary with bottle-feeding. Sucking 
and swallowing are very coordinated activity that starts during the last trimester of gestation, 
and appropriate nasal breathing is important for these activities. Such coordinated actions (e.g., 
breathing and sucking) play a role in the stimulation of the structures involved in maxillary 
growth early in life. Mastication between 6 to 12 months of age is an added stimulus for such 
growth and involve a cortico-geniculum pathway and development of “active swallowing” on 
the top of the “swallowing reflex” involving only brain-stem neuronal networks. Anomalies in 
these functions will increase the risk of abnormal development of the bone structures supporting 
the UA leading to an increased risk of collapsibility of the UA during sleep [64]. 
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To maintain a UA lumen that avoids the risk of collapsibility during sleep means appropriate 
orofacial development during childhood. 
We question if specific risks factors for the occurrence of SDB exist early during postnatal 
development, and if these risk factors can be identified in children developing OSA.  
 
l Short lingual frenulum and oral-facial development  
We have already reported several factors that impact normal growth of the oral-facial structures 
leading to the development of OSAS in both children and adults. Another risk factor which has 
not yet been linked to the development of OSAS is “a short lingual frenulum “. Normally at 
birth, the tongue is placed high in the palate, and its continuous activity related to sucking, 
swallowing and masticating induces stimulation of the intermaxillary synchondrosis [65], which 
is active until 13–15 years of age, leading to normal oral-facial growth. Normal nasal breathing 
is associated with this tongue position. A short lingual frenulum has been associated with 
sucking and swallowing difficulties early in life, leading to “clipping” of the frenulum in the 
newborn [66-69]. In older children speech difficulties have been related to an untreated short 
frenulum [69-71]. It was also shown to lead to mouth breathing with modification of the position 
of the tongue and secondary orthodontic impacts resulting in an anterior and posterior crossbite, 
a disproportionate growth of the mandible and an abnormal growth of the maxilla [69,71,72]. 
All these anatomical changes impact the size of the upper airway and increase the risk of its 
collapse during sleep. But the association between a short lingual frenulum and OSAS is 
currently often unrecognized. “Clipping” of the short lingual frenulum is still proposed when 
difficulties are recognized during very early infancy, but if a simple clipping is performed after 
the first few months of life, the long-term results are reported as unpredictable, with persistence 
of an abnormal short lingual frenulum due to fibrosis occurring on the clipped abnormal vestigial 
tissue. [Our study presented here, investigated the association between a short lingual frenulum 
and OSAS in children and results of limited treatment.]  
In summary: To maintain a UA lumen that avoids the risk of collapsibility during sleep means 
appropriate orofacial development during childhood. Moreover, early recognitions of these 
factors may potentially lead to early interventions aimed at preventing OSA from occurring. 
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III-4. Neurodevelopmental dysfunctions in prematurely born neonates 
The prevalence and risk factors of neurodevelopmental sequelae, such as cerebral palsy, 
kernicterus, hearing loss, and cognitive deficiencies are the major topics of premature infants 
[73-75]. However, prematurely born neonates without major neurological deficits have been 
proven to be at higher risk of developing subtle neuromotor dysfunctions, such as difficulties 
with gross motor skill, social contact, or learning [76]. The frequency of these minor 
neurodevelopmental dysfunctions (MNDs) is usually assessed in early childhood (age 2-6 years) 
[73,75-77], and assessment of the quality of general movement during this period is found to be 
a powerful instrument to predict later neurological and behavioral developmental difficulties at 
school age [78-80].  Given the fact that the most common disability of premature infants at 2 
years of age is developmental and cognitive impairments and these assume great significance at 
their school years, it is imperative to understand the prevalence and risk factors of these 
disabilities. Besides, few studies have provided data related to neurodevelopmental outcomes 
of late-preterm infants [81-83], and it is unknown whether these MNDs can be detected at earlier 
age of young infancy.  
The aim our present study was to determine the prevalence of MNDs and cognitive and motor 
functions at 6 months corrected age in a cohort of premature neonates, and also to investigate 
which neonatal factors are associated with MNDs, and to figure out if MNDs in these high-risk 
neonates is associated with pediatric SDB. 
 
III-5. Neurocognitive function and pediatric SDB  
OSA not only affects cardiovascular functions and growth problem but also causes behavioral 
and cognitive dysfunction in children [84]. But the mechanisms involved are still unknown. 
OSA syndrome affects the sleep and neurocognitive functioning of children [44,85-87] 
including symptoms of attention deficit/hyperactivity disorder [44,87]. Pediatric OSA results in 
long-term effects on children’s health and development [88-90]. The factors involved in the 
decrease in cognition, learning and memory are still incompletely chartered. In our study we 
investigated some of the pathophysiology of the cause and the effect of cognitive dysfunction 
and pediatric SDB. 
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(1). Pediatric OSA and inflammatory cytokines  
 
There is an interaction between OSA and chronic diseases [91-93]. The most acceptable 
hypothesis associates occurrence of chronic systemic inflammation with OSA [94-96]. Increase 
in pro-inflammatory cytokines (C reactive protein (CRP), tumor-necrotic-factor (TNF-α), 
interleukines (IL-6, and IL-10) in adult OSA patients and high-specific C reactive-protein (HS-
CRP) in pediatric OSA patients) supports this hypothesis [96-98], with a possible association 
between the apnea-hypopnea-index (AHI) and inflammatory cytokine levels. The inflammatory 
responses may be reversed after OSA treatment [99,100]. In the recent past, advances in our 
understanding of the precursors of some of the measured cytokines have occurred. Also very 
recently, the discovery of functional lymphatic vessels lining the dural sinuses and expressing 
the molecular hallmarks of lymphatic endothelial cells and carrying fluid and immune cells from 
the cerebrospinal fluid with connection to the cervical lymphatic nodes, has been reported [101]. 
 
(2). The pro-inflammatory cytokines IL-17 and IL-23   
 
The pro-inflammatory cytokines IL-17 and IL-23 have been recently emphasized. IL-17 is a 
pro-inflammatory cytokine secreted predominantly by T helper 17 cells (TH 17) and various 
cells including innate immune cells and non-immune cells [98]. It is referred to as IL-17A as it 
is a member of the IL-17 family [102]. The IL-17-producing cells secrete IL-17A and another 
family member, IL-17F, under the stimulation of cytokines such as IL-1, IL-6, and IL-23 
secreted by antigen-presenting-cells (APC) in response to antigen stimulation [102,103]. The 
interaction is as follow: IL-17A and IL-17F form homodimers or heretodimers that bind to the 
IL-17 receptor complex on inflammation-related cells such as macrophages, epithelial cells and 
endothelial cells [104,105]. The activated inflammatory cells produce various cytokines 
including IL-1, IL-6 and TNF-α. The stimulation of these cytokines and inflammatory cells 
leads to inflammatory responses such as neutrophil recruitment, tissue destruction and 
neovascularization. The overreacted immune responses resulted in autoimmune diseases and 
allergy. During inflammation, expression of IL-17 and IL-17F is upregulated [104,105], with 
expression of high levels of IL-17 in patients with severe allergy, chronic inflammatory diseases 
and autoimmune diseases [105,106]. IL-17 also takes part in neutrophilic inflammation in the 
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respiratory system [106,107], and leading to chronic inflammation of the airway [107]; as 
example there is high expression level of IL-17F in asthma [108]. IL-17 has been linked to adult 
OSA: there is an up-regulated Th17/T-regulatory –Treg-cell ratio, and an overexpression of IL-
6 and IL-17 in plasma cytokine suggesting that the imbalance of Th17/Treg and the 
microenvironment created by over-secreted pro-inflammatory cytokines contribute to the 
development of OSA [109]. In OSA children, cytokine profile obtained from tonsils shows high 
levels of IL-1b, IL-10 and IL-17A production, indicating a T cell activation in response to local 
inflammation [110].   
IL-23, is a cytokine with immunomodulatory effects [111]. It acts on memory-cluster –
designation-4(+) T-cells, activates the transcription activator, and stimulates the production of 
interferon-gamma [112,113]. Studies showed that TH17 cells can be regulated by IL-23 [114].  
Factors leading to cognitive changes in children with OSA are still subject of research: sleep 
fragmentation, hypoxemia, hypercapnia, change in cerebral-blood-flow may be involved, 
Inflammatory cytokines may also play a role.  
We investigated interleukins 17 and 23 and cognition changes in children, we hypothesized that 
chronic inflammation not only causes cardiovascular diseases in pediatric OSA patient, but also 
affect cognitive functions and we wondered if a correlation between psychometric test and these 
cytokines could be shown [98]. A previous study had found a relationship between abnormal 
level of C-reactive protein and cognitive dysfunction in school age children but investigation of 
interleukins 17 and 23 will give a much more important view on the inflammatory status present 
in children with OSA and potential correlations with specific cognitive testing.  
We prospectively examined whether the plasma levels of the inflammatory cytokines are altered 
in children with pediatric OSA related to enlarged T&A and we simultaneously surveyed  the 
changes of neurocognitive tests: We investigated the potential relationship between increase in 
inflammatory cytokines and neurocognitive functions investigated by psychometric tests, 
correlating the level of CRP, TNF-α, IL-1, IL-2, IL-6, Il-10, IL-17 and IL-23 with 
polysomnogram-PSG- results and neurocognitive test findings. 
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l IV. Methodology 
IV-1. Study Process: 
Ethics: 
The study was approved by the Chang Gung Hospital and Medical College Ethic Committee. 
All parents of the included infants signed an informed consent. 
Subjects:  
(1) Number of subjects: A total of 400 infants (300 preterm and 100 full term infants) were 
eligible for inclusion in this study. The study included in the conditions of a total of 300 
premature infants. (Effect = 0.25, a = 0.05, power = 0.95, total sample size = about 180. 
Considering the long-term drop-out rate is about 40%, so 300 premature infants were included). 
(2) Inclusion criteria: 
(a). Study group A: All neonates born in our hospital before 37 completed gestational weeks, 
without presentation of exclusion criteria (temporary intubation of premature children can still 
be included in the study) comprised the preterm group.  
(b). This group of premature babies will be divided into two groups according to the “high and 
narrow hard palate”, one group is "high and narrow hard palate" group A1, the other group is 
no "high and narrow hard jaw" group A2. 
(c). Normal full term group: We also included 100 neonates that delivered at 37 to 40 weeks of 
gestational age with birth body weight of more than 2500 grams, without presentation of 
exclusion criteria comprised the normal “full-term-infants group”. 
(d). All parents had to sign consent form during the study period. 
(3) Exclusion criteria: 
(a). The neonates with severe physical impairments (such as severe congenital heart diseases, 
DiGeorge syndrome, congenital hydrocephalus and kernicterus) due to perinatal insults or 
hypoxic ischemic encephalopathy.  
(b). We also excluded bronchopulmonary dysplasia or requirement of oxygen support (nasal 
canula) after discharge. 
(c). Neonates with confirmed severe congenital malformations were excluded. 
(e). Parents that cannot sign the informed consent and cannot be involved in systematic 
following. 
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(f). Subjects judged by the investigator to be inappropriate as a subject of the study.  
 
Duration: 2009.01.09 to 2016.01.09. 
Procedure: 
(1). Visit 1: Infants who meet the inclusion criteria had an oral photography within 48 hours of 
birth (included the photo of upper hard and soft jaw, tongue and uvula part). Physical (PE) and 
neurological (NE) examination was performed at the same time by experienced neonatal 
pediatrician. 
(2). Visit 2: The same procedure for photography, PE and NE was followed at 3 months after 
birth. In the same time Parents were asked to complete the Children's Sleep   Questionnaires. 
(3). Visit 3 to 14: The same procedure of photography, PE and NE was followed at  
6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 42 months, 48 months, 54 
months, 60 months, 66 months and 72 months after birth.  
Parents were asked to complete the Children's Sleep Questionnaires, Sleep Log and 
developmental, emotional and behavioral questionnaires. In the same time, experienced 
pediatric psychiatrist routinely performed the developmental assessment (such as DDST), and 
pediatric psychologists performed Bayley test (or WPPSI and WISC test) every year.  
(4). Sleep assessment: sleep focused interview, portable actigraphy-watch, night 
polysomnography (PSG) were performed every year. 
(5). Craniofacial 3D-CT or cephalometric X ray was performed at the age of four, five and six 
years old. 
(6). The collected craniofacial and oral pictures were sent to Stanford Sleep Center and the 
Department of Craniofacial Surgery (in a blind) to score blindly the palate and craniofacial 
profile. 
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IV-2. Framework:  
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
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IV-3. Study Flux diagram:  
 
The following diagram shows the number of children, both included and lost for follow up in 
each evaluation time point  		T0m											 							T6m																										T12m																					T	24m																							T	36m																						T	48m																						T	60m																	T72m	n=392							n=367													n=334											n=290													n=258														n=215								on	going																												loss	=25									loss=58								loss=102								loss=134								loss=177	
 
IV-4. Research Instruments:	
 
(1). Infant Polysomnography: Development of a Pediatric Sleep Lab in Taiwan 
 
All our studies involved monitoring of sleep, a particularly arduous task the younger and the 
more premature the child is, and the presented data took several years to collect and to process, 
and implied the development from scratch of a Pediatric Sleep Lab in Taiwan.  
The recording protocol was the same over-time: 
Monitoring of sleep means that polysomnography –PSG-was systematically performed in the 
laboratory.  
PSG was always performed following the recommendations of the American Academy of Sleep 
Medicine-AASM [115]. The following variables were systematically monitored: 4 EEG leads 
referred to the contra-lateral mastoid: F1-M2, C3-M2, C4-M1, O1-M2 (2 extra channels were 
placed- F2-M1 and O2-M1- to be able to monitor these brain-regions if the initial recordings 
showed technical problems during the long-sleep related-recording) 2 eye-leads (E1-M2, E2-
M1) 3 chin-EMG (right, central and left) with possibility of monitoring chin EMG between 2 of 
these electrodes. We also monitored leg (right and left) muscle contractions (tibial anterior EMG) 
and intercostal/diaphragmatic activity. Respiration was monitored using nasal cannula-pressure 
transducer, mouth thermistor, thoracic and abdominal respiratory inductive plethysmography 
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bands, finger-oximetry, and a neck sound recording device. Children were continuously video 
monitored during the recording; mother were always present during recordings.  
 
Example of a 30 seconds of a PSG recording during stage 2 NREM sleep in a snoring child 
with a montage as indicated above. 
 
(2). Actigraphy:  
 
All infants were set up with an actigraph (Philips Respironics actiwatch 2, with a small size 
well-suited for use with younger subjects or those sensitive to wrist-worn devices) on the left 
leg of the non-dominant side. The equipment measured body movements and light exposure. It 
was placed on the infant at the time of the visits and kept for 7 days, and was analyzed with 
commercially available software with one point every 2 minutes and indicated activity/non-
activity. The equipment was correlated with a log simultaneously kept by care-givers. Therefore, 
actigraphy data can be analyzed in many ways including estimation of PSG endpoints such as: 
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total sleep time, wake after sleep onset, sleep latency sleep efficiency, and movement during the 
night. Moreover the daytime activity and circadian rhythms can also be evaluated [116]. 
(3). Development of Chinese-version of Infant Sleep Questionnaire: “Brief Infant Sleep 
Questionnaire-Chinese version,” (CBISQ): (published article # 1) 
(a). The Brief Infant Sleep Questionnaire (BISQ) [117] was developed by Avi Sadeh. The 
original BISQ had 13 items distributed in 3 categories, evaluating sleep duration, night 
awakenings, and method of falling asleep of infants aged 29 months or younger. It was found 
to be correlated significantly with sleep measures derived from actigraphy 
and sleep diaries. BISQ measures (number of night wakings and nocturnal sleep duration) were 
the best predictors for distinguishing between clinical and control samples. High test-retest 
correlations (r >0.82) were demonstrated for BISQ measures for a subsample of 26 infants. The 
study demonstrated that BISQ measures derived from a large Internet survey provided 
developmental and sleep ecology-related findings that corresponded to the existing literature 
findings on sleep patterns in early childhood. [117]. 
(b). To validate the Chinese version of the BISQ:  
First, we translated and then back-translated the BISQ from English to Chinese. Following this, 
it was translated back to English simultaneously by two bilingual individuals until the versions 
were considered completely interchangeable conceptually and linguistically. 
 2nd step, we originally signed up 229 premature infants from the PICU, but only 191 (83.41%) 
completed the study when they were 6 months old. The 191 6-month-old premature infants in 
the preterm infants group comprised 99 boys and 92 girls with an average birth body weight of 
1646.66 g. The average gestational age was 31.52 weeks, with a maximum of 36 weeks and 
minimum of 24 weeks. There were 68 6-month-old infants in the full-term infants group, 
including 34 boys and 34 girls with an average birth body weight of 3169.69 grams and average 
gestational age of 38.35 weeks. (The small group (n = 68) of full-term infants (the “controls”) 
whose parents signed the consent form underwent a similar evaluation and was studied the same 
way as the premature infants). Then we did the test-retest study for Chinese version of the BISQ 
to check the reliability of CBISQ.  
3rd step, all parents completed the BISQ-Chinese version and sleep diaries. At the same time, 
all premature infants were submitted to one night of polysomnography (PSG) in the sleep 
laboratory and also were set up with an actigraph kept for 7 days.  
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4th step, to confirm CBISQ is a reliable and valid tool for sleep measurement, the statistical 
software package SPSS, Version 18 was used for data analysis. Variables are presented as either 
mean ± standard deviation (SD) or frequency. We used the t-test and Chi-square test for 
evaluation of differences between these 2 groups. The Pearson correlation coefficient was used 
in analysis of correlation between questionnaire and sleep Lab data. The statistical significance 
was defined at the 0.05 level. 
 
(4). Development of Chinese-version Pediatric Obstructive Sleep Apnea Questionnaire: 
Chinese version OSA-18 (published article # 2) 
 
To develop a questionnaire with good reliability that allows early detection of symptoms and is 
easy to use in the follow-up of pediatric OSA is clearly important, but such an instrument in 
Chinese is very few. Therefore, to validate empirically the Chinese version of the OSA-18 and 
to evaluate its ability to screen the effect of treatment of OSAS children is important. Moreover, 
we aim at analyzing the frequency of symptoms and finding the difference in symptom-reports 
of OSA between Asian and Caucasian children.  
(a). The OSA-18 is a questionnaire evaluating pediatric SDB that has been shown to possess 
satisfactory test retest reliability and internal consistency in English-speaking groups [118,119].  
The survey consists of 18 items grouped into 5 domains: sleep disturbance (4 items), physical 
suffering (4 items), emotional distress (3 items), daytime problems (3 items), and caregiver 
concerns (4 items). Items are scored on a 7-point ordinal scale and have excellent test-retest 
reliability (R _ 0.74). The overall survey score is calculated as the mean of the 18 items, which 
correlates significantly with the respiratory distress index (R _ 0.43) and adenoid size (R _ 0.43). 
It also provides a direct global rating of SDB-related quality of life (QOL) via a 10-point visual 
analogue scale with specific semantic anchors. Therefore OSA-18 is designed for screening 
OSA syndrome and it has good test-retest reliability and construct validity and can be used for 
screening OSA syndrome [118,119]. 
(b). To validate the Chinese version of the OSA-18:  
First step, we got the permission to translate the OSA-18 into Chinese before the start of the 
study. English version into Mandarin Chinese by one of the investigators. Following this, it was 
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translated back to English simultaneously by two bilingual individuals until the versions were 
considered completely interchangeable conceptually and linguistically. 
 2nd step: The participants in the study were recruited from kindergarten and school settings. We 
contacted the school counseling centers and explained to teachers the purpose of the study and 
necessary procedures. All eligible children and their respective parents were informed that 
participation in the survey was completely voluntary, and thereafter parental approval and 
signed informed consent were obtained. In all, 191 children were recruited. A package of 
questionnaires, including the OSA-18 and basic demographic questions, was completed by the 
parents (or caregivers). The OSA-18 was given again 4 weeks later to obtain re-test data. 
Participants with missing data or who did not complete the questionnaire twice were excluded 
from the study (n=28); 163 children (school group) completed the study. The ratio of gender 
had no significant difference either. 3rd step, the clinical participants included 88 children with 
OSA (apnea–hypopnea index (AHI) >1/hour) who were treated with TA and were followed up. 
The participants and their respective parents were informed that participation was completely 
voluntary, and thereafter parental approval and signed informed consent were obtained. The 
patients were recruited from a sleep disorder center in a children's hospital, and were diagnosed 
by a pediatric psychiatrist and a pediatric department of otolaryngology, both with expertise in 
pediatric sleep medicine. OSA syndrome was diagnosed based on clinical interview and clinical 
evaluation followed by one nocturnal PSG recording. Using the International Classification of 
Sleep Disorders Second Edition (ICSD II) diagnostic criteria, 88 children presented symptoms 
and clinical features associated with OSA and had an AHI >1/h associated with breathing-
related arousals or oxygen desaturation in one nocturnal PSG recording. Once diagnoses were 
confirmed, a research assistant administered to the participants' parents a package of 
questionnaires consisting of the OSA-18 and demographic questions. The OSA-18 was 
administered again to those treated with TA at the 6-month post-treatment follow-up visit. To 
establish the construct validity of a measure, nomological validity was taken into consideration. 
We also used nomological validity to analyze the relation between QOL and the constructs for 
OSA-18 in the pretest and post-test.  
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(5). Neurodevelopmental assessments: 
 
(a). The Bayley Scales of Infant and Toddler Development (Bayley II and III) Test: Bayley test 
is the most widely used developmental assessment tools in preschool-aged children. It is 
considered to be an integrative developmental assessment that borrows from different areas of 
child development. The Bayley is now being used extensively in both clinical and research 
paradigms to diagnose the developmental delays and to determine subsequent qualification for 
early intervention services. The Bayley Scales of Infant Development-2nd Edition (BSID-II) 
consists of a mental score, which yields a Mental Developmental Index (MDI) and a motor score, 
which yields a Psychomotor Developmental Index (PDI). In 2006, the third edition, the Bayley-
III (3), was published which has separate cognitive and language scales. There are three domains 
“Cognitive “, “language” and “motor “in Bayley-III. The cognitive and language scores <85 or 
CB-III scores <80 provide the best correspondence with Bayley-II MDI scores <70, it means 
developmental delay [120,121]. 
(b). Denver Developmental Screening Test (DDST): DDST is used for developmental 
measurements in preschool children and consists of four subscales: personal-social contact, fine 
motor, language and gross motor. Each of them is scored as either passed or failed. For each 
category in the overall assessment, patients were considered to be developmentally delayed if 
they failed two or more considered to be developmentally delayed if they failed two or more 
test items that 75 to 90% of children of their age could pass or if they failed one or more test 
items that more than 90% of children younger than their age could pass. Otherwise, the 
development of the children was considered to be normal [122]. 
 
IV-4. Analytical Methods 
 
Statistical analysis: 
• SPSS 20th Edition for data analysis and processing was used. All p values are two-sided, and 
those less than 0.05 were considered statistically significant. 
• Demography data analysis of the gestation age, body weight and height, sex, endotracheal 
intubation, presence of feeding difficulties, tongue location, presence of "high and narrow 
palate", developmental problems, sleep problems and other characteristics of preterm infants 
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were present as a percentage. The Chi-Square test or Fisher exact tests were used for categorical 
data, and Student t test was used for continuous variables with normal distributions. The 
Wilcoxon/Mann-Whitney U test or the Kruskal-Wallis test were used for continuous variables 
without a normal distribution.  
• The relationship between developmental delay, neurological cognitive dysfunction and 
pediatric sleep problems was assessed by the Pearson correlation coefficient.  
• The relationship between the craniofacial profile such as” high and narrow hard palate” and 
the age and the sleep pediatric SDB was assessed by the Pearson correlation coefficient. 
• Multivariate analysis of gender, gestation age, craniofacial characteristics and other variables 
with "high and narrow hard palate" was performed to understand their interactions on the 
impact of pediatric SDB and also was used to determine the independent risk factors (Simple 
main effect mode, interactive mode analysis). 
• ANOVA was used to compare different variables in different groups in preterm infants and 
full term group. 
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l V. Results  
 
We created in Taipei (Taiwan) a prospective cohort of 300 infants born between 25 and 37 
weeks of gestational age. Three hundred children involved in the cohort have been followed 
until 24 months of age at the minimum. The cohort study is still on going. According to the 
preliminary data, we organize into several important reports. 
 
V-1. Development of the “ Brief Infant Sleep Questionnaire-Chinese version” and 
investigation of “ Sleep and breathing” in premature infants at 6 months post-natal age 
( # 1 article was published in BMC Pediatrics, 2014 )  
 
(A) Background 
Poor sleep contributes to the developmental problems seen in preterm infants. We evaluated 
sleep problems in preterm infants 6 months of post-gestational age using the subjective Brief 
Infant Sleep Questionnaire (BISQ) and objective sleep tests. Therefore, we had to develop a 
“Brief Infant Sleep Questionnaire-Chinese version” (CBISQ) questionnaire first.  
 
(B) Method 
The study included 68 6-month-old full-term healthy infants and 191 premature infants born at 
<37 weeks gestation. All parents completed the BISQ-Chinese version and sleep diaries. At the 
same time, all premature infants were submitted to one night of polysomnography (PSG) in the 
sleep laboratory and also were set up with an actigraph kept for 7 days. Statistical analyses were 
performed using correlation coefficients and the t-test with SPSS version 18 to compare 
questionnaire responses with other subjective and objective measures of sleep. 
 
(C) Results: 
(1) Demographic data 
We originally signed up 229 premature infants from the PICU, but only 191 (83.41%) completed 
the study when they were 6 months old. The 191 6-month-old premature infants in the preterm 
infants group comprised 99 boys and 92 girls with an average birth body weight of 1646.66 g. 
The average gestational age was 31.52 weeks, with a maximum of 36 weeks and minimum of 
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24 weeks. There were 68 6-month-old infants in the full-term infants group, including 34 boys 
and 34 girls with an average birth body weight of 3169.69 grams and average gestational age of 
38.35 weeks (Table 1). 
Table 1 Demographic data of the study subjects  
Preterm infants (n = 191) Full-term infants (n = 68) P value 
Gender Male n = 99 (51.83%) n = 34 (50%) 
 
Female n = 92 (48.17%) n = 34 (50%) 
 
Birth body weight (g) 1646.66 ± 588.60 3169.69 ± 410.58 <0.001* 
Birth body height (cm) 39.96 ± 5.11 49.61 ± 1.88 <0.001* 
Head circumference (cm) 28.88 ± 3.33 34.25 ± 1.24 <0.001* 
Gestational age (weeks) 31.52 ± 3.21 38.35 ± 1.43 <0.001* 
Birth body weight, Birth body height and Head circumference were all assessed at birth. 
 
(2) The test–retest reliability of CBISQ:   
The original BISQ had 13 items distributed in 3 categories, evaluating sleep duration, night 
awakenings, and method of falling asleep of infants aged 29 months or younger. To validate the 
Chinese version of the BISQ, we first translated and then back-translated the BISQ from English 
to Chinese. The test–retest reliability of the CBISQ was acceptable. There was significant 
correlation between the repeated sleep measures for location of sleep (r = 0.678*), preferred 
body position (r = 0.796*), nocturnal sleep duration (r = 0.534*), method of falling asleep (r = 
0.848*), difficulty in falling asleep (r = 0.785*), number of night awakenings (r = 0.439*), 
daytime sleep duration (r = 0.455*), and subjective consideration of sleep problems (r = 0.663*). 
In order to evaluate respiratory sleep problems compared with actigraphy and PSG, we added 3 
questions to the BISQ to create the CBSIQ version; these included “time spent with mouth 
breathing” (r = 0.568*), “severity of loud-noisy breathing” (0.760*), and “time spent crying 
during the night” (r = 0.206). 
(3) Validation of CBISQ (table 2): We compared the subjective CBISQ to other objective data 
obtained from sleep diaries, actigraphy and PSG data. These items of CBISQ showed sleep 
measures of “nocturnal sleep duration, number of night awakenings, daytime sleep duration and 
loud-noisy breathing” were significantly correlated with sleep diary, actigraphy and PSG. Items 
such as “mouth breathing” and “loud-noisy breathing” correlated with “total number of 
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obstructive apnea during sleep” in PSG. Longer “Daytime sleep duration” also correlated with 
AHI >1; We were interested in these correlations as “mouth breathing” and “Loud-noisy 
breathing” are common symptoms associated with pediatric obstructive sleep apnea. Moreover, 
higher AHI means severe OSA will interrupt sleep and increase night awakenings and then 
induce daytime sleepiness. Therefore, the trend in the correlation between “AHI” and “number 
of obstructive apnea” in PSG and “Daytime sleep duration” in CBISQ were important and 
meaningful. The additional questions in the CBISQ pertaining to respiratory sleep problems also 
were shown to correlate with PSG. 
The PSG data showed that 80.6% of 6-month-old premature infants had an apnea–hypopnea 
index (AHI) >1 event/hour (mean AHI = 3.63 ± 3.24), mean SaO2 97.01 ± 1.00%, total sleep 
time 368.83 ± 55.05 mins, sleep efficiency 82.43 ± 14.66%, and REM 24.03 ± 6.43% at 
polysomnography. 
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Table 2 Subjective and objective sleep problems of premature infants 
Questionnaire Objective sleep measure r P value 
CBISQ  
Nocturnal sleep duration 
Criterion of Sleep diary 
Nocturnal sleep duration 
 
0.757 
 
0.011* 
Number of night awakenings Nocturnal awake time 0.632 0.002* 
Numbers of night awakening 0.580 0.001* 
Nocturnal sleep efficiency −0.644 <0.001* 
Daytime sleep duration Daytime sleep duration 0.630 0.002* 
Loud-noisy breathing Daytime sleep duration 0.348 0.064+ 
CBISQ  Actigraphy Criterion 
  
Time spent with mouth breathing Awakening time during sleep 0.514 0.042* 
Nocturnal sleep efficiency −0.255 0.013* 
CBISQ  PSG Criteria 
 
Nocturnal sleep duration Nocturnal sleep duration 0.545 0.002* 
Number of night awakenings Desaturation index 0.636 0.003* 
Daytime sleep duration AHI in sleep 0.767 0.075+ 
Awakening after sleep onset 0.350 0.080+ 
Time spent with mouth breathing Obstructive apnea count 0.509 0.026* 
Loud-noisy breathing Arousal count 0.401 0.089+ 
Obstructive apnea count 0.535 0.018* 
*: P value < 0.05. +: P value < 0.10. 
AHI: Apnea-Hypopnea Index (events/hour); Desaturation index: desaturation events/hour; “Arousal 
count ” means total number of arousal during sleep ; “Obstructive apnea count” means total number of 
obstructive apnea during sleep. 
 
(4) Comparison of the differences between full-term and premature infants (table 3) 
Since our CBISQ was shown to be a reliable and valid tool for sleep measurement, we used the 
data to compare the differences in sleep between the preterm-infant and full-term-infant groups. 
The results revealed, as expected, a significant difference between the 2 groups: The premature 
group preferred a side body position and being held when falling asleep, had more night 
awakenings, greater subjective mention of presence of a sleep problem by caregivers, louder 
noisy breathing and more time spent crying during the night. Also, the premature infants had 
longer nocturnal and daytime sleep duration. 
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Table 3 Comparison of the preterm-infants group and the full-term-infants group using 
the CBISQ 
CBISQ Sleep measure Preterm infants Full-term infants P value 
Location of sleep Infant crib in a separate room 1.0% 0.0% - 
Infant crib in parents’ room 33.0% 33.3% 0.965 
In parents’ bed 64.9% 66.6% 0.828 
Infant crib in room with sibling 1.0% 0.0% - 
Preferred body position On his/her back 52.2% 51.0% 0.876 
On his/her side 37.7% 31.4% 0.397 
On his/her belly 10.1% 17.6% 0.193 
Nocturnal sleep duration (minutes, mean ± SD) 544.87 ±81.93 490.71 ±134.48 0.027* 
Nocturnal sleep-onset time# (mean ± SD) 2.61 ± 1.31 2.53 ± 1.02 0.782 
Method of falling asleep While feeding 19.8% 23.1% 0.555 
Being rocked 23.4% 21.5% 0.752 
Being held 24.8% 23.1% 0.769 
In bed alone 12.2% 12.3% 0.986 
In bed near parent 19.8% 20.0% 0.969 
Difficulty falling asleep# (mean ± SD) 2.47 ± 1.93 2.16 ± 1.71 0.494 
Number of night awakenings# (mean ± SD) 2.28 ± 0.93 1.72 ± 0.67 0.014* 
Daytime sleep duration (minutes, mean ± SD) 364.07 ±152.1 271.67 ±133.16 0.014* 
Subjective consideration of sleep problems# (mean ± SD) 1.53 ± 0.69 1.21 ± 0.54 0.024* 
Time spent with mouth breathing# (mean ± SD) 1.47 ± 0.57 1.20 ± 0.42 0.077+ 
Loud-noisy breathing# (mean ± SD) 1.88 ± 0.69 1.44 ± 0.51 0.010* 
Time spent with crying during night# (mean ± SD) 1.64 ± 0.71 1.26 ± 0.45 0.003* 
*: P value < 0.05. +: P value < 0.10. 
#: These questions were evaluated by severity, and scored from 1 to 4. 
 
(D). Summary of the study # 1:    
(1) CBISQ was shown to be a reliable and valid tool for infant’s sleep measurement. 
(2) Premature infants have more sleep problems than full-term infants (such as “nocturnal 
sleep duration”, “being held to fall asleep”, “number of nighttime awakenings”, “daytime 
sleep duration”,” loud-noisy breathing”, and “duration spent crying during the night”), 
also including the known risk of “abnormal breathing during sleep” at 6 months corrected 
age. 
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(3) PSG confirmed the presence of a very high percentage (80.6%) of premature infants with 
AHI > 1 event/hour at 6 months corrected age. 
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V-2. Minor neurodevelopmental dysfunctions at age 6 months in prematurely born 
neonates (#2 article published in Early Human Development,2013)  
 
(A) Background 
To investigate the 6-month neurodevelopmental outcomes of prematurely born neonates and 
find the determining neonatal factors of minor neurological dysfunctions (MNDs). 
 
(B) Method 
We examined data collected prospectively on 151 infants born before 37th week of gestation in 
2010 who were assessed at 6 months corrected age with the Bayley Scales of Infant 
Development-2nd Edition (BSID-II) and the Denver Developmental Screening Test (DDST). 
According to gestational age, the study subjects were analyzed separately into three cohorts: 
very preterm (GA ≦ 28 weeks), preterm (GA 29-32 weeks), and late-preterm (GA 33-36 weeks). 
The Chi-Square test or Fisher exact tests were used for categorical data, and Student t test was 
used for continuous variables with normal distributions. The Wilcoxon/Mann-Whitney U test 
or the Kruskal-Wallis test was used for continuous variables without a normal distribution. All 
p values are two-sided, and those less than 0.05 were considered to be statistically significant. 
Multivariate logistic regression was used to determine the independent risk factors of MNDs in 
preterm neonates. The following social and demographic characteristics were included in the 
analysis: mother’s nationality (foreign spouses, Taiwanese or aboriginal residences), maternal 
educational level (university level or not), SES, and mother’s age (<20, 20-29, or ≧30 years). 
Neonatal characteristics were determined from medical records as described above. Potential 
risk factors found individually significant at p ≦ 0.05 were entered together into a set of 
backward selection for choosing the most significant indicators. These variables were finally 
analyzed by multivariate logistic regression model adjusted for GA and birth body weight (BBW) 
after their collinear coefficients were checked by Collinearity Diagnostics. All statistics were 
performed using the commercially available software SPSS 18.0 for Windows. 
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(C) Results 
(1) Demographic data (table 1) 
Of all premature neonates whose parents were approached and signed the informed consent to 
participate this study, 151 neonates were completely assessed at 6 months corrected age. 
Seventy-eight percent (118/151) of the neonates had neurodevelopmental assessments between 
5.5 to 6.5 months corrected age; of the other 33 children, most were assessed before 7 months 
of corrected age. The neonatal and family characteristics of three cohorts, defined according to 
the gestational age, were summarized in Table 1. It worth noticing that most of the mothers were 
moderately educated and 80% of them were older than 30 years. Approximately one-fourth of 
children in the study were multiple births (twin, triplet, or higher order). Nearly 8.6% of the 
cohort was SGA and the rest was all appropriate for gestational age (AGA). The rate of neonates 
with an Apgar score ≦ 7 at 5 minutes was 29.1%. 
 
Table 1. Characteristics of 151 premature infants assessed at 6 months corrected age: 
total cohort, very preterm, preterm, and late-preterm infants 
 Total cohort 
(n=151) 
Very preterm cohort 
(GA ≦ 28 wks,  
n=37) 
Preterm cohort 
(GA 29-32 wks,  
n=53) 
Late preterm 
(GA 33-36 wks, 
n=61) 
Gestational age (wks), 
 median (range) 
32 (24-36) 26 (24-28) 31 (29-32) 34.5 (33-36) 
Birth body weight (g),  
median (range) 
1515 (582-
3935) 
890 (582-1595) 1430 (700-2620) 2135 (1085-
3935) 
Gender (male: female) 82: 69 19: 18 27: 26 36: 25 
Mode of delivery (C/S, n [%]) 110 (72.8) 19 (51.4) 40 (75.5) 51 (83.6) 
Maternal age     
  < 20 y/o, n (%) 3 (2.0) 1 (2.7) 0 (0) 2 (3.3) 
  20-29 y/o, n (%) 27 (17.9) 9 (24.3) 10 (18.9) 8 (13.1) 
  ≧30 y/o, n (%) 121 (80.1) 27 (73.0) 43 (81.1) 51 (83.6) 
Small for gestational age, n (%) 13 (8.6) 1 (2.7) 5 (9.4) 7 (11.5) 
5 min Apgar score ≦ 7, n (%) 44 (29.1) 26 (70.3) 12 (22.6) 6 (9.8) 
Prenatal betamethasone use, n (%) 106 (70.2) 35 (94.6) 50 (94.3) 21 (34.4) 
Postnatal dexamethasone use, n 
(%) 
12 (7.9) 9 (24.3) 3 (5.7) 0 (0) 
Multiple births, n (%) 40 (26.5) 7 (18.9) 17 (32.1) 16 (26.2) 
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Socio-economic status     
   High, n (%) 12 (7.9) 3 (8.1) 4 (7.5) 5 (8.2) 
   Middle, n (%) 113 (74.8) 26 (70.2) 41 (77.4) 46 (75.4) 
   Low, n (%) 26 (17.2) 8 (21.6) 8 (15.1) 10 (16.4) 
Maternal educational level     
   Master or higher, n (%) 8 (5.3) 3 (8.1) 1 (1.9) 4 (6.6) 
   University or Collage, n (%) 49 (32.5) 9 (24.3) 20 (37.7) 20 (32.8) 
   High school, n (%) 89 (58.9) 23 (62.2) 30 (56.6) 36 (59.0) 
   Below elemental school, n (%) 5 (3.3) 2 (5.4) 2 (3.8) 1 (1.6) 
Maternal Nationality      
   Normal residences, n (%) 142 (94.0) 33 (89.1) 50 (94.3) 59 (96.7) 
   Foreign spouses*, n (%) 5 (3.3) 2 (5.4) 2 (3.8) 1 (1.6) 
   Aboriginal residences, n (%) 4 (2.6) 2 (5.4) 1 (1.9) 1 (1.6) 
*Including woman from Mainland China 
C/S: Caesarean section delivery 
 
(2). Neonatal morbidity of premature infants: (table 2) 
The majority of the infants had respiratory difficulties at birth and required respiratory support 
during hospitalization in our NICU (table 2). 11.3% (17/151) of the neonates did not need any 
respiratory support. RDS, TTNB, and PPHN were diagnosed in 31.8%, 29.1%, and 3.3% of our 
neonates, respectively. BPD developed in one-fourth of infants, and 9.3% of neonates still 
required oxygen support (nasal canula) at discharge. As expected, the distributions of these 
respiratory difficulties were highly associated with their gestational ages. PDA was found near 
one-fifth of neonates, and three-fourth of those with PDA were treated surgically. Cranial 
ultrasound showed IVH in 25 (16.3%) neonates, and severe intracranial lesions (IVH grade 
III/IV or PVL) in 9 (6.0%) neonates. More severe ROP (stage II with plus disease or ≧ stage 
III) was present in 9.3% of the infants, and 7.3% of them required laser therapy. 
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Table 2. Neonatal morbidity of 151 premature infants during NICU admission 
 Total cohort 
(n=151) 
Very preterm 
cohort 
(GA ≦ 28 wks, 
n=37) 
Preterm cohort 
(GA 29-32 wks, 
n=53) 
Late preterm 
(GA 33-36 wks, 
n=61) 
Length of hospitalization (d), median 
(IQR) 
45 (24-74.5) 96.5 (73.7-123) 53 (39-65) 22.5 (14.5-30.8) 
Duration of ventilation (d), median 
(IQR) 
21 (5-51) 75 (53.5-97) 28 (12-44) 4.5 (0-12) 
Diagnosis of respiratory diseases     
   Respiratory distress syndrome, n (%) 48 (31.8) 28 (75.7) 17 (32.1) 3 (4.9) 
   TTNB, n (%) 20 (13.2) 1 (2.7) 12 (22.6) 7 (11.5) 
   Bronchopulmonary dyplasia, n (%) 38 (25.2) 27 (73.0) 11 (20.7) 0 (0) 
   PPHN, n (%) 5 (3.3) 2 (5.4) 1 (1.9) 2 (3.3) 
   Nasal nanula required at discharge, n 
(%) 
14 (9.3) 11 (29.7) 3 (5.7) 0 (0) 
Congenital heart disease     
   PDA (indomethacin/surgery), n (%) 23 (15.2)/7 (4.6) 15 (40.5)/5 (13.5) 6 (11.3)/2 (3.8) 2 (3.3)/0 (0) 
   ASD ± VSD, n (%) 16 (10.6) 1 (2.7) 6 (11.3) 9 (14.8) 
   Complicated CHD, n (%) 1 (0.7) 0 (0) 1 (1.9) 0 (0) 
IVH (Grade≦II/Grade III&IV), n (%) 19 (12.3)/6 (4.0) 8 (21.6)/4 (10.8) 5 (9.4)/2 (3.8) 6 (9.8)/0 (0) 
PVL, n (%) 4 (2.6) 2 (5.4) 2 (3.8) 0 (0) 
NEC (probable/definite), n (%) 4 (2.6)/3 (2.0) 2 (5.4)/2 (5.4) 2 (3.8)/1 (1.9) 0 (0)/0 (0) 
ROP     
Stage II with plus disease or ≥ stage 
III, n (%) 
11 (7.3) 4 (10.8) 7 (13.2) 0 (0) 
 Laser treatment required, n (%) 14 (9.3) 13 (35.1) 1 (1.9) 0 (0) 
History of neonatal sepsis     
   Early-onset neonatal sepsis, n (%) 1 (0.7) 1 (2.7) 0 (0) 0 (0) 
   Late-onset neonatal sepsis, n (%) 26 (17.2) 12 (32.4) 10 (18.9) 4 (6.6) 
   Rule out sepsis, n (%) 37 (24.5) 15 (40.5) 17 (32.1) 5 (8.2) 
Use of TPN, n (%) 108 (71.5) 37 (100) 48 (90.5) 23 (37.7) 
Cholestasis, n (%) 17 (11.3) 11 (29.7) 3 (5.7) 3 (4.9) 
IQR: interquartile range, TTNB: transient tachypnea of newborn, PDA: patent ductus arteriosus, ASD: atrial 
septal defect, VSD: ventricular septal defect, CHD: congenital heart disease, IVH: intraventricular hemorrhage, 
PVL: periventricular leukomalacia, NEC: necrotizing enterocolitis, ROP: retinopathy of prematurity, TPN: total 
parenteral nutrition 
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(3). The developmental evaluation results:  
In table 3 the median BSID-II scores and the results of DDST are presented. A MDI and a PDI 
of < 70 were noted in 6 (4.0%) and 20 (13.2%) of our study subjects, respectively. All six 
neonates with MDI < 70 were found to have PDI < 70. There are obvious trends of mental delay 
and psychomotor delay as gestation decreases, although the difference did not reach statistical 
significance. Extremely low birth weight (ELBW, BBW < 1000g) neonates accounted for half 
of those with psychomotor delay and the majority of mental delay (4/6, 67%) in our study 
population. By DDST, 22 (14.6%) infants had at least one of four categories of delay at 6-
months-old assessments; 2 had delay in all four categories, 5 had delay in two categories, and 
15 had delay in one category. The most common category of delay was gross motor skills, which 
was noted in approximately 13.2% infants. The results of DDST gross motor subscale and PDI 
were found to be highly corrected; among those who failed in the DDST gross motor subscale 
by examiners, all had a PDI below 70. No significant difference in the rate of 
neurodevelopmental delay was found between SGA children and AGA children. 
We determined which of the maternal sociodemographic or neonatal factors were associated 
with MND in the three cohorts. After combination of BSID-II and DDST, a total of 20 infants 
were found to have MNDs. None of the mothers’ social and demographic characteristics (as 
recorded at birth) were found to be significantly associated with MND.  
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Table 3. Bayley Scales of Infant Development-II: psychomotor and mental index scores 
and Denver Development Screening Test in preterm neonates at 6 months of corrected 
age 
 GA ≦ 28 weeks  
(n= 37) 
GA 29-32 weeks  
(n= 53) 
GA 33-<37 weeks  
(n= 61) 
BSID-II index    
  MDI, median (IQR) 98.0 (90.0-103.5) 97.0 (89.8-102.8) 96.5 (91.0-105.0) 
  MDI < 70 (n, %) 4 (10.8) 1 (1.9) 1 (1.6) 
  PDI, median (IQR) 85.0 (73.0-101.5) 88.0 (79.0-97.0) 91.5 (85.0-104.0) 
  PDI < 70 (n, %) 8 (21.6) 7 (13.2) 5 (8.2) 
DDST    
  Any delay, n (%) 8 (21.6) 9 (17.0) 5 (8.2) 
   Personal-Social delay, n 
(%) 
2 (5.4) 0 (0) 0 (0) 
   Fine motor delay, n (%) 2 (5.4) 2 (3.8) 1 (1.6) 
   Language delay, n (%) 4 (10.8) 2 (3.8) 0 (0) 
   Gross motor delay, n (%) 8 (21.6) 7 (13.2) 5 (8.2) 
BSID-II: Bayley Scales of Infant Development-II (Bayley 1993), DDST: Denver Development Screening 
Test, IQR: interquartile range, MDI: Mental Developmental Index, PDI: Psychomotor Developmental 
Index 
 
(4). The relationships between neonatal factors and the presence of MNDs: 
Table 4 shows the univariate analyses and the final multivariate models that explain the 
relationships between neonatal factors and the presence of MNDs. Several neonatal factors, 
including BBW, low Apgar score at 5 minutes and acute fetal distress in the delivery room, 
confirmed neonatal sepsis, chronic lung disease, cholestasis, length of mechanical ventilation, 
postnatal corticosteroid use, and the presence of ROP were found to be associated with MNDs 
of neonates at 6 months old. After multivariate logistic regression adjusted for GA and BBW, 
MND was independently associated with postnatal corticosteroid use (odds ratio [OR], 11.2; 
95% confidence interval [CI], 1.9-66.0, P= 0.008) and cholestasis (OR, 6.2; 95% CI, 1.16-33.1, 
P=0.033). Besides, neonates with BBW less than 1000g were significantly associated with 
MNDs when compared with those with BBW more than 2000g (OR, 51.4; 95% CI, 1.9-1369, 
P=0.019). 
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Table 4. Neonatal characteristics associated with psychomotor delay in 6-month-old 
neonates born preterm, with multivariate analysis comparing normal vs psychomotor 
developmental delay 
Characteristic Neonates, No. (%)  Univariate Analysis  Multivariate Analysis 
Normal  
(n=131) 
MND  
(n=20) 
 Crude OR 
(95% CI) 
P value  AOR (95% CI) P value 
GA, (weeks)         
   ≦28 29 (22.1) 8 (40.0)  3.1 (0.9-10.3) 0.066  10.0 (0.8-127) 0.075 
   29-32 46 (35.1) 7 (35.0)  1.7 (0.5-5.7) 0.389  17.4 (0.9-347) 0.062 
   33-36 56 (42.7) 5 (25.0)  1 (references)   1 (references)  
Birth body weight, (g)         
   <1000 18 (13.7) 10 (50.0)  22.2 (2.6-
186.9) 
0.004  51.4 (1.9-
1369) 
0.019 
   1000-1499 42 (32.1) 4 (20.0)  3.8 (0.4-35.6) 0.241  5.8 (0.4-79.8) 0.190 
   1500-1999 31 (23.7) 5 (25.0)  6.5 (0.7-58.1) 0.096  10.2 (0.9-106) 0.052 
   ≧2000 40 (30.5) 1 (5.0)  1 (references)   1 (references)  
SGA 12 (9.2) 1 (5.0)  0.5 (0.1-4.2) 0.543    
Male gender 68 (51.9) 14 (70.0)  2.2 (0.8-6.0) 0.137    
Caesarean section delivery 96 (73.3) 14 (70.0)  0.9 (0.3-2.4) 0.759    
Multiple births 35 (26.7) 4 (20.0)  0.6 (0.2-2.1) 0.722    
Antenatal steroids 63 (48.1) 13 (65.0)  1.8 (0.7-4.8) 0.242    
Apgar score ≦ 7 at 5 min 33 (25.2) 11 (55.0)  3.4 (1.3-8.9) 0.014    
Acute fetal distress 
requiring resuscitation in 
the delivery room* 
7 (5.3) 4 (20.0)  4.2 (1.1-15.9) 0.036    
Postnatal corticosteroid 
therapy 
10 (7.6) 12 (60.0)  20.1 (5.3-77.0) <0.001  11.2 (1.9-66.0) 0.008 
Bronchopulmonary 
dysplasia 
28 (21.4) 10 (50.0)  3.5 (1.3-9.2) 0.012    
Length of mechanical 
ventilation (d) per 
additional 10 days 
increase** 
- -  1.3 (1.2-1.6) <0.001    
Confirmed neonatal sepsis 19 (14.5) 8 (40.0)  3.7 (1.3-10.3) 0.012    
Retinopathy of prematurity# 16 (12.2) 9 (45.0)  5.6 (2.0-15.5) 0.001    
Cholestasis 9 (6.9) 8 (40.0)  8.6 (2.8-26.4) <0.001  6.2 (1.16-33.1) 0.033 
Intraventricular hemorrhage 
(Grade III or IV) 
4 (3.1) 2 (10.0)  3.4 (0.6-19.7) 0.179    
Periventricular 
leukomalacia (PVL) 
4 (3.1) 0 (0)  - 0.549    
Oxygen requirement at 
discharge¶ 
10 (7.6) 4 (20.0)  2.9 (0.8-10.3) 0.104    
Breast feeding at discharge 113 (86.3) 18 (90.0)  1.3 (0.3-4.4) 0.578    
*Including those required cardiac massage or epinephrine through endotracheal tube in the delivery room 
**Including conventional ventilation and high frequency oscillatory ventilator use 
#Including those with stage II with plus disease or  stage III or those required laser therapy 
 
(D) Summary of study # 2: 
(1). Premature neonates, even those born at 33 to 36 weeks, are found to have MNDs as early 
as 6 months corrected age by BSID-II and DDST, with risk increasing as gestation decreases.  
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(2). Moreover, we used multivariate logistic regression to evaluate the relationships between 
neonatal factors and the presence of MNDs. After multivariate logistic regression adjusted for 
GA and BBW, MND was independently associated with postnatal corticosteroid use and 
cholestasis. Besides, neonates with BBW less than 1000g were significantly associated with 
MNDs when compared with those with BBW more than 2000g. 
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V-3. Sleep-disordered breathing, Craniofacial development and Neurodevelopment in 
Premature Infants: A 2 years following Study (This article is going to be submitted/ 
unpublished) 
 
(A) Background 
Premature infants are reported to be at greater risk of developing sleep disordered breathing and 
obstructive sleep apnea has been reported not only to be more severe in adults with past history 
of prematurity, but also to be associated with clear narrow hard palate and very narrow upper 
airway. How does that risk develops, what is the frequency of such risk, is it associated with 
greater risk of poor sleep in premature children and does the association of SDB early on impact 
early development of premature infants are the questions that have not been previously 
responded. The relationship between specific findings and pathophysiology is also still unclear. 
Our study aims at bringing further information on the development of SDB in premature infants, 
its relations with anatomic development of the oro-pharynx based on clinical information and 
the potential impact on neuro-cognitive development. To investigate these issues we created a 
prospective cohort of premature infants recruited at birth and followed up to 2 years of age 
collecting information on general development and sleep and mental development, presence of 
obstructive SDB and association with narrow upper airway. 
 
(B) Method 
Neonates of gestational age less than 37 weeks were enrolled. Basic obstetric and birth data 
were collected and participants were followed up at 6, 12, 18, and 24 months of corrected age. 
The assessments (1) craniofacial assessment by inspection and photo documentation of the 
shape of the hard palate or cephalometric x ray and water view, (2) sleep recording by Chinese 
Brief Infant Sleep Questionnaire (CBISQ), sleep diary, actigraphy, and night-time 
polysomnography, and (3) development assessment by the Bayley-Scales of Infant 
Development (BSID)–II and the Denver Developmental Screening Test (DDST) were done at 
each visit. Demographic data are calculated. Paired-sample t test is performed to compare 
follow-up data with their initial values. Statistics are performed on the software PASW Statistics 
(SPSS) 18. 
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(C) Results 
(1) Demographic data (table 1) 
 244 premature and 30 full term infants were enrolled. The demographic and initial data at 
time of enrollment are presented in table 1. Premature infants are more frequently with high-
and-narrow palate (HNP) at birth (62.3%) than term infants (10.0%). Premature infants are 
further divided into 2 groups according to presence of HNP. Individuals with HNP have 
smaller body size figures, especially head circumference, and are at higher risk of intubation 
and difficult feeding than those without. 
 
Table 1 Demographic data of premature infants, with and without high-and-narrow 
palate (HNP) at birth. 
 Full term 
infants 
 
Premature infants 
 (n = 30) Total (n = 244)  HNP 
(n = 152, 
62.3%) 
No HNP 
(n = 92, 
37.7%) p value 
 
Male gender, n (%) 15 (50.0) 139 (57.0)  84 (55.3) 55 (59.8) 0.490  
Birth history        
Gestational age 
(weeks), mean ± SD 39.27 ± 1.01 31.54 ± 3.22**  31.23 ± 3.31 32.03 ± 3.01 0.060 
 
Body weight (grams), 
mean ± SD 3131.0 ± 390.0 
1691.9 ± 
593.9**  1665.0 ± 625.3 1736.3 ± 538.2 0.365 
 
Body height (cm), 
mean ± SD 
 
49.38 ± 2.03 40.54 ± 5.26**  40.19 ± 5.56 41.11 ± 4.72 0.194 
 
Head circumference 
(cm), mean ± SD 
 
34.07 ± 1.21 29.41 ± 3.42**  29.07 ± 3.53 29.97 ± 3.18 0.050* 
 
Cesarean section, n 
(%) 9 (30.0) 172 (70.5)††  104 (68.4) 68 (73.9) 0.424 
 
Intubation, n (%) 2 (6.7) 134 (54.9)††  91 (59.9) 43 (46.7) 0.062  
Difficult feeding, n 
(%) 3 (10.0) 114 (46.7)††  80 (52.6) 34 (37.0) 0.025† 
 
HNP at birth, n (%) 3 (10.0) 152 (62.3)††  - - -  
Polysomnographic data        
AHI (events/hour), 
mean ± SD n/a 3.00 ± 2.95  3.52 ± 3.32 2.02 ± 1.73 0.000** 
 
*Significant difference between groups (independent t test p < 0.05) 
**Highly significant difference (independent t test p < 0.001) 
†Significant difference between groups (Pearson’s χ2 test p < 0.05) 
††Highly significant difference between groups (Pearson’s χ2 test p < 0.001) 
AHI, apnea-hypopnea index. 
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(2). Polysomnographic data and neurodevelopment is different between premature infants 
with and without high-and-narrow palate (HNP) 
With regard to sleep problems: the mean apnea-hypopnea index (AHI) obtained from PSG is 
significantly higher in HNP group (3.52* ± 3.32) than in the non-HNP group (2.02* ± 1.73) 
(Figure 1). Table 2 displays the detailed PSG findings of premature infants, showing 
significantly higher proportion of infants with sleep problem (defined by AHI > 1) in the HNP 
group (84.7%) than in the non-HNP group (68.7%). 
Table 2a Polysomnographic characteristics in premature infants, with and without high-
and-narrow palate (HNP) at birth. 
Variables 
Total 
(n = 181) 
 HNP: 65.2% 
(n = 118) 
No HNP:34.8% 
(n = 63) p value 
AHI (1/hour) in sleep, mean ± SD 3.00 ± 2.95  3.52 ± 3.32 2.02 ± 1.73 0.000** 
AHI > 1, n (%) 143 (79.0)  100 (84.7) 44 (68.7) 0.011† 
AI (1/hour), mean ± SD 1.03 ± 1.05  1.03 ± 1.00 1.01 ± 1.15 0.924 
HI (1/hour), mean ± SD 2.21 ± 2.73  2.62 ± 3.10 1.44 ± 1.58 0.001** 
RDI (1/hour), mean ± SD 3.99 ± 3.76  4.30 ± 4.05 3.37 ± 3.07 0.163 
RERA (counts), mean ± SD 3.41 ± 6.73  3.30 ± 7.35 3.62 ± 5.31 0.786 
Sleep latency (min), mean ± SD 15.51 ± 27.06  15.39 ± 22.84 15.80 ± 33.52 0.934 
Sleep efficiency (%), mean ± SD 83.9 ± 13.8  83.3 ± 14.5 84.8 ± 12.4 0.485 
N1 sleep (%), mean ± SD 15.3 ± 8.9X  15.5 ± 9.2X 15.0 ± 8.4X 0.716 
N2 sleep (%), mean ± SD 40.3 ± 10.6  39.1 ± 10.8 42.7 ± 9.7X 0.027* 
      
N3 sleep (%), mean ± SD 18.2 ± 11.4  19.2 ± 12.7 16.3 ± 8.2X 0.107 
REM sleep (%), mean ± SD 23.7 ± 6.5X  24.0 ± 6.9X 23.1 ± 5.6X 0.400 
PLMS index (1/hour), mean ± SD 3.19 ± 7.97  3.89 ± 9.18 1.96 ± 5.17 0.294 
Mean SaO2 (%), mean ± SD 97.60 ± 0.84X  97.54 ± 0.92X 97.70 ± 0.66X 0.152 
*Significant difference (independent t test p < 0.05)  
**Highly significant difference (independent t test p < 0.001) 
†Significant difference (Pearson’s χ2 test p < 0.05) 
‡Only 181 of the 244 infants received PSG examination. 
AHI, apnea-hypopnea index; AI, apnea index; HI, hypopnea index; RDI, respiratory disturbance 
index; RERA, respiratory-effort related arousal; PLMS index, periodic leg movements in sleep 
index; Mean SaO2, mean oxygen saturation. 
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Table 2b PSG data following 2 years in premature infants 
Corrected age, years (n =181) 0.5 year 1 year 1.5year 2 year 
AHI, mean ± SD 5.61 ± 3.75 5.41 ± 4.16 3.54 ± 4.98 4.03 ± 1.67 
AHI > 1/hr, n (%) 99.5% 97.2% 86.2% 88.2% 
AI, mean ± SD 1.84 ± 1.77 1.59 ± 1.63 1.29 ± 1.56 1.49 ± 0.85 
HI, mean ± SD 4.25 ± 4.25 3.78 ± 3.72 2.37 ± 3.94 1.58 ± 1.55 
RDI, mean ± SD 8.10 ± 4.59 6.70 ± 5.38 5.07 ± 6.89 4.39 ± 4.42 
Efficiency%, mean ± SD 85.75 ± 7.16 83.71 ± 9.19 82.17 ± 14.99 86.5 ± 10.78 
Awake%, mean ± SD 12.09 ± 5.94 12.19 ± 7.77 12.83 ± 15.27 8.30 ± 8.60 
REM%, mean ± SD 26.03 ± 5.36 25.43 ± 5.90 26.29 ± 14.11 24.15 ± 3.79 
TST, mean ± SD 384.4 ± 35.3 378.2 ± 34.6 371.0 ± 61.4 400.3 ± 45.3 
PLMS Index, mean ± SD 
MeanSaO2%, mean ± SD 
4.39 ± 7.01 
98.39 ± 0.84 
3.03 ± 6.07 
97.58 ± 1.45 
5.00 ± 10.85 
97.62 ± 0.82 
2.50 ± 5.74 
97.59 ± 0.66 
High and narrow palate (+),n (%) 118(65.2%) 101(55.8%) 108(59.7%) 96(53.0%) 
Table 3 shows proportions of premature infants with developmental delays, identified with 
Denver-II and BSID-II at follow-ups. The 244 infants were sorted into 4 groups, according to 
presentation of HNP at birth and subsequent alternations till 2 years corrected age. Infants with 
persistent presence and absence of HNP are classified as group 1 (n = 110) and group 2 (n = 68), 
respectively. In group 3 (n = 42) are Infants with HNP initially but who later improved, and in 
3.52 ± 3.32 
2.02 ± 1.73 
p = 0.011*
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group 4 (n = 24) are those infants born without but who later developed HNP. [We have not 
analyzed the data of group 3 and 4 in this article].  
Comparing group 1 and group 2, a higher proportion of group 1 infants are with developmental 
delays identified with all Denver-II items at all of the time points. Figure 2 representatively 
shows proportions of infants with Denver-II total score (i.e., any delay)-defined delays in group 
1 and 2. Regarding BSID-II, using 75 as cutoff, higher proportion of group 1 infants has low 
psychomotor development index (PDI); but proportions with low mental development index 
(MDI) render no difference. 
 
Table 3 Relationship between HNP and Developmental delays (DDST and Bayley–II) 
Age 6 months  12 months 
(N = 244) Total Group 1‡ Group 2‡‡   Total Group 1 Group 2  
Denver–II          
Any delay 14.8% 17.6% 1.5%   27.8% 34.3% 17.5%  
Personal-social delay 02.5% 01.9% 1.5%   10.3% 10.5% 07.9%  
Fine-motor adaptive delay 02.5% 03.7% 0.0%   05.1% 08.6% 01.6%  
Language delay 02.9% 01.9% 0.0%   20.9% 28.6% 09.5%  
Gross motor delay 12.3% 16.7% 1.5%   15.4% 16.2% 07.9%  
BSID–II          
MDI < 75 06.4% 04.8% 5.4%   09.7% 08.2% 08.7%  
PDI < 75 19.1% 25.8% 2.7%   18.5% 24.6% 08.7%  
Age 18 months  24 months 
 Total Group 1 Group 2   Total Group 1 Group 2  
Denver–II          
Any delay 28.3% 28.8% 25.4%   16.6% 19.5% 11.1%  
Personal-social delay 08.1% 10.6% 03.4%   05.5% 09.1% 00.0%  
Fine-motor adaptive delay 06.3% 09.6% 01.7%   05.5% 07.8% 02.2%  
Language delay 23.8% 25.0% 18.6%   11.7% 10.4% 11.1%  
Gross motor delay 10.8% 12.5% 08.5%   08.0% 11.7% 00.0%  
BSID–II          
MDI < 75 20.0% 13.8% 13.3%   19.4% 18.2% 18.8%  
PDI < 75 07.3% 06.9% 00.0%   08.3% 09.1% 00.0%  
‡Group 1: children with persistent presence of high and narrow palate till 2 years corrected age. 
‡‡Group 2: children with persistent absence of high and narrow palate till 2 years corrected age. 
Denver–II, Denver Developmental Screening Test–II; BSID–II, Bayley Scales of Infant Development–II; MDI, 
mental development index; PDI, psychomotor development index. 
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Figure 2   
 The relationship between developmental delay (Denver-II: any delay) and HNP 
 
 
Different sleep problems of premature infants in the following years were showed in Table 4. 
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Table 4. CBISQ data in premature infants following 2 years 
Corrected age 
(N=244) 
0.5 years 
(N=244) 
1 year 
(N=226) 
P 
value 
1.5 years 
(N=203) 
P value 2 years 
(N=151) 
P value 
BISQ1_a, n (%) 3(1%) 6(2.4%) - 5(0.9%) - 4(2.7%) - 
BISQ1_b, n (%) 94(32.9%) 54(10.2%) - 45(22.6%) - 21(14.3%) - 
BISQ1_c, n (%) 178(62.2%) 185(74.6%) - 148(74.4%) - 101(68.7%) - 
BISQ1_d, n (%) 2(0.7%) 2(0.8%) - 0(0%) - 7(4.8%) - 
BISQ2_a, n (%) 173(60.7%) 96(38.7%) - 77(38.7%) - 46(31.3%) - 
BISQ2_b, n (%) 117(41.1%) 153(61.7%) - 107(53.8%) - 90(61.2%) - 
BISQ2_c  33(11.6%) 76(30.6%) - 86(43.2%) - 51(34.7%) - 
BISQ3min  523.92±107.7 537.89±84.77 .019 548.97±88.51 .009 555.30±70.39 .006 
BISQ3_1 2.67±1.38 2.44±1.38 .019 2.16±1.16 .000 2.34±1.32 .007 
BISQ3_2_a  77(28.4%) 67(27.1%) - 31(15.7%) - 22(15%) - 
BISQ3_2_b  92(17.3%) 39(15.8%) - 21(10.6%) - 8(5.4%) - 
BISQ3_2_c  113(41.5%) 41(16.6%) - 26(13.1%) - 5(3.4%) - 
BISQ3_2_d  44(16.2%) 38(15.4%) - 54(27.3%) - 27(18.4%) - 
BISQ3_2_e  74(27.2%) 124(50.2%) - 111(56.1%) - 108(73.5%) - 
BISQ3_3 2.55±1.91 2.12±1.75 .044 1.80±1.63 .000 1.85±1.53 .000 
BISQ3_3_1 2.34±2.42 2.79±4.04 .075 2.63±5.03 .857 3.07±6.28 .314 
BISQ3_4 4.31±2.93 3.77±3.03 .249 3.21±2.60 .000 2.72±2.36 .000 
BISQ3_5  2.05±0.94 1.97±0.98 .158 1.81±0.98 .090 1.65±0.77 .000 
BISQ3_5_1  1.85±1.35 1.78±1.42 .780 1.42±1.26 .003 1.18±0.70 .000 
BISQ3_6  1.62±1.10 1.70±1.49 .394 1.33±0.96 .046 1.23±0.73 .005 
BISQ3_6_1 2.54±2.70 2.86±4.32 .824 3.40±6.07 .405 3.30±6.75 .716 
BISQ4_1  1.84±1.79 1.60±1.41 .557 1.45±1.31 .126 1.42±1.05 .012 
BISQ4_2  1.61±2.43 1.94±3.65 .067 2.55±5.63 .511 2.68±6.44 .606 
BISQ5min 276.34±135.0 223.42±99.70 .000 198.49±97.90 .000 172.96±89.18 .000 
BISQ6 1.53±0.72 1.55±0.73 .161 1.48±0.72 .117 3.10±19.55 .326 
BISQ7  1.41±0.54 1.49±0.60 .219 1.55±0.62 .510 1.56±0.63 .004 
BISQ8  1.58±0.67 1.47±0.59 .004 1.47±0.63 .021 1.46±0.60 .895 
BISQ9  1.59±0.67 1.48±0.64 .050 1.40±0.65 .000 1.40±0.60 .011 
 
(D) Summary of the study # 3: 
These data showed that:  
(1). Premature infants are presenting with a more narrow and high-arched palate, more SDB-
related sleep problems, and more neurodevelopmental deficits than normal full-term infants. 
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(2). Till age 2 years, premature infants with narrow and high-arched palate have more SDB-
related sleep problems and more neurodevelopmental deficits than those without. 
(3). These findings support our hypothesis that high and narrow-arched palate in premature 
infants plays a role in the development of sleep problems and neurodevelopmental delays.  
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V-4. Development of Chinese-version Pediatric Obstructive Sleep Apnea 
Questionnaire( OSA-18) and  To find the common symptoms of Pediatric OSA in 
Taiwan ( # 4  article was published in Psychiatry and Clinical Neurosciences, 2016) 
 
(A) Background 
The OSA-18 is designed to screen OSA and has good reliability and validity. The goal of this 
study is to validate the Chinese version of the OSA-18, and to analyze the frequency of 
symptoms and find the common symptoms of OSA in Taiwanese children.  
 
(B) Method 
We validated the OSA-18 on an ethnic Chinese group and compared the treatment outcomes to 
show the sensitivity of the questionnaire. The caregivers completed the questionnaire twice at 
an interval of 4 weeks to test reliability. In the validation study, we included 88 OSA children. 
The OSA-18 and follow-up PSGs were performed before and 6 months post-adenotonsillectomy. 
 
(C) Results 
(1) Demographic data:  
We enrolled 163 students (89 boys and 74 girls, mean age: 9.5+1.7 years) whose parents 
completed the questionnaire twice were included in study 1 (the school group). The clinical 
participants for study 2 included 88 subjects (72 boys and 16 girls, mean age: 8.9+2.7 y/o, 
BMI=19.54 + 4.64) with OSA who had TA surgical treatment (the OSA group).  
The PSG data of the OSA children showed an AHI= 13.54+7.23 events/hour (range: 1.9 to 19.7 
events/hour). The reliability statistics showed the Cronbach's alpha of the Chinese-language 
version of the OSA-18 questionnaire to be 0.897, meeting the significance level.  
(2). The validation of Chinese version of the OSA-18 
The study results showed a well-fitting model for the sample (CFI = 0.97, RMSEA = 0.073, 
SRMR = 0.079). Standardized coefficients are reported in Table 1. Factor loadings of the “Sleep 
Disturbance items” of the pretest ranged from 0.57 to 0.70, and those of the post-test ranged 
from 0.66 to 0.76 and were significant. Loadings of the “Physical Suffering items” of the pretest 
ranged from 0.40 to 0.85, and those of the post-test ranged from 0.50 to 0.84 and were significant. 
Loadings of the “Emotional Distress items” of the pretest ranged from 0.77 to 0.88, and those 
of the post-test ranged from 0.79 to 0.85 and were significant. Loadings of the “Daytime 
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Situation items” of the pretest ranged from 0.51 to 0.88, and those of the post-test ranged from 
0.58 to 0.86 and were significant. Loadings of the “Caregiver Concern items” of the pretest 
ranged from 0.77 to 0.82, and those of the post-test ranged from 0.79 to 0.84 and were significant. 
There was a demonstration of convergent validity for these 10 latent factors (Figure 2). 
Correlations of the 5 latent factors for the pretest ranged from 0.40 to 0.75, and those of the 
post-test ranged from 0.52 to 0.85 and were not higher than 0.85, indicating discriminate validity 
for the pretest and the post-test. The factor intraclass correlations of “Sleep Disturbance”, 
“Physical Suffering”, “Emotional Distress”, “Daytime Situation”, and “Caregiver Concern” 
were 0.91, 0.78, 075, 0.76, and 0.89, respectively (see Table 1), demonstrating the presence of 
sufficient test-retest reliability. The composite reliability coefficients for these 10 factors were 
acceptable (the Sleep Disturbance of the pretest: CR = 0.72; the Physical Suffering of the pretest: 
CR = 0.83; the Emotional Distress of the pretest: CR = 0.86; the Daytime Situation of the pretest: 
CR = 0.73; the Caregiver Concern of the pretest: CR = 0.88; the Sleep Disturbance of the post-
test: CR = 0.79; the Physical Suffering of the post-test: CR = 0.84; the Emotional Distress of 
the post-test: CR = 0.86; the Daytime Situation of the post-test: CR = 0.75; the Caregiver 
Concern of the post-test: CR = 0.89). The Chinese version of the OSA-18 demonstrated good 
reliability. 
 
Table 1 Correlation matrix of latent factors 
     SD_1 PS_1 ED_1 DS_1 CC_1 SD_2 PS_2 ED_2 DS_2 
PS_1 0.71                  
ED_1 0.45  0.40             
DS_1 0.56  0.50  0.75          
CC_1 0.75  0.61  0.62  0.60         
SD_2 0.91  0.57  0.43  0.49  0.64      
PS_2 0.61  0.78  0.34  0.47  0.59  0.67     
ED_2 0.56  0.43  0.75  0.64  0.61  0.63  0.52      
DS_2 0.56  0.48  0.66  0.76  0.71  0.62  0.59  0.85   
CC_2 0.68  0.53  0.48  0.52  0.89  0.72  0.66  0.67  0.79  
Note: SD_1: Sleep Disturbance of the pretest; PS_1: Physical Suffering of the pretest;ED_1: 
Emotional Distress of the pretest; DS_1; Daytime Situation of the pretest; CC_1; Caregiver 
Concern of the pretest; SD_2:Sleep Disturbance of the post-test; PS_2: Physical Suffering of 
the post-test; ED_2: Emotional Distress of the post-test; DS_2; Daytime Situation of the post-
test; CC_2; Caregiver Concern of the post-test; The bold numbers are the test-retest reliability. 
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To establish the construct validity of a measure, nomological validity should be taken into 
consideration. Nomological validity generally deals with whether the constructs under 
investigation are related to other constructs in a way that is theoretically meaningful. In this 
study, we presented 2 kinds of nomological network. One is the relation of the constructs of the 
OSA-18 with QOL, and the other is the difference shown by the 2 subject groups (AHI>1 and 
AHI≦1) in the scores of the constructs for OSA-18. There was a presence of substantial 
correlation between QOL and the constructs for OSA-18 in the pretest and post-test (Tables 2a 
and 2b); these results demonstrated the strong nomological validity of the Chinese version of 
the OSA-18. The results also showed an improvement in the QOL score, from 5.12+1.58 to 
6.05+1.76 (p=0.001) after AT.  
 
Table 2a. Correlation of the constructs of OSA with QOL  
     SD_1 PS_1 ED_1 DS_1 CC_1 
QOL_pre -0.40*** -0.35*** -0.41*** -0.38*** -0.57*** 
 SD_2 PS_2 ED_2 DS_2 CC_2 
QOL_post -0.44*** -0.37*** -0.37*** -0.48*** -0.61*** 
Note: The correlation coefficients are derived from CFA.  
 ***p<0.001;       QOL: quality of life  
 
In terms of discriminating pediatric OSA from normal controls using the OSA-18, the area under 
the curve (AUC) for differentiating pediatric OSA from normal controls was 0.856. The value 
of 0.50 was not included within a 95% confidence interval of the AUC (0.80–0.96), strongly 
suggesting that the discriminative capability of the Chinese version of the OSA-18 is statistically 
sound. The ROC analysis included sensitivity and specificity, positive predictive value (PPV) 
and negative predictive value (NPV), with cut-off scores ranging from 65 to 66 (Table 3). 
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Table 3 - ROC analysis for discrimination of OSA and school groups in Chinese version 
of the OSA-18 (receiver operator characteristic) 
Cut-off point sensitivity specificity PPV NPV 
55 score 0.87 0.64 0.80 0.74 
59 score 0.84 0.64 0.80 0.70 
60 score 0.84 0.64 0.80 0.70 
63 score 0.84 0.64 0.80 0.70 
64 score 0.84 0.64 0.80 0.67 
65 score 0.82 0.71 0.84 0.68 
66 score 0.79 0.77 0.86 0.68 
PPV: positive predictive value; NPV: negative predictive value  
 
(2) The common symptoms of pediatric OSA in Taiwanese children:  
AHI and SaO2 significantly improved after AT without significant change in BMI (Table 4). 
There was improvement in all items of the OSA-18 6 months' post-TA (Table 4). Moreover, the 
most common symptoms of pediatric OSA were: + Poor attention span (93.1%), + Loud snoring 
(88.0%), +Caregiver worries about child's health(87.1%), +Difficulty awakening (86.1 ), and 
+mouth breathing (79.2%) (Table 4). After TA surgery, the most improved symptoms were 
“Daytime drowsiness and Poor attention span” (Table 5).  
 
Table 4 PSG data and the clinical characteristic data pre- and 6 months post-TA 
Variable 
(N=88) 
Pre-surgery 
 
Post-surgery  
(6 months)  
P value 
Male (%) 
Female (%) 
N=72(81.8%) 
N=16(18.2%) 
N=72(81.8%) 
N=16(18.2%) 
- 
Age (y/o) (mean±SD) 8.9 + 2.7 9.6 ± 2.53 0.73 
BMI (Kg/m2)  
(mean±SD) 
19.54 ±4.64 19.31 ±4.17 0.778 
Tonsil hypertrophy (more 
than grade 2) 
97.7% 0 <0.001 
Adenoid hypertrophy 
PSG findings(n=88) 
84.1% 0 <0.001 
AHI (events/hr) 13.54+7.23 3.47 ±2.01 .001 
AI (events/hr) 4.06 ±3.69 1.03 ±0.70 .023 
PMLI (events/hr) 1.58 ±3.65 1.02 ±1.19 .878 
REM (%) 11.14±6.05 14.00±6.31 .021 
Stage 1 (%) 19.09 ±8.65 15.39 ±7.58 .072 
Stage 2 (%) 35.11 ±12.71 26.11 ±4.48 .069 
Stage 3+Stage 4 (%) 35.54 ±6.01 44.53 ±10.10 .034 
Mean SaO2 96.20 ± 2.10 96.92 ± 1.56 .032 
sleep efficiency (%) 87.26 ±12.72 88.73 ± 10.52 .395 
Sleep latency (mins) 18.97 ± 9.36 15.02 ±7.41 .040 
Total sleep time (mins) 425.79  ± 35.26 429.21  ± 36.48 .287 
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BMI: Body Mass Index, BW: body weight AHI: Apnea-Hypopnea Index, AI: Apnea Index; 
mean SaO2: mean oxygen saturation; PLMI: Periodic Leg Moment Index 
 
Table 5 Change in OSA-18 Chinese version questionnaire scores after 
adenotonsillectomy (n=88) 
 Pre-surgery Post-surgery 6 months  
Item 
score 
(No. 1 to No. 3) 
score 
(No. 4 to No. 7) 
score 
(No. 1 to No. 3) 
score 
(No. 4 to No. 7) 
P value 
Item 1 12.0% 88.0% 24.8% 75.2% .001 
Item 2 38.4% 61.6% 88.2% 11.8% .001 
Item 3 49.0% 51.0% 88.4% 11.6% .001 
Item 4 37.6% 62.4% 76.8% 23.2% .001 
Item 5 24.8% 79.2% 76.7% 23.3% .001 
Item 6 31.7% 68.3% 73.1% 26.9% .001 
Item 7 27.7% 72.3% 56.5% 43.3% .001 
Item 8 23.0% 77.0% 72.8% 27.2% .001 
Item 9 36.6% 63.4% 58.0% 42.0% .001 
Item 10 51.5% 48.5% 69.6% 30.4% .001 
Item 11 39.4% 60.6% 60.9% 39.1% .001 
Item 12 28.0% 72.0% 71.2% 28.8% .001 
Item 13 6.9% 93.1% 42.0% 58.0% .001 
Item 14 13.9% 86.1% 40.6% 59.4% .001 
Item 15 12.9% 87.1% 55.1% 44.9% .001 
Item 16 24.8% 75.2% 66.2% 33.8% .001 
Item 17 51.5% 48.5% 73.9% 26.1% .001 
Item 18 51.4% 48.6% 53.6% 46.4% .001 
 (scale 1 to 5) (scale 6 to 10) (scale 1 to 5) (scale 6 to 10)  
QOL item 61.2% 38.8% 38.2% 61.8% .001 
Item 1 Loud snoring; 2 Breath holding/pauses; 3 Choking or gasping; 4 Fragmented sleep; 5 Mouth 
breathing; 6 Frequent colds or URIs; 7 Rhinorrhea; 8 Dysphagia; 9 Mood swings or tantrums; 10 
Aggression/hyperactivity; 11 Discipline problems; 12 Daytime drowsiness; 13 Poor attention span; 14 
Difficulty awakening; 15 Caregiver worried about child's health; 16 Caregiver concerned child does 
not have enough air; 17 Caregiver missed activities; 20 Caregiver frustration. ( scale 1 means “ non of 
the time”; scale 4 means “some of the time”; scale 7 means “all of the time”). QOL item: quality of life 
(QOL) via a 10-point visual analogue scale. (The higher scale comes with higher quality of life). 
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We also analyzed the correlation between OSA-18 and AHI, tonsil size and adenoid hypertrophy. 
The results showed a statistically significant correlation between OSA-18 total score and AHI 
(r=0.291*, p <.05) and the hypopnea index (r=0.29*, p <.05). Also, there was a significant 
correlation (r=.532*, p <.01) between adenoid hypertrophy and OSA-18 total score. However, 
tonsil size did not correlate with OSA-18 total score. 
 
(D) Summary of the study # 4: 
(1). The Chinese-language version of the OSA-18 questionnaire for pediatric OSA is a reliable 
and valid instrument. It is a suitable screening tool and outcome measure for OSA in Taiwanese 
children.  
(2). The common symptoms in non-obese OSA children were “Poor attention span, Loud 
snoring, Caregiver worries about child’s health, Difficulty awakening, and mouth breathing”. 
The symptom of “mouth breathing” was the most improvement after TA in all symptoms. As 
we know the “mouth breathing” is associated with the pediatric orofacial development. 
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V-5. Sleep-Disordered Breathing and oral-facial development in the premature infant (# 
5 article was published in Frontier in Neurology, 2013)  
 
(A) Background 
From the previous researches and our premature infant study, we hypothesize that “pediatric 
OSA in non-obese children is a disorder of oral facial growth”. Therefore, we review of evidence 
in support of an oral-facial growth impairment in the development of pediatric sleep apnea in 
non-obese children. 
(B) Review of findings 
(1). Review of early historical data in the orthodontic literature indicating the abnormal oral-
facial development associated with mouth breathing and nasal resistance.  
(2). Review of the progressive demonstration of sleep disordered breathing in children who 
underwent incomplete treatment of OSA with adenotonsillectomy, and demonstration of 
abnormal oral-facial anatomy that must often to be treated in order to achieve the resolution of 
OSA.  
(3). Review of long term recurrence data on OSA and indication of oral-facial myofunctional 
dysfunction in association with the recurrence of OSA. 
Since the report of obstructive sleep apnea syndrome in children in 1976 (Guilleminault et al), 
recognition of abnormal breathing during sleep has progressed. Follow- up of the first cases of 
children treated by tracheostomy, then by home nasal CPAP that was not well accepted in these 
teen-agers, led to usage of more specific surgery oriented toward treatment of the upper airway, 
performing maxilla-mandibular surgery (Powell et al., 1983) with follow-up for more than 25 
years in one case indicating complete long term resolution of the OSAS. 
 
(a) Lessons from OSA treatment with adenotonsillectomy :  
Despite the widespread use of techniques with limited ability to identify the complete cessation 
of abnormal breathing and its effects during sleep, studies progressively reported an absence of 
complete elimination of sleep-disordered-breathing despite significant initial improvement in 
many tests. Early on two studies showed that prepubertal adolescents who were considered to 
be completely cured from OSA presented with OSA again as teenagers (Guilleminault et al., 
1989). Interestingly, these subjects had a narrowing behind the base of tongue and orofacial 
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anatomical abnormalities that either did not exist initially or had not been recognized at its 
earlier stage. Tasker et al (2002) also confirmed the presence of an abnormal upper airway and 
SDB twelve years after adenotonsillectomy. In more recent studies with larger number of 
patients, this point was made very clear: Despite a clear improvement of clinical symptoms, 
Guilleminault et al (2004) reported a complete resolution of OSA following adenotonsillectomy 
in only 51% of the non-obese prepubertal children they successively studied with systematic 
PSG at approximately 3 months post-surgery. Tauman et al (2006), Guilleminault et al (2007) 
and Huang et al (2013) confirmed these findings. In a more recent multi-center study 
(Bhattacharjee et al., 2010), though 50% of the 500 recruited children had been obese, 
adenotonsillectomy again improved clinical symptoms and PSG results but did not cure the 
syndrome in about 70% of the enlisted children. Recently, Chen et al (2012) reported on a 
systematic prospective study of prepubertal children treated with adenotonsillectomy, who were 
then considered to have normal PSG according to AASM 2007 scoring criteria (Iber et al., 2007). 
All children whose parents signed informed consent were included in the prospective follow-up 
study, which spanned a 5-year period, and included not only systematic PSGs and clinical 
evaluations, but also attentional neurocognitive testing performed during the daytime that was 
interpreted blindly by the same trained psychologist and 3D-CT of the upper airway that was 
also interpreted blindly by the same cranial-facial specialist. The follow-up evaluations 
performed at 3- and 6- months showed normal PSG (AASM criteria) and neurocognitive scores. 
However, further follow-up showed once again the simultaneous presence of abnormal 
breathing during sleep (AASM criteria) and abnormal neurocognitive test results in 40% of the 
prepubertal children. Moreover, 3D-CT analysis showed abnormal oral-facial development in 
these children. Kim and Guilleminault (2011) also reported on a systematic investigation of the 
presentation of anatomical oral-facial abnormalities noted in 400 prepubertal children diagnosed 
with OSA and enlarged adenotonsillectomy before otolaryngological treatment. It came out that 
nearly all the children with OSA had at least one type of oral-pharyngeal abnormality from the 
list of pre-defined potential problems. As expected based on previous findings, clinical 
symptoms and abnormal PSG persisted in some children at 3-months follow-up after 
adenotonsillectomy. However, the study showed that many children had one of the many 
anatomical oral-facial abnormality investigated before surgery and scored based on systematic 
pre-established evaluation scales: this non-specific scoring was insufficient to predict complete 
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or incomplete results from adenotonsillectomy. Further analyses produced more specific clinical 
examination findings that better predicted persistence of abnormal PSG results post 
adenotonsillectomy. Similar to an analysis performed by Guilleminault and his coworkers 
(2007), the clinical findings included the presence of a Mallampati (or Friedman-Mallampati) 
scale score of 3 or 4 (Mallampati et al., 1985), the presence of a deviated septum, and the 
presence of a small mandible. The Mallampati scale does not identify one particular anatomical 
abnormality, but an abnormal score represents a combination of deficiencies involving both the 
nasomaxillary complex and the position of the mandible.  
In summary: The findings suggest the need to assess the upper airway on anatomic elements 
more related to oral facial growth and possibly more generalized oral-pharyngeal growth 
impairment rather than looking at many anatomic deviations from what is considered the norm. 
 
(b) Lessons from orthodontia and the experimental infant monkey model 
European orthodontists showed that abnormal nasal resistance induced by enlarged adeno-
tonsils in children were associated with mouth breathing and led to important cranio-facial 
changes (Haas, 1961; Linder-Aronson, 1969; 1970; Wertz, 1970; Timms, 1974; Gray, 1975; 
Hershey et al., 1976;McNamara, 1981;Timms, 1984). Ablation of the adeno-tonsils led to 
cessation of the mouth breathing and progressive return to normal facial development facilitated 
by orthodontia use in follow-up studies. Other orthodontists stricken by narrowness of the 
maxilla and its very negative impact on teeth position and facial growth during prepubertal 
development had performed “rapid maxillary expansion” (RME), and reported that such 
treatment had also made an impact on a sleep-related complaint. For example, treated children 
experienced elimination of their nocturnal enuresis. However, the most important findings were 
obtained on the infant monkeys, when the important role of abnormal nasal resistance during 
the developmental period was demonstrated.  
Between 1970 and 1980, a number of very important experiments on newborn rhesus 
monkeys were performed, whereby a small silicone head was placed within the nostrils of infant 
monkeys and held by a thin thread to the nostrils in order to induce a clear nasal resistance for 
the first 6 months of life, and subsequent removal of the nasal obstruction thereafter (Harvold 
et al., 1981;Vargervik et al., 1984). As reported by Harvold and his team (1981), the blockade 
of the nasal passage led to narrowing of dental arches, decrease in maxillary arch length, anterior 
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cross bite, maxillary over-jet and increase in anterior face height. These results were well 
illustrated, but the most significant findings in our view, was the report by Vargervik et al (1984) 
and Miller et al (1984). These researchers from the same team showed that experimentally 
induced abnormal nasal resistance led to systematic changes in the orofacial muscles. The 
changes were noted in the systematic recording of different muscles, more particularly the 
geniohyoid, the genioglossal muscles that constitute the tongue, and also, in the suprahyoid 
dorsal tongue fibers – the upper lip elevators, and the digastric muscles. 
EMG changes were reported to show abrupt induction of rhythmic discharge patterns. This is 
contrary to normal firing, which is near continuous and desynchronized in any normal individual. 
Tonic EMG discharges changed back to the normal pattern when nasal breathing was restored 
at the end of the 6-month experiment. These alterations were entirely related to the abnormal 
nasal breathing accompanying the increase in nasal resistance. Increase in nasal resistance has 
a dramatic effect on the maxillomandibular skeleton, halting growth (Harvold et al., 1981) and 
bringing about adaptive changes in the soft tissues that are associated with deviation in jaw 
posture and tongue activity (Miller et al., 1984;Vargervik et al., 1984). That is, the nasal 
obstruction induces functional changes in the nasomaxillary complex and on the mandible. The 
consequences of the experiments were as follows: There was an absence of development, which 
impacted the maxilla and restricted the nose and upper jaw; there was a displacement of the 
mandible leading to mouth breathing and; oral breathing developed in association with increase 
in nasal resistance, leading to mouth opening and mouth breathing that occurred day and night. 
These led to the narrowing of the cranial skeleton (Harvold et al., 1981;Miller et al., 
1984;Vargervik et al., 1984;Rubin, 1987;Vargervik and Harvold, 1987). Further follow-up 
showed that these changes were reversible if the experimental nasal resistance was withdrawn 
while the infant monkey was still in its developmental phase. 
In summary: (1) In growing animals in which the nasal airway is gradually occluded, there is 
an adverse effect on the morphology of the nasomaxillary complex, mandible, and pharyngeal 
airway space. (2) The morphometric changes are induced by altered functioning of the muscles, 
with changes in muscle firing that are triggered by abnormal nasal resistance. Obstructive sleep 
apnea syndrome was mostly unknown at the time of this investigation and no sleep recording 
was performed on the experimental animals. 
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(c)  Application of work in orthodontia in the field of SDB 
More recently, findings that support the incomplete resolution of abnormal oral-pharyngeal 
growth by adenotonsillectomy have led to the usage of orthodontic techniques to help treat 
pediatric SDB. Several studies were performed over time, based on reports demonstrating the 
important role of the mesio-palatine suture in the nasomaxillary complex growth and examining 
its ossification process in depth.  Cartilage is a connective tissue made of chondrocytes 
embedded in a matrix rich in collagen (particularly type II), associated with proteoglycans in 
hyaline cartilage that strengthens it, and often elastin-(depending on the type of cartilage). 
Hyaline cartilage is the forerunner of skeletal bones in the fetus, and endochondral ossification 
is the process leading to formation of the nasomaxillary complex.  
Rapid Maxillary Expansion- RME-(Pirelli et al., 2004) is a procedure applying orthopaedic 
forces on the mid-palatal sutures using the first molars and permanent premolars as anchor teeth; 
while in deciduous dentition, the second primary molars are selected as long as they can provide 
the required firmness. The device is composed of a central expansion screw with four arms: 2 
front arms and 2 back arms; the bone distraction at suture level enables an effective enlargement 
of the maxillary skeletal base. Enlargement is visually appreciable as the bone distraction leads 
to an inter-incisive space (a diastema), and with X-rays (as the gain appears as a 
radiotransparency corresponding to the visually seen space). The procedure usually last 3 to 4 
weeks with daily turning of a mid-line screw that allows enlargement (distraction) of the space 
at the level of mid-line suture: The transpalatal force, that exceeds the orthodontic one, produces 
an orthopaedic force that opens the mid-palatal suture leading to maxillary movement without 
tipping teeth. Once the needed extension is obtained (end of the activation phase), the midline 
screw is blocked, and the device is kept in place for at least 4 to 6 months more, to let the newly 
formed bone strengthen. Unfortunately, such important cartilage is missing from the mandible. 
Nevertheless, manipulation and verticalization of teeth can stimulate mandibular growth and 
such bimaxillary distraction is often needed in OSA children. In addition, maxillary widening 
also seems to independently impact mandibular growth. One negative element of RME is in its 
anteroposterior lengthening capabilities. That is, it is a limited approach when anteroposterior 
lengthening is needed. In the past, appliances such as the Herbs appliance or its equivalent were 
thought to be capable of producing anterior-posterior growth in prepubertal children. However, 
while such appliances may protrude the lower jaw forward, there is no evidence to date that 
73 
 
more growth than expected with age is attained. Distraction osteogenesis may be performed in 
these cases, but while such approach is performed in children with clear malformations at birth, 
it has not been recommended in non-syndromic children with OSA till oral-facial growth is well 
advanced (Guilleminault and Li, 2004). Normally, 60% of the facial growth is obtained by 6 
years of age and about 90% near 11 to 12 years. Thus, distraction osteogenesis is not usually 
performed before approximately 14 years of age in non-syndromic children with OSA. At that 
time, there is always a question of whether the anteroposterior advancement will be sufficient 
on its own or whether the teenager will need both the anteroposterior and the lateral extension. 
If the latter is need, as is most commonly the case, MMA (Holty and Guilleminault, 2010) is the 
best recommendation. On the other hand, distraction osteogenesis may be useful in certain cases, 
such as in the elimination of residual OSA. 
In summary: (1) The studies presented here indicate that adenotonsillectomy in non-obese 
children does not “cure” OSA in many prepubertal children, and that oral-facial anatomical 
problems are clearly involved in the development of OSA in children. Moreover, these 
anatomical problems may be amenable to orthodontic treatment but not in all subjects. (2) 
Several studies have shown that RME or bimaxillary distraction have a clear impact on pediatric 
OSA and may resolve the residual problem that is seen post adenotonsillectomy. The 
combination of adenotonsillectomy and RME may potentially resolve OSA symptoms 
completely and a small prospective follow-up study indicates that results may be sustained 36 
months’ post treatment (Villa et al., 2011). 
 
(d) Interaction between adenotonsils and orofacial growth and evidences from our 
premature infants 
Swedish investigators suggested that children first become mouth breathers, and then their 
tonsils become subjected to repetitive abnormal stimulations related to mouth breathing, which 
leads to an inflammatory reaction (Zettergreen et al., 2002). The resulting tonsilar enlargement 
will involve inflammatory factors such as leukotriene. 
 
Our Premature infants study 
Method: Our prospective cohort of 300 infants born between 25 and 37 weeks of gestational 
age. These infants are evaluated shortly after birth (within the first week) and at 3 months, 6 
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months, 12 months, 18 months, and 24 months post-birth. Children received clinical evaluations 
that included developmental scales, and neurological evaluation that included feeding behaviors, 
actigraphy, PSG, and systematic photographs of the face (frontal and lateral) and of oral regions. 
Fiber optic illumination is used in the photographs of the oral regions to evaluate the size and 
presentation of the hard palate, and photos are scored blindly by a specialist who is not involved 
in the clinical evaluations. 
Preliminary results: Three hundred children involved in the cohort have been followed until 24 
months of age at the minimum. For this review of findings, infants who had nasal or mouth tube 
placed at birth were eliminated from evaluation.  
(1) The current results showed that all infants below 34 weeks of age present a high and narrow 
hard palate. The width of the palates was between 27 and 31 mm in infants born at 37weeks 
GA and in 35% of infants born at 36 weeks GA, it was smaller than 27mm in all other infants 
with smaller width the more premature the infant was. Feeding behavior problems were 
present in infants 36 weeks and younger. All infants that had to stay in hospital due to 
premature birth were bottle-fed. Only older infants were breast fed. Moreover, in this series 
of studies, any infant kept in the hospital immediately after birth was thus separated from 
their mothers and was bottle-fed with either formula or expressed breast milk. 
(2) Currently, 82% of the studied infants (n=207/252) present with a high and narrow hard 
palate, as well as apnea and/or hypopnea during sleep. Mouth breathing is noted in these 
children and became more apparent with age, particularly noted at the 1st follow-up visit at 
+3months post birth. 
(3) All children at 35 weeks and younger exhibited limb hypotonia during the general 
neurological evaluation, older infants demonstrated also hypotonia but in lower number with 
longer pregnancy duration, hypotonia was indicated by the persistence of a positive “scarf” 
sign and this positive finding was noted even at 37 weeks of gestational age (Korobkin and 
Guilleminault, 1979). 
(4) At 6 months after birth (i.e., with different degree of maturation due to different gestational 
age), the 207 mentioned above children without history of intubation showed no sign of an 
abnormally enlarged tonsil at the clinical evaluation and at the photographic evaluation, but 
all of them presented with a high and narrow hard palate. 
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(5) In summary: Enlarged tonsils when present were only noted at later examination after mouth 
breathing earlier documentation of high and narrow hard palate and mouth breathing during 
sleep. The hypothesis that the enlargement of tonsils occurs only after the growth and 
presence of the high narrow hard palate and the development of mouth breathing is 
supported by evidence from this cohort. However, no valid study of adenoids could be done 
with the study design as no optic-scopy at the back of the nose was performed. Nevertheless, 
documentation of a high and narrow hard palate present at birth indicates the presence of 
abnormal oral-facial feature existing at birth in most cases. 
(6) Development of abnormal hard palate after birth: The most interesting cases are the small 
fraction of subjects, 9% (n=23), that had a normal hard palate at birth, but then presented 
with an abnormal hard palate during the investigation at 6 months of age. These children 
were all in the 36 weeks and older age group. None of them had ICU hospitalization, but 
they were considered to show positive scarf signs indicative of the presence of some degree 
of hypotonia. Also, all of these children were quickly bottle-fed due to difficulties with 
breast feeding. At the 6-month evaluation, their tongue was placed flat and low on all photos 
and at examination: the presentation is similar to that of a hypotonic tongue. These children 
had normal breathing during sleep at birth evaluation but developed SDB as documented by 
sleep recording during the follow-up period. 
(7) Infants with normal palate at follow-up: In this study only nine per cent of subjects (n=22) 
had a completely normal hard palate, normal breathing during sleep and normal 
development. Most were in the 36 weeks and older age group and had normal breast feeding. 
However, there was a pair of twins who belonged to the 34 weeks gestational age group. 
These twins were followed by a special myofunctional reeducation team applying tongue 
reeducation techniques to strengthen tongue and oral muscles very early after birth And they 
were bottle-fed but a special “hard” nipple, with hardness and size adjusted overtime, was 
used to elicit more effort from their tongue muscles when feeding. 
(8) Hard and narrow hard palates were seen at birth in most premature infants and SDB was 
recorded in most of them; mouth breathing and sleep-disordered breathing were noted at 
follow-up; enlargement of tonsils was not observed when hard and narrow hard palate was 
documented; adenoids were not studied. But a small number of children (9%) had normal 
hard palates including two early premature twins treated with myofunctional techniques 
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recommended to strengthen oral-facial muscles. Also, a small group of children with normal 
palate at birth and normal breathing during sleep, there was a concomitant appearance of 
SDB, development of hard and narrow palate, mouth breathing and clinically noted tongue 
hypotonia at follow-up indicative of development of oral-facial growth problem and post-
natal SDB. 
In summary: Premature infants and some full-term infants may present with abnormal oral-
facial presentation, particularly a high and narrow hard palate. Such presentation is associated 
with oral facial hypotonia. Systematic follow-up up to 36 months of post birth-age indicates 
persistence of abnormal tongue position and of abnormal breathing with presence of mouth 
breathing during PSG. 
 
(D)  Summary of the findings from study # 5: 
(1) The different data accumulated over time on SDB children and the experimental data 
obtained from the infant monkeys, years ago all lean toward the same direction: There is a 
strong association between “normal oral-facial muscle tone” and “normal development of 
the nasomaxillary complex and the mandible”. Presence of abnormal muscle tone, either 
experimentally induced by creation of abnormal nasal resistance or due to premature birth, 
is quickly associated with mouth breathing particularly during sleep, abnormal placement of 
the tongue, and either development –as shown in the rhesus monkey and in some infants- or 
worsening of the oral-facial anatomy. In humans, SDB is noted in association with the 
pathological hypotonia of the tongue muscles: In a small group of infants seen at birth with 
a normal hard palate, development of a high and narrow hard palate and SDB was 
documented in children who also presented oral-facial hypotonia. When high and narrow 
hard palate was noted at birth, hypotonia was present and SDB was noted. In rare cases 
efforts to counteract oral-muscle hypotonia and high and narrow hard palate very early in 
life may bring normal development and absence of SDB at follow-up.  
(2) As suggested by Swedish investigators, enlargement of tonsils appears to be a secondary 
phenomenon, but it further impacts nasal resistance (no information on adenoids has been 
obtained in our infant studies, but it was obtained in the long-term follow-up of older 
children with 3D-CT scans). Adenotonsillectomy is often insufficient for the complete 
resolution of breathing problems.  
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(3) Interruption of normal development with premature birth may explain the frequency of 
breathing problems during sleep in premature infants, but it may be seen in full term infants 
and may have very negative consequences (Rambaud and Guilleminault, 2012). Could the 
abnormality leading to oral-facial hypotonia begin in utero? It is possible: Investigation of 
facial expression and movements shows that beginning in early pregnancy, the fetus exhibits 
regular movements in the mouth and face; For example, the most frequent movement during 
the second trimester is sucking (Kurjak et al., 2005). Abnormal pregnancy and/or 
impairment of these movements may impede normal muscle activity at birth. 
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V-6. Short lingual frenulum, mouth breathing and abnormal oral facial growth (# 6 
article was published in  Int J Pediatr Res ,2015) 
 
(A) Background 
In our follow-up investigation we observed that some of the children in our cohort had a short 
lingual frenulum. No data was available on the role of short frenulum and abnormal breathing 
during sleep. The Stanford University group engaged in the study on the association of presence 
of short lingual frenulum and OSA, our goal was more modest and complimentary with this 
Stanford study: It was to appreciate if simple clipping of the short lingual frenulum at the age 
of recognition in our cohort was sufficient investigating oral facial functioning in children and 
impact on OSA. 
 
(B) Method 
We performed a retrospective study of children and teenagers referred for suspicion of sleep-
disordered breathing (SDB) during the last five years.  
The de-identified charts of children, age 2 to 17 years, referred for suspicion of SDB were 
selected. Obese and syndromic children were eliminated from the review. To be included in the 
analysis, charts contained information on initial complaints leading to consult with usage of 
Pediatric Sleep Questionnaire , report of clinical evaluation of orofacial findings indicating 
investigation of tonsils using the Friedman scale , investigation of subjective upper airway 
opening using the Mallampati-Friedman scale , evaluation of inferior nasal turbinates, dental 
crowding, presence of over jet and/or overbite , and determination of “facial harmony” with 
frontal measurements. If nasal allergies were suspected, a consult with an allergist for treatment 
was obtained, and if orthodontic problems were suspected, results of evaluation by a specialist 
were available. Indication of short lingual frenulum and its potential association with speech, 
swallow, or mastication problems were outlined. All patients had in-laboratory diagnostic 
polysomnography (PSG). The conclusion of the testing was abnormal breathing during sleep 
with indication of the treatment plan. Post treatment follow-up was available indicating: (a) 
Selected treatment (b) Changes compared to baseline, including questionnaire data  (c) Post-
treatment PSG findings Based on the results obtained, a follow-up decision contained any 
further treatment recommendations and subsequent follow up information including PSG data. 
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The data were collected and organized on spreadsheets. Sleep and respiratory scoring of PSGs 
followed the pediatric scoring guidelines, according to the American Academy of Sleep 
Medicine (AASM- 2007) [115] . The presence of nasal flow limitation was determined using 
criteria published by Guilleminault et al. and Palombini et al.  The time spent mouth-breathing 
during sleep was also calculated as a percentage of total sleep time . Data were analyzed using 
t-test for repeated measures. 
 
(C) Results 
(1) Demographic data:  
We identified 27 patients with association of short lingual frenulum and SDB who met entry 
criteria (Figure 1). The mean age was 11.4 years (range: 2 to 16 years). Children presented with 
symptoms of SDB (Table 1) such as snoring, poor sleep, and fatigue but also a history of 
symptoms associated with short lingual frenulum such as problems with speech, swallowing or 
suction, particularly early in life. Children with speech problems may have been sent to speech 
therapy, but none of the children had frenulum treatment. As can be seen (Table 1), 10 children 
had enlarged tonsils (Friedman scores of 3 and 4), five children had been recommended to 
consult an orthodontist due to evident crowding of dentition, 22 children presented with an 
abnormal Mallampati-Friedman score of 3 or 4 .  
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Table 1. Disease characteristics at entry and after first treatment 
 
 “ +” indicates that symptom was reported during pre-pubertal period but not present 
necessarily at time of evaluation. 
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(2) Short lingual frenulum had associated with anatomic problems and high and narrow hard 
palate 
In all cases, there was presence of a high and narrow hard palate and distortion of the “harmonic 
face”  with either a longer lower third of the face or reduction of the middle third compared to 
the other thirds. All children presented with abnormal orofacial anatomy and reduced oral cavity 
size. All children had PSG s with an abnormal apnea-hypopnea-index (AHI) and abnormal nadir 
of oxygen saturation during sleep. Results are presented in Table 1.  
On initial presentation, children with a short lingual frenulum had associated anatomic problems 
linked to abnormal breathing during sleep, such as adenotonsillar hypertrophy, but all presented 
with orofacial features favoring collapse of the upper airway during sleep with presence of a 
high and narrow palatal vault . Finally, detailed family history revealed that one parent had a 
short frenulum in 6 out of our 27 cases, and short frenulum was present in three siblings of the 
patients. Following recognition of abnormal breathing during sleep, some children (n=10) had 
been referred to ear-nose-throat specialists (ENT) for T&A and frenectomy when large tonsils 
were present, and 8 children with normal sized tonsils (confirmed by nasopharyngoscopy and/or 
lateral radiographs) were also referred to ENT for frenectomy. Nine children were referred to 
orthodontists for rapid maxillary expansion (RME) and need for frenectomy was also mentioned. 
Children were asked to have post-treatment follow-up by sleep medicine including investigation 
with PSG.  
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(3) Follow-up post treatment#1 
The sleep medicine follow-up occurred between three and four months post T&A with 
frenectomy or isolated frenectomy; and about one month after rapid maxillary expansion, with 
expander in place, for children sent to orthodontists. None of the children sent for orthodontia 
treatment had frenectomy and two children had T&A without frenectomy. In summary: 13 
children had frenectomy either isolated (n=5) or in association with T&A (n=8), but frenectomy 
was not performed in 14 children despite recommendation to perform such treatment. 
Table 1 presents the results obtained post treatment #1, independent of its type. There was an 
overall improvement by clinical evaluation and PSG including children in which frenectomy 
had not been performed; parents reported, however, persistence of some symptoms particularly 
of “fatigue” and “poor sleep” in about one third of the cases. The AHI was significantly 
decreased, and oxygen saturation nadir was significantly improved (p=0.01 for each condition, 
paired t-test); flow limitation was also improved (p=0.05 paired t-test) but to a lesser degree. 
There was persistence of mouth-breathing: only two children, treated by both T&A and 
frenectomy spent less than 10% of their sleep mouth breathing, a percentage considered as 
normal . All others had abnormal mouth-breathing during sleep, including the five children that 
underwent isolated frenectomy. The conclusion of this first follow-up was that children 
recognized with OSA were clearly improved after either T&A or orthodontics, performed with 
or without frenectomy. However, 92.5% of the treated children still had an abnormal amount of 
mouth-breathing during sleep. After collection of data, children without frenectomy were 
referred back to ENT and recommended to undergo treatment (n=16). Considering the prior 
finding of persistence of mouth-breathing despite frenectomy, all children with residual AHI, 
flow limitation, and mouth-breathing were recommended to have myofunctional treatment with 
a specialist after surgery (n=25). 
 
(4) Follow-up post treatment #2 
Eleven patients came back for further follow-up, six months after the first post treatment 
investigation. They had treatment with myofunctional therapy for 4 to 6 months . These included 
those who underwent frenectomy with orthodontia (n=5), isolated frenectomy (n=4)), and 
children post T&A with new frenectomy subsequent to the first follow up visit  (n= 2). None of 
these 11 patients or their parents had clinical complaints. At follow-up PSG, these cases had a 
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mean AHI of 0.8 ± 0.9, a mean oxygen saturation nadir of 97.2 ± 1.0%, a mean flow limitation 
during sleep of 7.5 ± 6%, and time spent mouth breathing during sleep of 4 ± 4.1%. 
 
(D) Summary of the findings from study # 6: 
(1) Short lingual frenulum may lead to abnormal orofacial growth early in life, a risk factor for 
development of SDB.  
(2) Careful surveillance for abnormal breathing during sleep should occur in the presence of 
short lingual frenulum. 
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V-7  Inflammation, Cytokines, Neurocognition and  Pediatric sleep-disordered-breathing 
( # 7 article was published in Medicine J, 2016) 
 
(A) Background 
Pediatric OSA results in long-term effects on children’s health and development. It also affects 
the sleep and neurocognitive functioning of children [1-4] including symptoms of attention 
deficit/hyperactivity disorder. The factors involved in the decrease in cognition, learning and 
memory are still incompletely chartered.  Previous researches showed there was an interaction 
between OSA and chronic diseases. The most acceptable hypothesis associates occurrence of 
chronic systemic inflammation with OSA. Therefore, we hypothesized that chronic 
inflammation not only causes cardiovascular diseases in pediatric OSA patient, but also affect 
cognitive functions and wondered if a correlation between psychometric test and these cytokines 
could be shown. This study aimed to investigate the status of pro-inflammatory cytokines, 
particularly IL-17and IL 23 and cognition in pediatric OSA. 
 
(B) Method 
Controls and OSA children, participated in the study. Exclusion criteria were 
adenotonsillectomy, heart, neurological and severe psychiatric diseases, craniofacial syndromes 
and obesity. Polysomnogram was followed by serum testing for inflammatory markers and 
neurocognitive tests such as Continuous-performance-task (CPT) and Wisconsin-Card-Sorting-
Test (WCST), questionnaires, analyses of plasma high-sensitivity C- reactive- protein (HS-
CRP), tumor-necrosis-factor-alpha (TNF-α), interleukins 1 (IL-1), 6 (IL-6), 17 (IL-17) and 23 
(IL-23). 
 
(C) Results 
(1) Demography data : 
Eighty-two children, 4-12 years old, were enrolled; there were 3 drop-outs (3.6%).  
Demographic of the 78 children (mean age 7.43 + 0.6 year) are in table 1. The OSA group was 
significantly different with symptoms of ADHD and enuresis (p=0.001 and p=0.036), presence 
of tonsil and adenoid hypertrophy (p<0.001), body-mass-index [BMI], BMI z score (p=0.001 
and 0.036).  
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Table 1 Demographic characteristics of OSA and healthy children 
 Control 
(n=32) 
OSA 
(n=47) 
p value 
Number of males (%) 21 (65.6%) 30 (63.8%) 0.428 
Age (years) 7.02±0.65 7.84±0.56 0.366 
BMI (kg/m2) 16.55±0.58 16.95±0.47 0.601 
BMI z score a -0.12±0.27 0.15±0.21 0.442 
AHI(events/h) 0.37±0.06 9.13±1.67 <0.001*** 
PLMI (events/h) 0.13±0.10 0.93±0.41 0.067† 
PLM disorder (%) 0(0%) 3(6.4%) 0.083† 
Learning disorder (%)b 0(0%) 1(2.1%) 0.461 
ADHD (%)b 2(6.2%) 18(38.3%) 0.001** 
Enuresis (%)b 4(12.5%) 15(31.9%) 0.036* 
Other Physical Comorbidity History 
 Asthma (%) c 4(12.5%) 6(12.8%) 0.561 
 Allergic rhinitis (%) c 4(12.5%) 23(48.9%) <0.001*** 
Findings of ENT examination  
 Tonsil hypertrophy (more than Gr. 2) (%) c 4(12.5%) 32(68.1%) <0.001*** 
 Adenoid hypertrophy (%)c 3(9.3%) 24(51.1%) <0.001*** 
 Turbinate hypertrophy (%) c 1(3.1%) 6(12.8%) 0.158 
 Nasoseptal deviation (%) c 0(0%) 1(2.1%) 0.461 
†0.05≦P0.1. *P<0.05. **P<0.01. ***P<0.001. BMI, body mass index; ENT, ear, nose and throat; 
ADHD, attention deficient hyperactivity disorder; PLM, periodic limb movement. aCorrected BMI 
z score based on the Center for Disease Control (CDC) growth charts. bDiagnosed according to the 
criteria of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision. 
cDiagnosed by pediatricians.  
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(2) PSG data:  
The PSGs showed (see table 2) significantly higher AHI, AHI in REM, AI, Desaturation Index 
[DI] and snore index in OSA children (p<0.001, p<0.001, p=0.001, p<0.001 and p=0.002 
respectively).  
 
Table 2 Comparison of polysomnographic findings in OSA and healthy children 
 
 
Control 
(n=32) 
OSA 
(n=47) 
p value 
BMI (kg/m2) 16.55±0.58 16.95±0.47 0.601 
BMI z score -0.12±0.27 0.15±0.21 0.442 
Polysomnographic findings 
AHI(events/h) 0.37±0.06 9.13±1.67 <0.001*** 
AHI/REM (events/h) 0.65±0.18 16.25±3.68 <0.001*** 
AI(events/h) 0.18±0.05 2.12±0.51 0.001** 
Desaturation Index(events/h) 0.41±0.06 7.27±1.59 <0.001*** 
Sleep efficiency (%) 89.70±1.32 83.65±2.28 0.131 
Awake (%) 6.74±1.42 10.90±2.36 0.305 
REM (%) 18.62±1.406 19.11±1.16 0.820 
Stage N1 (%) 10.46±1.70 10.24±1.44 0.935 
Stage N2 (%) 41.65±2.67 42.56±2.74 0.853 
 Stage N3 (%) 28.28±2.71 30.40±1.28 0.434 
 TST (mins) 405.26±10.96 383.34±11.15 0.274 
 Sleep latency(mins) 17.67±3.84 20.86±3.74 0.629 
 PLM Index(events/h) 0.13±0.10 0.93±0.41 0.067† 
 Snore Index(events/h) 30.41±15.28 156.02±35.62 0.002** 
Mean SaO2 (%) 
Systolic pressure 
Diastolic pressure 
95.97±1.12 
100.80±17.20 
60.00±22.36 
90.12±3.61 
106.76±19.40 
66.79±11.86 
0.332 
0.387 
0.141 
†0.05≦P0.1. *P<0.05. **P<0.01. ***P<0.001. BMI, body mass index; AHI, apnea-hypopnea index; 
AHI/REM, AHI during REM; AI, apnea index; REM, rapid eye movement; TIB, Time in Bed; SPT, 
Sleep Period Time; TST, Total Sleep Time; WASO, Wake time after sleep onset; PLM, Periodic 
Limb Movement; Mean SaO2, mean oxygen saturation; Lowest SaO2, lowest oxygen saturation. 
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(3)  Inflammatory cytokines result: 
In addition, (see table 3), the expression of inflammatory cytokines IL-17, IL-23 and HS-CRP 
was significantly elevated in children with OSA (p=0.002, p=0.024, p=0.047 respectively). 
Plasma levels of TNF-α, IL-1, IL-6 and IL-10 showed a non-significant elevation comparing 
with normal control.  
Table 3 - Comparison of inflammatory cytokines in healthy and OSA children 
 
 
Control(n=32) 
mean±SD 
OSA(n=47) 
mean±SD 
 
p value 
HS-CRP mg/l 0.41±0.48 1.90±0.44 0.002** 
TNF-αug/dl 12.62±0.94 12.58±0.83 0.974 
IL-1βpg/ml 0.42±0.27 0.36±0.16 0.857 
IL-6 pg/ml 1.10±0.18 1.66±0.23 0.104 
IL-10 pg/ ml 2.10±0.28 2.62±0.39 0.332 
IL-17 pg/ml 10.20±1.25 15.12±1.38 0.024 * 
IL-23 pg/ml 12.29±0.73 14.58±0.75 0.047* 
*P<0.05.**P<0.01. 
HS-CRP, high sensitivity-C reactive protein; TNF-α, tumor necrosis factor alpha; IL-1β, 
Interleukins 1 beta; IL-6, Interleukins 6; IL-10, Interleukins 10; IL-17, Interleukins 17; IL-23, 
Interleukins 23. 
 
(4) The neurocognitive test results: 
Results of CPT and WCST tests (see table 4) indicate significant differences between OSA and 
control in “Hit- RT- Std.- Error“(p=0.006) and “Hit-RT-ISI-Change” (p=0.004).   
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Table 4 - Comparison of CPT and WCST findings in OSA children 
 
 
Control 
total(n=32) 
OSA 
total(n=47) 
p value 
CPT (Continuous performance task)    
 Clinical, Confidence Index 39.34±15.91 49.51±24.46 0.142 
Omissions T score 46.57±5.36 52.33±17.93 0.074† 
Commissions T score 40.50±10.93 45.03±13.02 0.237 
Hit RT T score 49.94±8.86 57.08±13.03 0.056† 
Hit RT Std. Error T score 45.79±6.26 52.96±12.23 0.006** 
Variability T score 46.43±7.31 51.42±10.57 0.099† 
Detectability T score 40.87±12.39 54.62±15.72 0.316 
Response Style T score 51.57±14.97 53.12±14.69 0.732 
Perseverations T score 49.69±7.91 55.34±12.25 0.104 
Hit RT Block Change T score 48.99±6.54 50.43±6.73 0.479 
Hit SE Block Change T score 49.40±7.71 50.07±11.00 0.831 
Hit RT ISI Change T score 47.88±5.25 54.53±10.83 0.004** 
Hit SE ISI Change T score 46.80±8.80 51.70±9.06 0.077† 
WCST    
Total Errors Standard scores 107.20±20.97 99.67±24.26 0.392 
Total Errors T scores 54.80±13.97 49.81±16.19 0.395 
Perseverative Responses T scores 55.10±14.77 50.56±16.57 0.452 
Perseverative Errors T scores 56.30±15.10 50.74±16.42 0.357 
Non Perseverative Errors T scores 55.60±14.37 52.78±16.66 0.639 
% Conceptual Level Response T scores 54.50±4.60 50.19±3.31 0.487 
Learning to Learn -3.49±11.66 -3.90±9.78 0.712 
 
The result of CPT score is presented in T-scores. According to the Conners’ CPT Computer 
Program User’s Manual, high T-scores are designed to indicate an attention problem. Any T-
score above 60 is considered abnormal. The Confidence Index presents the summary of the 
CPT. The Omissions reveals the number of targets which the person did not respond to. The 
Commission reveals the number of times when the person responds to a non-target. Hit RT, Hit 
reaction time; which reflects the mean response time. Hit RT std. Error, Hit reaction time 
standard error; which measures the speed consistency. The variability, also a measure of 
response time consistency, which calculates the standard deviation of the 18 standard error 
values calculated for each sub-block. The detectability is a measure of discriminative power. 
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The higher response style T score indicates that the person act more cautiously to avoid 
commission error, and the lower score indicates that the person respond more freely to make 
sure they answer most of the target. The perseverations T score shows the frequency when 
responding time is lower than 100ms. Hit RT block change, Hit reaction time block change. 
The Hit RT block change shows the change in reaction time over the 6 time blocks; the higher 
Hit RT block change T scores indicates a slowing of reaction time as the test progress. Hit SE 
block change, Hit standard error block change, which indicates the consistency the person react 
to the targets as test progress. Hit RT ISI Change, Hit reaction time inter-stimulus interval 
change, reflects the change in reaction time over three inter-stimulus intervals (1,2 and 4 
seconds.) Higher score reflects slowing of reaction time as the intervals between targets 
increased. Hit SE ISI Change, Hit reaction time inter-stimulus interval change. Higher score 
reflects the person became more erratic as the time between targets increased.  
WCST, Wisconsin Card Sorting Test. The total errors scores is an overall score of WCST test, 
and the higher raw score indicates worse performance. The perseverative response and error 
raw score are higher in the person with worse performance of mental flexibility and insight. 
The non-perseverative error reflects difficulty to forming concepts and insight even in flexible 
answer. The conceptual level response score indicates the insights in correct principle of the 
card combination. Learning to learn depicts the average tendency over successive categories 
for efficiency to change.  
 
(5) Relationships between inflammatory cytokines and PSG data  
A Standardized Regression Test was performed to demonstrate the relationship of cytokines 
levels with PSG and neurocognitive outcomes after controlling the factors of “asthma, allergy, 
BMI, gender, tonsil hypertrophy, adenoid hypertrophy, turbinate hypertrophy, and naso-septal 
deviation” (see tables 5 and 6).  
It revealed significant relationships between pro-inflammatory cytokines and some PSG factors, 
such as HS-CRP with AI (β=0.390, P<0.05) and IL-17 with AHI severity (β=0. 329, P<0.05) 
(see table 6). Higher AI “influenced” serum levels of HS-CRP suggesting an impact of 
inflammatory cytokines on soft tissues hypertrophy. Similarly, higher serum levels of IL-23 
was “influenced” by higher AI (β=0.403, P<0.05). Also, lower mean SaO2 “influenced” IL-10 
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level (β= -0.567, P<0.01), and higher serum levels of TNF-α and IL-1β were “influenced” by 
higher diastolic pressure (β=0.469 and 0.659, P<0.01). 
 
Table 5 Relationships between inflammatory cytokines and PSG findings 
 HS-CRP TNF-α IL-1β IL-6 IL-10 IL-17 IL-23    
Polysomnographic data 
AHI severity a,c 0.237 -0.078 0.026 0.124 0.205 0.329* 0.184 
AHI(events/h) a  0.114 -0.109 -0.114 -0.095 -0.079 0.059 0.163 
AHIREM (events/h) a  0.022 -0.101 -0.095 -0.082 -0.027 0.095 0.331† 
AI (events/h) a 0.390* 0.162 -0.209 -0.074 -0.31† -0.238 0.403* 
HI (events/h) a 0.020 -0.100 -0.129 -0.036 0.080 0.225 0.276 
Desaturation Index 
(events/h) a 
0.156 0.076 -0.151 -0.088 -0.147 0.001 0.317† 
Sleep efficiency (%)a -0.037 0.041 -0.090 0.050 -0.150 -0.126 -0.077 
Awake (%)a -0.016 0.012 0.059 -0.046 0.139 0.089 0.054 
REM (%)a 0.111 0.064 0.057 0.318* 0.026 0.148 -0.090 
Stage N1 (%)a 0.022 -0.168 0.076 -0.011 0.139 -0.086 0.183 
Stage N2 (%)a -0.520 -0.174 -0.049 0.001 -0.220 0.026 -0.234 
 Stage N3 (%)a -0.261 -0.061 0.057 -0.189 0.330* 0.191 -0.206 
 TST a 0.118 -0.057 -0.27† 0.188 -0.224 0.034 0.067 
 Sleep latency a 0.162 -0.141 0.297* 0.014 0.092 0.012 0.133 
 PLM Index a -0.048 0.088 -0.006 -0.141 -0.201 -0.33* 0.230 
 Snore Index a -0.079 -0.145 0.133 -0.052 0.066 0.157 -0.052 
 Mean SaO2 (%)a 0.040 -0.159 0.012 -0.123 -0.57** -0.242 -0.023 
 Systolic pressure a -0.43† 0.064 0.09 -0.41† -0.14 0.088 -0.56* 
 Diastolic pressure a -0.15 0.47** 0.66** -0.18 -0.10 -0.10 -0.06 
aStandardized regression coefficient. Control factors: Asthma, allergy, BMI, gender, Tonsil hypertrophy, 
Adenoid hypertrophy, Turbinate hypertrophy, Nasoseptal deviation. †0.05≦P0.1. *P<0.05. **P<0.01. 
AHI, apnea-hypopnea index; cAHI severity: 5≧AHI>1 events/h (mild), 10≧AHI>5 events/h (moderate), 
AHI>10 events/h (severe); AI, apnea index; HI, hypopnea index; REM, rapid eye movement; TST, Total 
Sleep Time. 
 
(6) Relationships between inflammatory cytokines and neurocognitive function 
There was a significant relationship between lower performances of CPT test and pro-
inflammatory cytokines as shown in table 6. The Standardized-Regression-Test indicated 
significant findings between pro-inflammatory cytokines and neurocognitive-function tests. The 
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elevated cytokines are related to domains of inattention, vigilance, such as “Hit-RT-ISI-Change 
T- score” and HS-CRP (β= -0.426, P<0.05); “Response-Style T-score” and TNF-α (β= -0.432, 
P<0.05); “Hit RT ISI Change T score” and “Hit SE ISI Change T score” with IL23 (β= -0.545, 
-0.526, P<0.01); and higher “Confidence-Index” with IL17 (β= 0.424, P<0.05). When looking 
at the influence between inflammatory cytokines and WCST, the results indicate that elevated 
cytokines, such as TNF-α and IL6 are related to decrease of executive functions: such as “non-
Perseverative- Errors T-scores” (β= -0.553, P<0.05) ; “Learning-to-Learn” (β= -0.838, P<0.05) ; 
and “Percent-Conceptual-Level-Response- T-scores” (β= 0.476, P<0.05); especially IL-23 with 
significant poor performance of “non-Perseverative-Errors T- scores” (β= -0.729, P<0.01). 
 
Table 6 Relationships between inflammatory cytokines and neurocognitive function tests 
 HS-
CRP 
TNF-
α IL-1β IL-6 IL-10 IL-17 IL-23 
CPT 
Clinical, Confidence Index a -0.185 -0.177 -0.040 -0.027 0.181 0.424* -0.317 
Omissions T score a -0.256 -0.154 -0.067 -0.109 0.002 0.112 -0.336† 
Commissions T score a 0.037 0.075 0.170 0.030 0.250 -0.056 0.045 
Hit RT T score a -0.071 -0.127 0.006 -0.106 0.065 0.267 -0.249 
Hit RT Std.Error T score a -0.207 -0.216 0.083 -0.103 0.182 0.294† -0.322† 
Variability T score a -0.247 -0.098 0.160 -0.009 0.354† 0.274 -0.291 
Detectability T score a -0.116 0.032 0.136 -0.004 -0.050 -0.186 0.034 
Response Style T score a -0.044 -0.432* -0.101 -0.039 0.136 0.309† -0.129 
Perseverations T score a -0.253 0.109 -0.013 -0.112 0.155 0.184 -0.203 
Hit RT Block Change T score a -0.146 -0.328† -0.066 -0.017 0.105 -0.102 -0.051 
Hit SE Block Change T score a -0.100 -0.121 0.131 -0.029 0.201 -0.184 -0.051 
Hit RT ISI Change T score a -0.426* -0.155 0.003 -0.168 -0.012 -0.036 -0.545** 
Hit SE ISI Change T score a -0.389† -0.192 0.174 -0.159 0.049 0.114 -0.526** 
WCST 
Total Errors Standard scores a -0.123 -0.335 0.089 0.436† 0.065 -0.086 -0.443† 
Total Errors T scores a -0.124 -0.345 0.082 0.433† 0.068 -0.083 -0.446† 
Perseverative Responses T scores a -0.276 -0.093 0.186 0.324 -0.016 0.027 -0.179 
Perseverative Errors T scores a -0.262 -0.117 0.175 0.324 -0.021 0.012 -0.197 
nonPerseverative Errors T scores a 0.047 -0.553* -0.058 0.255 0.106 -0.250 -0.729** 
% Conceptual Level Response T scores 
a 
-0.131 -0.315 0.067 0.476* 0.081 -0.079 -0.404† 
Learning to Learn a 0.336 -0.838* 0.019 0.221 0.119 0.330 0.295 
aStandardized regression coefficient. Control factors: Asthma, allergy, BMI, gender, Tonsil hypertrophy, Adenoid 
hypertrophy, Turbinate hypertrophy, Nasoseptal deviation., †0.05≦P0.1. *P<0.05. **P<0.01. WCST, Wisconsin 
Card Sorting Test; CPT, Continuous performance task 
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(D) Summary of the findings in study # 7 
(1) Our study showed that an abnormal increase in HS-CRP, interleukins 17 and 23 is present 
in association with mild to moderate OSA children.  
(2) Lower neuro-cognitive test results are also demonstrated in the OSA children, and there are 
significant positive correlation between low scores at cognitive tests (showing decrease 
alertness and increase in inattention, inability to focus leading to erratic responses and to 
appropriately conceptualize) and abnormal level of inflammatory cytokines, more 
particularly Il-17 and Il-23. 
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l VI. Discussion 
VI-1. Sleep and breathing in premature infants 
 
(1) Our study validated the CBISQ; furthermore, it was the first study targeting the difference 
between premature and full-term infants through a reliable and valid screening questionnaire. 
Based on our results, premature infants, rather than full-term infants, preferred a side body 
position and being held when falling asleep. Apart from this, premature infants had longer 
nocturnal sleep duration, more night awakenings, and longer daytime sleep duration. The 
caregivers of premature infants noted that their children had more sleep problems. A 
significant difference between preterm and full-term infants is nocturnal sleep duration and 
loud-noisy breathing was noted. The number of night awakenings and time spent with 
mouth-breathing also varied between the 2 groups. These questionnaire findings indicated a 
higher prevalence of sleep-breathing disorders , and correlated with those obtained with PSG 
that showed a very high percentage (80.6%) of premature infants with AHI greater than 1 
event/hour. These disturbances impact nocturnal sleep duration and quality. 
(2) Our results provide new insights into the difference between premature and full-term infants 
regarding sleep problems. During the first year of life, infancy-sleep is a rapid maturational 
process , so the settling time, daytime sleep duration and time spent crying during the night 
may vary widely both among infants and between questionnaires repeated at several 
occasions. Infancy sleep maturation may impact the maturation of the central nervous 
system, overall functioning, and future cognitive, motor, and temperament development 
[123]. 
(3) Moreover, even till 2 years of age, premature infants with narrow and high-arched palate 
have more SDB-related sleep problems and more neurodevelopmental deficits than those 
without. These findings support our hypothesis that high and narrow-arched palate in 
premature infants plays a role in the development of sleep problems and subsequent 
neurodevelopmental delays. 
 
(4) Limitations: There are some methodological limitations that should be noted when 
interpreting our findings. First, the sample sizes of the 2 groups in our study were very 
different, so some of the differences between the premature and full-term infants may not 
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be apparent in the CBISQ sleep measurement. Second, 16.59% of our study group 
(premature infants) did not complete the CBISQ assessment and sleep examination when 
they were 6 months old, but our follow-up study had more than 70% of the initially signed-
up children.  
(5) Strengths: Our study monitored simultaneously objective and subjective data investigating 
sleep problems of the premature. Actigraphy provides only integrated sleep data, not 
detailed parameters of the sleep status, so the validity testing of the CBISQ sleep measure 
with actigraphy, although providing quantitative biological parameters, is not totally 
satisfactory. Therefore we added PSG: , it is difficult to perform PSG in premature infants 
because of uncooperative child, night feeding and size of premature infant with too small 
limbs and torso for some equipments. However, our premature group was large, and 
actigraphy and PSG data were both obtained from a large number of premature infants.  
 
VI-2. Neurodevelopmental dysfunctions in prematurely born neonates  
 
(1) Our study shows that 13.2% of the preterm neonates have MNDs at the corrected age of 6 
months and even 8.6% of neonates born late-preterm (GA 33-36 weeks) have MNDs. 
Furthermore, as GA decreases, the proportion of children with MNDs confirmed by both 
PDI below 70 and failure of DDST gross motor subscale increases. Although several 
neonatal factors are found to be associated with MNDs, the multivariate model for these 
infants showed that postnatal corticosteroid use and cholestasis were independent predictors 
of MNDs at their 6 months corrected age. 
(2) It is difficult to compare our study with previous studies because our subjects were assessed 
at much earlier age. The proportion of MND in very preterm neonates and preterm neonates 
(GA ≦ 28 weeks and GA 29-32 weeks) is similar to other studies [27-29], but 28.6% (6/21) 
of our neonates with a birth weight ≦ 750g had MND, which is slightly higher than a recent 
study conducted by Claas MJ et al . The percentage of ELBW children with a MDI or a PDI 
of < 70 assessed with the BSID-II at or around 2 years of age ranged from 10.6% to 50%; 
this variability in the obtained results relates to the  different designs used and to selection 
bias of the different studies. For example, some studies evaluated infants with presumably 
fine motor function impairments and avoided those with moderate or severe dysfunctions; 
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others evaluated their results after an individualized developmental care. In our study group, 
4 of the 28 ELBW infants (14.2%) had a MDI of < 70, whereas 10/28 (35.7%) neonates 
assessed with the BSID-II had a PDI of < 70. Given the fact that comparable percentages of 
low PDI and MDI in each study subgroups were usually noted , our results strongly suggest 
that early detection of psychomotor delay maybe more feasible than mental developmental 
delay by the current screening tools. 
(3) In all cases the postnatal corticosteroid use in our infants corresponded to dexamethasone in 
low dose (0.05mg/kg/day) intravenously for chronic lung disease, which is proven effective 
to facilitate extubation without significant short-term side effects . Several human studies 
have found that postnatal dexamethasone exposure was associated with increased risk of 
long-term neurological and motor dysfunctions, but their steroid dosages were much higher 
(0.5mg/kg/day) and the administration period longer. A larger, randomized controlled trial 
is required to further assess the long-term effects of low dose dexamethasone. The prenatal 
steroid is inevitably used for prevention of RDS in premature neonates, which had no 
significant impact on the long-term neurological outcomes , in spite of the fact that most 
corticosteroids, including dexamethasone or betamethasone, are capable of transfusing to 
the fetus through placenta. Therefore, the real pathophysiological mechanisms of postnatal 
corticosteroid use and its effects upon the developing brain of premature infants are still 
unknown and deserve further in vitro and in vivo studies. Cholestasis, was another 
independent predictor of MNDs in our study; it may be an indicator of severe sickness in 
the high risk and very preterm neonates, rather than a direct cause of the MNDs at 6 months 
corrected age. 
(4) Several neonatal factors, including multiple birth, severe abnormalities on early cranial 
ultrasonography, breast feeding, treatment methods of PDA, chronic lung disease and SGA 
have been reported to independently influence the neurodevelopmental outcomes at 2 to 5 
years of age. The significant predictors of a low MDI and a low PDI are usually considered 
together, but the pathogenesis of developmental delay in psychomotor and mental domains 
are supposed to be different and supported by some evidences. The associations of 
ultrasound-defined lesions of the brain and developmental delays have been well 
documented in recent publications. Cerebral white matter injury, caused by systemic 
inflammatory response, transient hypoxia or prolonged mechanical ventilations during 
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hospitalization may also predispose to low MDI and low PDI scores. Our study, after 
excluding infants with cerebral palsy and major neurological deficits, focused on MNDs of 
grossly normal premature infants and can not conclude similar findings. 
(5) Although the Bayley test is the gold standard in screening developmental delay of early 
childhood, it is most reliable when performed at or around 24 months corrected age. Thus, 
DDST was applied as the supplemental tool to confirm the MNDs in our study. We found 
the results of BSID-II PDI < 70 and failure in DDST motor subscale were highly correlated;  
the NMDs in our study are defined as at least two abnormal measures, which decrease the 
possibility of false positivity. 
 
(6) Limitations:  This study has some limitations. Not all premature neonates born during the 
study period were enrolled, because their parents declined to participate in the study. We do 
not know whether those refusing to participate were significantly different from our study 
group, and whether this potential difference could have influenced our results. This study is 
also limited by its inadequate sample size, for which the drop out cases of the longitudinal 
follow-up and repeated examinations also contributed. 
 
VI-3. Sleep-Disordered Breathing and oral-facial development in the premature infant 
 
(1) Currently at 4 years of age, 77% of our premature infants have OSA and a high and narrow 
hard palate. There is a relationship between gestational age-GA- at birth and the presence of 
problem which increases with younger GA of the subject at birth. But, this is not the only 
factor. As found, children with normal palate and AHI may progressively deteriorate during 
the first post-natal months. Preliminary data indicates that normal functioning of suction, 
swallow, mastication and nasal breathing post-birth are key factors in the switch overtime 
to abnormal breathing and high and narrow hard palate. 
(2) Limitation: As any longitudinal study we have lost patients along successive years, however 
our sample to date is over 250 prematures at 4 years, the group with a transition from normal 
to abnormal is small (n=39);  eventually  some other factors are involved in this negative 
evolution; a larger study focusing only on this question is needed. 
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VI-4. Inflammation, Neurocognition and Pediatric sleep-disordered-breathing 
 
(1) From of our longitudinal study on premature children we had found out that mouth breathing 
was in frequent association with snoring and sleep-disordered-breathing and that tonsils 
were not initially enlarged in children that developed OSA, but become enlarged later on 
[see study #3]. We showed that children with enlarged tonsils and adenoids (T&A) treated 
with adenotonsillectomy may present relapse of OSA within 3 years.  Inflammatory factors 
have been mentioned as  potential factors in the development of co-morbidity in adult OSA 
[124, 125]. We question if inflammation could not play a role in the development of pediatric 
OSA and if persistence of inflammatory factors could not be abnormally elevated in 
pediatric OSA. The world of inflammatory factors has become complicated as many of the 
usually monitored interleukines such as interleukin1,6, 10 have been showed to be under the 
control of other interleukines more recently identified such as interleukines 17 and 23. In 
the search of biological markers of OSAS in children Kallikrein-1, uromodulin, urocotin-3, 
and orosomucoid-1 in the urine are eventually accurate as OSA diagnostic test in children 
[125] Furthermore, fundamental research has shown that functional lymphatic vessels 
expressing all of the molecular  hallmarks of the lymphatic endothelial cells are able to carry 
both fluid and immune cells from the cerebro-spinal-fluid and are connected to the deep 
lymphatic cervical ganglions , demonstrating a direct interaction with brain structures. 
Obesity is a further variable linking OSAS, Cognition and inflammation [126]; in our studies 
we have shown that OSA could occur in non-obese children, Taken altogether these 
considerations imply further research. 
(2) Children with OSA have neurological dysfunction, presenting symptoms of inattention and 
difficulty learning, this is a known co-morbidity of pediatric OSA. Abnormal inflammatory 
cytokines may be involved in the difficulties that children present when performing neuro-
cognitive testing. Our study evaluated the importance of the SDB, of the cytokines 
abnormalities and of neurofunctional cognition, questioning if a correlation could be found 
between these different abnormalities. If we have support for our hypothesis, this will lead 
later on to a second investigation looking at the impact of SDB treatment on the same 
variables.  
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(3) Limitations: Our study has limitations: despite the fact that we looked at 79 children- a high 
number for this type of study- this is still an overall low number. Also, our controls were 
somewhat “hyper-normal”: we eliminated from the study any child that had an indication of 
abnormal levels of inflammatory cytokines; finally, our children were not all with “severe” 
OSA (only 17% had AHI>10), all however presented abnormal PSG findings: Our findings 
are in line with data showing that even children with low but abnormal AHI have often 
memory, attention problems and school difficulties . Finally, as the total number of children 
is relatively limited, despite the usage of “standardized regression test” before performing 
correlation analyses and the inclusion of all studied children for statistical purpose, the 
results are considered preliminary andrequire confirmation with larger numbers subjects 
and/or evaluation of change after an appropriate treatment is used.  
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l VII. Conclusion and Recommendations 
 
Our work had a marked impact in Pediatric Sleep Research in Taiwan, with special 
reference to our Hospital, in which a Pediatric Sleep Laboratory has been developed and a 
multidisciplinary team was organized. 
Furthermore, we organized an observation cohort of preterm infants, in which sleep, as a 
main human body function, is measured together with other biological, neurodevelopmental 
data. 
It is still a work in progress.  
We are following our premature cohort, and despite the attrition that we expected, we see 
a persistence of abnormal breathing during sleep, with apnea and hypopnea in 77% of our group 
at 4 years of age. Premature infants have more learning and attention problems than control full-
term children but the children, and particularly premature infants, with sleep-disordered-
breathing –SDB-have more dysfunctions than those without SDB. 
Some of the premature as full term infants have short lingual frenulum , an anatomical 
presentation not checked in premature infants and often difficult to recognize in early premature, 
but that should be systematically checked with further growth. “Clipping” of the lingual 
frenulum may not be possible but dis-insertion of this vestigial abnormally placed fibrous tissue 
can be done.  
Many premature infants have generalized hypotonia at birth and this is particularly true the more 
premature the infant is. In our studies we selected infants that were “healthy premature” and not 
in need of tube feeding, intubation, ventilation support as example. Despite this initial status, 
our follow-up studies show that the long-term prognosis of these children is associated with 
abnormal cognition, abnormal oral facial development, abnormal sleep-wake and abnormal 
breathing during sleep. In the recent past, attention has focused on the role of some basic 
functions such as sucking, swallowing, chewing, nasal breathing, that are impaired in premature 
infants bellow 35 weeks of GA. Our findings indicate the defect, but have not address really the 
potential solutions. In the recent past the field of “myofunctional treatment”-MFT- has surged, 
but there is little objective information concerning-MFT- in infants, its easiness of application, 
and its outcome. However, the problem is important: the World Health Organization indicated 
that 15% of all pregnancies ended with a premature birth. Technological advances have allowed 
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survival of younger and younger premature, but to obtain survival is not enough: currently many 
survivors present handicaps that can be already demonstrated by 6 months post-birth. New 
treatment avenues must be developed, new approaches involving families have to be found, 
MFT is one of these new fields that may lead to improvement of the overall long term status of 
the premature infant at some level, but the current data are very limited. Our work outlined only 
some of the challenges that are currently faced. 
The involvement of inflammatory cytokines with SDB is also clear but much more work needs 
to be done in this area. Further works may indicate if a treatment is successful performing a 
blood test and not having to perform systematic PSG. But the field of cytokines is getting always 
more complex and the selection of which cytokine(s) to systematically follow is still uncertain, 
and much more work is needed in this area . The interaction between inflammatory cytokines 
and neuro-cognitive functions is also a wide-open field for further research 
Sleep is always affected in children with health problems, but sleep and investigation of vital 
variables during sleep is an important test in order to understand the development and worsening 
of SDB, and despite its challenges, it should be a test used much more in clinical practice when 
daytime problems cannot be easily resolved. Our contribution took several years to acquire, but 
raises many more questions than at the start of this work. Many fields will have to collaborate 
to cope with the challenges that prematurity brings to society. 
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Abstract: 
Aims: Review of evidence in support of an oral-facial growth impairment in the development of 
pediatric sleep apnea in non-obese children 
Method: Review of experimental data from infant monkeys with experimentally induced nasal 
resistance. Review of early historical data in the orthodontic literature indicating the abnormal oral-
facial development associated with mouth breathing and nasal resistance. Review of the progressive 
demonstration of sleep disordered breathing in children who underwent incomplete treatment of OSA 
with adenotonsillectomy, and demonstration of abnormal oral-facial anatomy that must often to be 
treated in order for the resolution of OSA. Review of long term recurrence data on OSA and indication 
of oral-facial myofunctional dysfunction in association with the recurrence of OSA.  
Results: Presentation of prospective data on premature infants and sleep-disordered-breathing (SDB)-
treated children, supporting the concept of oral-facial hypotonia. Presentation of evidence supporting 
hypotonia as a primary element in the development of oral-facial anatomic abnormalities leading to 
abnormal breathing during sleep. Continuous interaction between oral facial muscle tone, maxillary-
mandibular growth and development of SDB. Role of myofunctional re-education with orthodontics 
and elimination of upper airway soft tissue in the treatment of non-obese SDB children.  
Conclusion: Pediatric OSA in non-obese children is a disorder of oral facial growth. 
 
 
Key-words: Pediatric sleep-disordered-breathing, Non-obese, Oral-facial anatomy, Hypotonia 
Oral-facial growth, oral-facial myofunctional dysfunction 
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Introduction 
Since the report of obstructive sleep apnea syndrome in children in 1976 (Guilleminault et al), 
recognition of abnormal breathing during sleep has progressed. There was the introduction of the nasal 
cannula-pressure transducer (Serebrisky et al., 2002), a more accurate technique than thermistors, the 
commonly previously used definitions to score abnormal breathing during sleep in association with 
esophageal manometry (Pes). It has allowed to recognized well the pattern of “flow limitation”; 
associated with an abnormal increase or decrease in respiratory effort and related to demonstrated sleep 
EEG changes indicative of sleep disturbances (Hosselet et al., 1998,Aittokallio et al., 2001). The sleep 
EEG changes were also shown to be better recognized using the “cyclic-alternating-pattern” (CAP) 
scoring system, a visual scoring system commonly used in Europe and Latin America (Terzano et al., 
2002). This visual scoring system recognizes sleep disturbances, particularly arousals indicative of 
sleep disruption, better than the most commonly used atlas that require at least 3 seconds to score a 
disturbance. More accurate approaches have been used calling upon computerized analyses of the sleep 
EEG, based on specific algorithms (Chervin et al., 2004) or using well-known EEG analysis programs 
(fast-Fourier Transform, Wavelet or even better Hiller-Huang Transform programs). Usage of these 
recording techniques has allowed recognition of Sleep-Disordered-Breathing (SDB). 
Follow- up of the first cases of children treated by tracheostomy, then by home nasal CPAP that was 
not well accepted in these teen-agers, led to usage of more specific surgery oriented toward treatment 
of the upper airway, performing maxilla-mandibular surgery (Powell et al., 1983) with follow-up for 
more than 25 years in one case indicating complete long term resolution of the OSAS. 
 
Lessons from OSA treatment with adenotonsillectomy 
Despite the widespread use of techniques with limited ability to identify the complete cessation of 
abnormal breathing and its effects during sleep, studies progressively reported an absence of complete 
elimination of sleep-disordered-breathing despite significant initial improvement in many tests. Early 
on two studies showed that prepubertal adolescents who were considered to be completely cured from 
OSA presented with OSA again as teenagers (Guilleminault et al., 1989). Interestingly, these subjects 
had a narrowing behind the base of tongue and orofacial anatomical abnormalities that either did not 
exist initially or had not been recognized at its earlier stage. Tasker et al (2002) also confirmed the 
presence of an abnormal upper airway and SDB twelve years after adenotonsillectomy. In more recent 
studies with larger number of patients, this point was made very clear: Despite a clear improvement of 
clinical symptoms, Guilleminault et al (2004) reported a complete resolution of OSA following 
adenotonsillectomy in only 51% of the non-obese prepubertal children they successively studied with 
systematic PSG at approximately 3 months post-surgery. Tauman et al (2006) and Guilleminault et al 
(2007) confirmed these findings. In a more recent multi-center study (Bhattacharjee et al., 2010), 
though 50% of the 500 recruited children had been obese, adenotonsillectomy again improved clinical 
symptoms and PSG results but did not cure the syndrome in about 70% of the enlisted children. 
Recently, Chen et al (2012) reported on a systematic prospective study of prepubertal children treated 
with adenotonsillectomy, who were then considered to have normal PSG according to AASM 2007 
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scoring criteria (Iber et al., 2007). All children whose parents signed informed consent were included 
in the prospective follow-up study, which spanned a 5-year period, and included not only systematic 
PSGs and clinical evaluations, but also attentional neurocognitive testing performed during the daytime 
that was interpreted blindly by the same trained psychologist and 3D-CT of the upper airway that was 
also interpreted blindly by the same cranial-facial specialist. The follow-up evaluations performed at 3- 
and 6- months showed normal PSG (AASM criteria) and neurocognitive scores. However, further 
follow-up showed once again the simultaneous presence of abnormal breathing during sleep (AASM 
criteria) and abnormal neurocognitive test results in 40% of the prepubertal children. Moreover, 3D-CT 
analysis showed abnormal oral-facial development in these children. Kim and Guilleminault (2011) 
also reported on a systematic investigation of the presentation of anatomical oral-facial abnormalities 
noted in 400 prepubertal children diagnosed with OSA and enlarged adenotonsillectomy before 
otolaryngological treatment. It came out that nearly all the children with OSA had at least one type of 
oral-pharyngeal abnormality from the list of pre-defined potential problems. As expected based on 
previous findings, clinical symptoms and abnormal PSG persisted in some children at 3-months 
follow-up after adenotonsillectomy. However, the study showed that many children had one of the 
many anatomical oral-facial abnormality investigated before surgery and scored based on systematic 
pre-established evaluation scales: this non specific scoring was insufficient to predict complete or 
incomplete results from adenotonsillectomy. Further analyses produced more specific clinical 
examination findings that better predicted persistence of abnormal PSG results post 
adenotonsillectomy. Similar to an analysis performed by Guilleminault and his coworkers (2007), the 
clinical findings included the presence of a Mallampati (or Friedman-Mallampati) scale score of 3 or 4 
(Mallampati et al., 1985), the presence of a deviated septum, and the presence of a small mandible. The 
Mallampati scale does not identify one particular anatomical abnormality, but an abnormal score 
represent a combination of deficiencies involving both the nasomaxillary complex and the position of 
the mandible. The findings suggest the need to assess the upper airway on anatomic elements more 
related to oral facial growth and possibly more generalized oral-pharyngeal growth impairment rather 
than looking at many anatomic deviations from what is considered the norm. 
 
Lessons from  orthodontia and the experimental infant monkey model 
European orthodontists showed that abnormal nasal resistance induced by enlarged adeno-tonsils in 
children were associated with mouth breathing and led to important cranio-facial changes (Haas, 
1961;Linder-Aronson, 1969; 1970;Wertz, 1970;Timms, 1974;Gray, 1975;Hershey et al., 
1976;McNamara, 1981;Timms, 1984). Ablation of the adeno-tonsils led to cessation of the mouth 
breathing and progressive return to normal facial development facilitated by orthodontia use in follow-
up studies. Other orthodontists stricken by narrowness of the maxilla and its very negative impact on 
teeth position and facial growth during prepubertal development had performed “rapid maxillary 
expansion” (RME), and reported that such treatment had also made an impact on a sleep-related 
complaint. For example, treated children experienced elimination of their nocturnal enuresis. However, 
the most important findings were obtained on the infant monkeys, when the important role of abnormal 
nasal resistance during the developmental period was demonstrated.  
Between 1970 and 1980, a number of very important experiments on newborn rhesus 
monkeyswere performed, whereby a small silicone head was placed within the nostrils of infant 
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monkeys and held by a thin thread to the nostrils in order to induce a clear nasal resistance for the first 
6 months of life, and subsequent removal of the nasal obstruction thereafter (Harvold et al., 
1981;Vargervik et al., 1984). As reported by Harvold and his team (1981), the blockade of the nasal 
passage led to narrowing of dental arches, decrease in maxillary arch length, anterior cross bite, 
maxillary over-jet and increase in anterior face height. These results were well illustrated, but the most 
significant findings in our view, was the report by Vargervik et al (1984) and Miller et al (1984). These 
researchers from the same team showed that experimentally induced abnormal nasal resistance led to 
systematic changes in the orofacial muscles. The changes were noted in the systematic recording of 
different muscles, more particularly the geniohyoid, the genioglossal muscles that constitute the 
tongue, and also, in the suprahyoid dorsal tongue fibers – the upper lip elevators, and the digastric 
muscles. 
EMG changes were reported to show abrupt induction of rhythmic discharge patterns. This is 
contrary to normal firing, which is near continuous and desynchronized in any normal individual. 
Tonic EMG discharges changed back to the normal pattern when nasal breathing was restored at the 
end of the 6-month experiment. These alterations were entirely related to the abnormal nasal breathing 
accompanying the increase in nasal resistance. Increase in nasal resistance has a dramatic effect on the 
maxillomandibular skeleton, halting growth (Harvold et al., 1981) and bringing about adaptive changes 
in the soft tissues that are associated with deviation in jaw posture and tongue activity (Miller et al., 
1984;Vargervik et al., 1984). That is, the nasal obstruction induces functional changes in the 
nasomaxillary complex and on the mandible.The consequences of the experiments were as follows: 
There was an absence of development, which impacted the maxilla and restricted the nose and upper 
jaw; there was a displacement of the mandible leading to mouth breathing and; oral breathing 
developed in association with increase in nasal resistance, leading to mouth opening and mouth 
breathing that occurred day and night. These led to the narrowing of the cranial skeleton (Harvold et 
al., 1981;Miller et al., 1984;Vargervik et al., 1984;Rubin, 1987;Vargervik and Harvold, 1987). Further 
follow-up showed that these changes were reversible if the experimental nasal resistance was 
withdrawn while the infant monkey was still in its developmental phase. 
In summary: In growing animals in which the nasal airway is gradually occluded, there is an adverse 
effect on the morphology of the nasomaxillary complex, mandible, and pharyngeal airway space. The 
morphometric changes are induced by altered functioning of the muscles, with changes in muscle 
firing that are triggered by abnormal nasal resistance. 
Obstructive sleep apnea syndrome was mostly unknown at the time of this investigation and no sleep 
recording was performed on the experimental animals. 
 
Application of work in orthodontia in the field of SDB 
More recently, findings that support the incomplete resolution of abnormal oral-pharyngeal growth by 
adenotonsillectomy have led to the usage of orthodontic techniques to help treat pediatric SDB. Several 
studies were performed over time, based on reports demonstrating the important role of the mesio-
palatine suture in the nasomaxillary complex growth and examining its ossification process in depth.  
Cartilage is a connective tissue made of chondrocytes embedded in a matrix rich in collagen 
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(particularly type II), associated with proteoglycans in hyaline cartilage that strengthens it, and often 
elastin-(depending on the type of cartilage). Hyaline cartilage is the forerunner of skeletal bones in the 
fetus, and endochondral ossification is the process leading to formation of the nasomaxillary complex. 
Rapid Maxillary Expansion- RME-(Pirelli et al., 2004) is a procedure applying orthopaedic forces on 
the mid-palatal sutures using the first molars and permanent premolars as anchor teeth; while in 
deciduous dentition, the second primary molars are selected as long as they can provide the required 
firmness. The device is composed of a central expansion screw with four arms: 2 front arms and 2 back 
arms; the bone distraction at suture level enables an effective enlargement of the maxillary skeletal 
base. Enlargement is visually appreciable as the bone distraction leads to an interincisive space (a 
diastema), and with X-rays (as the gain appears as a radiotransparency corresponding to the visually 
seen space). The procedure usually last 3 to 4 weeks with daily turning of a mid-line screw that allows 
enlargement (distraction) of the space at the level of mid-line suture: The transpalatal force, that 
exceeds the orthodontic one, produces an orthopaedic force that opens the mid-palatal suture leading to 
maxillary movement without tipping teeth. Once the needed extension is obtained (end of the 
activation phase), the midline screw is blocked and the device is kept in place for at least 4 to 6 months 
more, to let the newly formed bone strengthen. Unfortunately, such important cartilage is missing from 
the mandible. Nevertheless, manipulation and verticalization of teeth can stimulate mandibular growth 
and such bimaxillary distraction is often needed in OSA children. In addition, maxillary widening also 
seems to independently impact mandibular growth. One negative element of RME is in its 
anteroposterior lengthening capabilities. That is, it is a limited approach when anteroposterior 
lengthening is needed. In the past, appliances such as the Herbs appliance or its equivalent were 
thought to be capable of producing anterior-posterior growth in prepubertal children. However, while 
such appliances may protrude the lower jaw forward, there is no evidence to date that more growth 
than expected with age is attained. Distraction osteogenesis may be performed in these cases, but while 
such approach is performed in children with clear malformations at birth, it has not been recommended 
in non-syndromic children with OSA till oral-facial growth is well advanced (Guilleminault and Li, 
2004)Normally, 60% of the facial growth is obtained by 6 years of age and about 90% near 11 to 12 
years. Thus, distraction osteogenesis is not usually performed before approximately 14 years of age in 
non-syndromic children with OSA. At that time, there is always a question of whether the 
anteroposterior advancement will be sufficient on its own or whether the teenager will need both the 
anteroposterior and the lateral extension. If the latter is need, as is most commonly the case, MMA 
(Holty and Guilleminault, 2010) is the best recommendation. On the other hand, distraction 
osteogenesis may be useful in certain cases, such as in the elimination of residual OSA. 
In summary: Several studies have shown that RME or bimaxillary distraction have a clear impact on 
pediatric OSA and may resolve the residual problem that is seen post adenotonsillectomy. The 
combination of adenotonsillectomy and RME may potentially resolve OSA symptoms completely and 
a small prospective follow-up study indicates that results may be sustained 36 months post treatment 
(Villa et al., 2011). 
 Two investigations have looked at the effects of RME versus adenotonsillectomy  either via random 
distribution of initial treatment or via initial selection based on the presence or absence of infectious 
tonsils (Guilleminault et al., 2011;Pirelli et al., 2012). In the initial investigation, there was presentation 
of both adenotonsil enlargement with the tonsils scored as level 3 + on the Friedman et al scale 
(Friedman et al., 1999) at entry and narrow jaws. Except for one child who only needed orthodontic 
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treatment, all other children needed both adenotonsillectomy and orthodontic treatment in order to see 
improvement. In the second study, a pre-selection was done with children with infectious tonsils sent 
first to adenotonsillectomy and others to orthodontic treatment; with plan to send children to the other 
arm of treatment if incomplete results were noted. More children were treated only with orthodontics, 
indicating that oral-facial factors may be dominant in at least a subgroup of OSA children. In both 
studies, several children were not completely cured with these approaches indicating that more 
aggressive treatment may be needed. The persistent oral-facial problems were always the prominent 
factor associated with the absence of a complete cure. 
In summary, the studies presented here indicate that adenotonsillectomy in non-obese children does not 
“cure” OSA in many prepubertal children, and that oral-facial anatomical problems are clearly 
involved in the development of OSA in children. Moreover, these anatomical problems may be 
amenable to orthodontic treatment but not in all subjects. 
 
Role of oral facial muscle hypotonia and usage of myofunctional reeducation 
The investigation of the infant monkeys and  the findings of the changes in EMG firing  demonstrated 
that abnormal nasal resistance early in life leadsd to mouth breathing associated with abnormal muscle 
tone with oral-facial hypotonia and secondary changes in maxillary-mandibular growth (Harvold et al., 
1981;Miller et al., 1984;Vargervik et al., 1984;Vargervik and Harvold, 1987). 
In the 1970s, the concept that orofacial muscles were involved in many important functions 
including swallowing, breathing, phonation, mastication, facial mimic, and overall head posture was 
well demonstrated (Leech, 1958;Ricketts, 1958;Hawkins, 1965;Linder-Aronson, 1969; 1970;Solow et 
al., 1984;Rubin, 1987;Behlfelt et al., 1990). Orthodontists in different European countries concluded 
that myofunctional reeducation of the orofacial region was an important part of the treatment aimed at 
rehabilitation of abnormal local muscle activity when performing orthodontic treatment(Chauvois et 
al., 1991) aiming at correcting abnormal maxillary and mandibular growths and their impacts on teeth 
positions and normalcy of bite. Creation of oral-facial muscle reeducation programs meant training of 
specialized reeducators, and cumulated in specific university training with eventual deliverance of 
university diploma. Combine orthodontic and myofunctional reeducation was there after applied in 
children with narrow-jaws with investigation of long term outcome in orthodontia. The combination of 
both treatments was deemed more successful long term than one treatment alone. More recently, after 
demonstrating the involvement of maxillary-mandibular growth problems in SDB, children were 
treated with both myofunctional reeducation and orthodontia (Chauvois et al., 1991;Guilleminault et al, 
2012in press). Brazil was one of the places at the forefront of such a treatment approach and these 
treatment were applied in children but also in adults, and a Brazilian team has published results of the 
combined treatment approach for adult OSA (Guimaraes et al., 2009). However, outcome reports of 
using myofonctional reeducation in SDB children continue to be rare. But the evaluation of children 
with abnormal oral-facial development seen for orthodontic treatment without sleep investigation, is 
well described in orthodontic monographs from the 1990s (Chauvois et al., 1991), including results 
obtained from appropriate reeducation regimen. Despite usage of combined approaches in specific 
geographic places for orthodontic problems, no prospective long-term study has been published where 
orthodontics and myofunctional reeducation were combined in the treatment of SDB children. Studies 
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have recently been initiated comparing results of adenotonsillectomy to that of orthodontic treatment 
without association to myofunctional treatment, and we performed one study investigating the role of 
myofunctional therapy in association with orthodontia in children with SDB. While our own 
investigation was limited due to its retrospective nature and the difficulty of retrieving original data 
from its multi–center setting, it produced evidence that the persistence of mouth breathing during sleep, 
which is related to myofacial hypotonia, led to the reoccurrence of SDB (Guilleminault et al., 2012b;a). 
The recurrence was documented along with the presentation of clinical symptoms, clinical signs and 
PSG findings in children appropriately treated with adenotonsillectomy and orthodontics. 
Myofunctional clinical evaluation revealed the presence of oral-facial hypotonia and of important 
mouth breathing during PSG in the children who experienced a recurrence of SDB. In this limited 
retrospective study (Guilleminault et al., 2012a) involving 24 early teen-agers with SDB previously 
diagnosed between 3 and ½ and 7 years of age and appropriately treated by adenotonsillectomy and 
orthodontia with recommendation of myofunctional reeducation, recurrence of OSA at teen-age in 13 
of them, was  associated with presence of oral-facial hypotonia, mouth breathing during sleep, and 
absence of myofunctional reeducation; while the other studied subjects with normal breathing at long 
term follow-up were with normal oral-facial tone and nasal breathing during sleep, and had completed 
myofunctional therapy. 
 In sum, this retrospective study indicated that myofunctional treatment may be an important tool in the 
treatment of SDB children and that having normal PSG findings may not be always sufficient to 
establish long-term control of abnormal breathing. Myofunctional reeducation is much less applied in 
early infancy. The premature cohort investigation indicates well that SDB is seen very early and that 
abnormal anatomic features of structures limiting the upper airway are also present very early. 
Applications of myofunctional reeducation techniques when the abnormalities of growth are 
recognized may be helpful. But if orthodontists are aware of these treatment approaches, their diffusion 
is rare in the pediatric arena, despite the fact that presence of generalized hypotonia is well known in 
premature infants and well investigated by neonatologist-neurologists.  
Page (2003) has indicated the importance of dealing with oral-facial hypotonia and how to deal with it 
in infancy, as oral-facial hypotonia may be associated with negative facial anatomy problems at a later 
age. Today, there is data showing that the way an infant suck on a nipple (breast or bottle) is important 
for the development of normal oral-facial muscle tone and the prevention of local hypotonia (Davis and 
Bell, 1991;Paunio et al., 1993;Ogaard et al., 1994). Breastfeeding is a complex reflex for infants and 
considerable strength must be generated in order to succeed. Premature infants may experience 
significant apnea with severe drop in oxygen saturation during feeding. Thus, they often cannot 
breastfeed sufficiently well at their mothers’ breasts and frequently end up being bottle-fed, an activity 
that requires less tongue and sucking efforts than breastfeeding. In our premature infant prospective 
study, more than 90% of women with premature infants bottle-fed their infants for many reasons, even 
though some fed their babies expressed breast milk. Several researchers have considered the oral-facial 
hypotonia presented by premature infants. As example Page (2003) has raised the issue of how to deal 
with such hypotonia in infancy: Bottle feeding may be performed with special nipples that require 
more effort from the orofacial muscles (e.g., NUK-Gerber nipples)(Ogaard et al., 1994) with different 
nipple adjustments possible and with usage of triggering early in life oral reflexes triggered by finger 
stimulation of lips and mouth. Progressive development of a normal palate can be attained using such 
approaches(In one case, there was documentation of sustain results up to 6 years of age -personal 
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communication Dr MJ Boileau, Dept of Orthodontics Bordeaux University Dental School France). In 
our own group, a non-randomized small study with 5 infants showed that when mothers follow feeding 
recommendations and use bottle nipples that require more effort from infants during feeding (but were 
otherwise similar to the less demanding regular nipple) and finger stimulation of oral reflexes, a 
progressive normalization of abnormal palatal anatomy associated with normal breathing during sleep 
was observed at 24-months follow-up, which was not the case in GA-matched infants with regular 
nipples. This was also demonstrated in our report above of the pair of premature twins with secondary 
development of normal oral-facial features and absence of SDB. Feeding was associated with usage of 
a special pacifier but reeducation of muscle hypotonia involved more participation from mothers, 
including stimulation of infants' lips by placing a parent’s finger on the lips, and using chewing toys 
approved by the FDA after 6 months of age (e.g., ARK’s GrabbersTM chewing toys)(Bahr, 2010). 
These studies are very limited and are similar to case-reports but they add to the observations in older 
children and recurrence of SDB without myofunctional therapy associated with other SDB treatment 
when needed Guilleminault et al., 2012a). 
 In summary: Premature infants and some full-term infants may present with abnormal oral-facial 
presentation, particularly a high and narrow hard palate. Such presentation is associated with oral facial 
hypotonia. Systematic follow-up up to 36 months of post birth-age indicates persistence of abnormal 
tongue position and of abnormal breathing with presence of mouth breathing during PSG. 
Information from orthodontists indicates that performing special oral-facial exercises during feeding 
and chewing in the first 2 years of life may eliminate the abnormal anatomy and result in a 
repositioning of the tongue and development of a normal nasomaxillary complex and mandible. A 
small non-randomized study indicates that premature infants may develop normal nasomaxillary 
complex and mandible when a strong effort is made to induce a normal oral-facial musculature. Years 
of experience in orthodontia also support the important role of myofunctional reeducation in the 
presence of abnormal oral-facial anatomy independent of sleep studies (Chauvois et al., 1991). In our 
investigations, absence of SDB is associated with normal nasal breathing during sleep, but recurrence 
of OSA at teen-age is associated mouth breathing during sleep and documentation of oral facial 
hypotonia. 
 Conclusion 
The different data accumulated over time on SDB children and the experimental data obtained from the 
infant monkeys years ago all lean toward the same direction: There is a strong association between 
normal oral-facial muscle tone and normal development of the nasomaxillary complex and the 
mandible. Presence of abnormal muscle tone, either experimentally induced by creation of abnormal 
nasal resistance or due to premature birth, is quickly associated with mouth breathing particularly 
during sleep, abnormal placement of the tongue , and either development –as shown in the rhesus 
monkey and in some infants- or worsening of the oral-facial anatomy. In humans, SDB is noted in 
association with the pathological hypotonia of the tongue muscles: In a small group of infants seen at 
birth with a normal hard palate, development of a high and narrow hard palate and SDB was 
documented in children who also presented oral-facial hypotonia. When high and narrow hard palate 
was noted at birth, hypotonia was present and SDB was noted. In rare cases efforts to counteract oral-
muscle hypotonia and high and narrow hard palate very early in life may bring normal development 
and absence of SDB at follow-up.  
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As suggested by Swedish investigators, enlargement of tonsils appears to be a secondary 
phenomenon, but it further impacts nasal resistance (no information on adenoids has been obtained in 
our infant studies, but it was obtained in the long-term follow-up of older children with 3D-CT scans). 
Adenotonsillectomy is often insufficient for the complete resolution of breathing problems.  
Understanding the continuous interaction between muscle activity of the tongue and other oral-
facial muscles as well as the development of normal anatomic structures supporting the upper airway 
may give potential avenues for more appropriate treatments involving myofunctional reeducation in 
our therapeutic arsenal. When does the interaction between oro-facial muscles and oro-facial other 
anatomic structures limiting the upper airway began is unknown.  
Interruption of normal development with premature birth may explain the frequency of breathing 
problems during sleep in premature infants , but it may be seen in full term infants and may have very 
negative consequences (Rambaud and Guilleminault, 2012). Could the abnormality leading to oral-
facial hypotonia begin in utero? It is possible: Investigation of facial expression and movements shows 
that beginning in early pregnancy, the fetus exhibits regular movements in the mouth and face; For 
example, the most frequent movement during the second trimester is sucking (Kurjak et al., 2005). 
Abnormal pregnancy and/or impairment of these movements may impede normal muscle activity at 
birth. 
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Abstract:   
Backgrounds:  Pediatric Obstructive-Sleep-Apnea (OSA) is associated with cognitive impairments and 
with chronic systemic inflammation. This study aimed to investigate cognition in pediatric OSA and the 
status of pro-inflammatory cytokines, particularly IL-17and IL 23..  
 
Methods: Controls and OSA children, participated in the study. Exclusion criteria were 
adenotonsillectomy, heart, neurological and severe psychiatric diseases, craniofacial syndromes and 
obesity. Polysomnogram was followed by serum testing for inflammatory markers and neurocognitive 
tests such as Continuous-performance-task (CPT) and Wisconsin-Card-Sorting-Test (WCST), 
questionnaires, analyses of plasma high-sensitivity C- reactive- protein (HS-CRP), tumor-necrosis-
factor-alpha (TNF-α), interleukins 1(IL-1), 6 (IL-6), 17 (IL-17) and 23 (IL-23).  
 
Results: Seventy-nine, 4-12-year-old subjects in 2 groups ended the study: 47 non-obese OSA children 
(mean age=7.84 + 0.56 years, body mass index [BMI] = 16.95±0.47 kg/m2, BMI z score=0.15±0.21; 
mean AHI=9.13±1.67events/hour) and 32 healthy control children (mean age=7.02±0.65 years, with 
BMI =16.55±0.58 kg/m2, BMI z score=-0.12±0.27, mean AHI=0.41±0.07event/hour) were enrolled. 
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Serum cytokine analyses showed significantly higher levels of HS-CRP, IL-17 and IL-23 in OSA 
children (p=0.002, p=0.024, p=0.047).  
Regression test showed significant influence of HS-CRP, TNF-α, IL-6, IL-17 and specifically IL-23 with 
the Continuous-Performance-Test and Wisconsin-Card-Sorting-Test  
 
Conclusion : OSA children have abnormal neurocognitive testing and abnormal levels of IL-17, an 
interleukin related toTh17, a T helper cell involved in development of auto-immunity and 
inflammation,and of IL-23 The high expression level of IL-17 may contribute to the brain complications 
of pediatric OSA as also would abnormal level of;   IL-23  that show a significant influence on OSA 
abnormal neurocognitive testing. 
 
 
 
Keywords : pediatric obstructive-sleep-apnea, neurocognitive functions, inflammatory-cytokines, 
interleukin-17, interleukin 23 
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Introduction  
Symptoms of attention deficit/ hyperactivity disorder and neurocognitive functioning in children 
have been associated with obstructive sleep apnea (OSA) syndrome [1-4]. Pediatric OSA results in long-
term effects on children’s health and development [5-7]. The factors involved in the decrease in cognition, 
learning and memory associated with OSA are still incompletely chartered. 
Pediatric OSA and inflammatory cytokines  
There is an interaction between OSA and chronic diseases [8-10]. The most acceptable hypothesis 
associates occurrence of chronic systemic inflammation with OSA [11-12]. Increase in pro-
inflammatory cytokines ( C reactive protein (CRP), tumor-necrotic-factor (TNF-α), interleukin (IL)-6, 
and IL-10 in adult OSA patients and high-specific C reactive-protein( HS-CRP) in pediatric OSA 
patients) supports this hypothesis [13-15], with a possible association between the apnea-hypopnea-
index(AHI) and inflammatory cytokine levels. The inflammatory responses may be reversed after OSA 
treatment [16-18]. In the recent past, advances in our understanding of the precursors of some of the 
measured cytokines have occurred. Also very recently, the discovery of functional lymphatic vessels 
lining the dural sinuses and expressing the molecular hallmarks of lymphatic endothelial cells and 
carrying fluid and immune cells from the cerebro-spinal fluid with connection to the cervical lymphatic 
nodes, has been reported [19], and a direct impact of inflammatory cytokines and brain functioning 
may be occurring.   
 The pro-inflammatory cytokines IL-17 and IL-23 have been recently emphasized. IL-17 is a pro-
inflammatory cytokine secreted predominantly by T helper 17 cells (TH 17) and various cells including 
innate immune cells and non-immune cells [15]. It is referred to as IL-17A as it is a member of the IL-
17 family [20]. The IL-17-producing cells secrete IL-17A and another family member, IL-17F, under 
the stimulation of cytokines such as IL-1, IL-6, and IL-23 secreted by antigen-presenting-cells (APC) in 
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response to antigen stimulation [20,21]. The interaction is as follow: IL-17A and IL-17F form 
homodimers or heretodimers that bind to the IL-17 receptor complex on inflammation-related cells such 
as macrophages, epithelial cells and endothelial cells [22,23]. The activated inflammatory cells produce 
various cytokines including IL-1, IL-6 and TNF-α. The stimulation of these cytokines and inflammatory 
cells leads to inflammatory responses such as neutrophil recruitment, tissue destruction and 
neovascularization. The overreacted immune responses resulted in autoimmune diseases and allergy. 
During inflammation, expression of IL-17 and IL-17F is upregulated [22,23], with expression of high 
levels of IL-17 in patients with severe allergy, chronic inflammatory diseases and autoimmune diseases 
[23,24]. IL-17 also takes part in neutrophilic inflammation in the respiratory system [24,25], and leading 
to chronic inflammation of the airway [25]; as example there is high expression level of IL-17F in 
asthma[26]. IL-17 has been linked to adult OSA: there is an upregulated Th17/T-regulatory –Treg-cell 
ratio, and an overexpression of IL-6 and IL-17 in plasma cytokine suggesting that the imbalance of 
Th17/Treg and the microenvironment created by over-secreted pro-inflammatory cytokines contribute 
to the development of OSA and its co-morbidities [27]. In OSA children, cytokine profile obtained from 
tonsils shows high levels of IL-1b, IL-10 and IL-17A production, indicating a T cell activation in 
response to inflammation [28].   
IL-23, is a cytokine with immunomodulatory effects [29]. It acts on memory-cluster –designation-
4(+) T-cells, activates the transcription activator, and stimulates the production of interferon-gamma 
[30,31]. Studies showed that TH17 cells can be regulated by IL-23 [32].  
 Factors leading to cognitive changes in children with OSA are still subject of research: sleep 
fragmentation, hypoxemia, hypercapnia, change in cerebral-blood-flow may be involved, Inflammatory 
cytokines may also play a role. We investigated cognition changes in OSA children and presence of 
interleukins 17 and 23. We hypothesized that chronic inflammation not only causes cardiovascular 
diseases in pediatric OSA patient, but also affect cognitive functions and wondered if a correlation 
between psychometric test and these cytokines could be shown [15]. A study found a relationship 
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between abnormal level of C-reactive protein and cognitive dysfunction in school age children but 
investigation of interleukins 17 and 23 will give a much more important view on the inflammatory status 
present in children with OSA and potential correlations with specific cognitive testing.  
We prospectively examined whether the plasma levels of the inflammatory cytokines are altered 
in children with pediatric OSA related to enlarged T&A and we simultaneously surveyed  the changes 
of neurocognitive tests: We investigated the potential relationship between neurocognitive functions 
investigated by psychometric tests  and increase in inflammatory cytokines, [33] correlating the level of 
CRP, TNF-α, IL-1, IL-2, IL-6, Il-10, IL-17 and IL-23 with the sleep-polysomnogram-PSG- test results 
and neurocognitive test findings. 
 
Methods  
 
Inclusion/exclusion  
Children aged 4-12 years and their parents were prospectively approached. They were either 
presenting with complaints and symptoms of pediatric OSA (as defined in the International Classification 
of Sleep Disorders (ICSD)-2-2005)) or had no sleep-related or other symptoms (controls). Subjects were 
investigated at Chang Gung Memorial University Hospital (CGMH) after approval of the protocol by 
the institutional review board of CGMH.(#103-0601C) All caregivers (parents) signed an informed 
consent. Two groups of participants were collected: Group A: normal control (n=32); group B (n=47) 
pediatric OSA with sleep disturbances.  
Obesity, previous adenotonsillectomy craniofacial anomalies, neuromuscular diseases and other 
neurological and psychiatric disorders, presence of chronic medical problems, and IQ<70 defined as 
mental retardation, were exclusion criteria. In addition, children unable to cooperate with blood 
160 
 
withdrawal collection and PSG procedures were eliminated from the study. Obesity was defined based 
on Taiwan general public health tables. 
Inclusion criteria were either presence of signs and symptoms evoking OSA for at least 3 months 
with confirmation by polysomnography-PSG- findings (apnea-hypopnea-index-AHI greater than 1 
event/hour or respiratory-disturbance-index- RDI more than 5 events/hour ) (OSA group) or absence of 
complaint, AHI<1 and presence of a non-inflammatory status ( absence of asthma, allergies, eczema or 
other atopic/auto-immune diseases) (normal control).   
 
Procedures  
(a) All subjects underwent routine medical history and physical examination by otolaryngologist, 
craniofacial surgeon, pediatrician, and child psychiatrist assessing comorbidities.  
(b) Demographic data, (age, sex, height, weight) and all systemic comorbidities, were collected on a 
standardized data-sheet. 
(c) Tonsillar size was graded by specialists following standardized scale from 0 to +4. Adenoid tissue 
was examined with a lateral x-ray film of the neck, and flexible endoscope with amount of 
obstruction categorized into 4 grades (from grade 0 = 0–25%,to grade 3 = 75–100%). Allergic 
rhinitis was confirmed by a specific IgE blood test (ImmunoCAP® 100; Phadia, Uppsala, Sweden), 
and duration and persistence of symptoms and co-morbidities according to the Allergic Rhinitis and 
its Impact on Asthma classification.  
(d) Polysomnography (PSG)  
The following variables were monitored: EEG (4 leads), eye movement chin and leg EMG, ECG 
(one lead), body-position. The respiration was recorded with nasal pressure transducer, mouth 
thermo-couple, chest and abdominal inductive plethysmography bands, neck microphone, 
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diaphragmatic-intercostal muscle EMGs, pulse oximetry from which both oxygen saturation (SaO2) 
and finger-plethysmography were derived, data were collected on a 32 channel recording system, 
[Embla N7000 -Covidien, Ontario, Canada], with continuous video monitoring. A family member 
was present during the nocturnal recording. Sleep and wake were scored using  international criteria 
[33] with identification of stages 3 and 4. EEG arousal was defined according to the American Sleep 
Disorders Association [34]. Abnormal breathing events during sleep were analyzed using the 
definitions of apnea and hypopnea as outlined by the American Academy of Sleep Medicine [35], 
and the definition of flow limitation with abnormal increase in respiratory effort leading to arousals 
as outlined by Lin and Guilleminault et al. [36] The AHI and the respiratory disturbance index (RDI: 
number of apneas, hypopneas, and respiratory effort-related arousals per hour of sleep) were 
calculated. PSG scoring was performed by a technician blind to the clinical status of the child.  
(e) Inflammatory cytokine assessment 
Blood samples were collected and allowed to clot for 30 min. The samples were then centrifuged 
and the serum was frozen at -70°C until assay. All samples were collected morning after PSG. The 
serum levels of HS CRP, TNF-α, IL-1β, IL-6, IL-10, IL-17, and IL-23 were determined by  
commercially available ultra-sensitive enzyme-linked immunosorbent assay (ELISA) kits (R&D 
systems, Minneapolis, MN (see Appendix 1). There were duplications of each sample, and the mean 
was used as the unit of analysis for statistical evaluation of data. The Stem-and-leaf analysis (SPSS, 
Inc.) was employed in order to test for extreme outlying cytokine result.   
 
Questionnaire evaluations and neurocognitive tests  
Following PSG, four subjective questionnaires were filled out by caregivers to evaluating sleep 
quality and quality of life of children including the obstructive sleep disorder questionnaire (OSA-18), 
Children’s Sleep Habits Questionnaire (CHSQ), and Child Behavior Checklist (CBCL).  
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Evaluation of neurocognitive function was carried out using the WPPSI-R intelligence test for 3-
6 year-old children, the Wechsler-R intelligence (WPPSI-R) for 6-16 year-old children (WISC-) to 
assess IQ score; the Conners' Kiddie Continuous Performance Test(k-CPT) for 4-7 year old children (K-
CPT) the Continuous Performance Test (CPT) that measures the subject’s attention problem in three 
domains: inattention, impulsivity and vigilance and retention ability; and the Wisconsin Card Sorting 
Test for children assessing executive functioning ability.   
The results of Continuous-performance-task (CPT) score are presented in T-scores. High T-scores 
indicate an attention problem, with any T-score >60 considered as abnormal. The high T- score of 
omissions, commissions, Hit reaction time (Hit RT), Hit RT std. Error, variability, detectability, Hit 
reaction-time inter-stimulus-interval Change (Hit RT ISI Change) and Hit-standard-error inter-stimulus-
interval Change (Hit SE ISI Change) indicate inattention; while commission, Hit RT and Perseveration 
indicate impulsivity; and Hit reaction-time -block change (Hit RT block change) and Hit-standard- error 
(SE) block change indicate vigilance. 
The Wisconsin Card Sorting Test (WCST) measures the subject’s executive function. The total errors 
scores is an overall score of WCST, and higher score indicates worse performance. “Perseverative -
response”and “error-T-score”are higher in subject with worse performance of mental flexibility and 
insight. “Non-perseverative error” reflects difficulty to forming concepts and insight even in flexible 
answer. “Conceptual-level response score” indicates the insights in correct principle of card combination. 
“Learning to learn” depicts the average tendency over successive categories for efficiency to change. 
 
Statistical analysis:   
The data are shown as means ±standard deviation. Student t-tests were used to compare 
the findings in the OSA and control group. Taking into consideration the size of our group which limits 
usage of specific statistics such as “a mixed effects model” we used the “standardized regression test” 
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much better suited which was performed to demonstrate the relationship of cytokines levels with PSG 
and neurocognitive outcomes after controlling the factors of “asthma, allergy, BMI, gender, tonsil 
hypertrophy, adenoid hypertrophy, turbinate hypertrophy, and naso-septal deviation”. All the reported 
p-values are two-tailed with statistical significance set at <0.05. Statistics were performed with SPSS 
version 18 
 
Results  
Eighty-two children, 3-12 years old, were enrolled; there were 3 drop-outs (3.6%).  
Demographic of the 78 children (mean age 7.43 + 0.6 year) are in table 1. The OSA group was 
significantly different with symptoms of ADHD and enuresis (p=0.001 and p=0.036), presence of 
tonsil and adenoid hypertrophy (p<0.001), body-mass-index [BMI], BMI z score (p=0.001,and 0.036). 
The PSGs showed  (table2) significantly higher AHI, AHI in REM, AI, Desaturation Index and snore 
index in OSA children (p<0.001, p<0.001, p=0.001, p<0.001 and p=0.002 respectively). In addition, 
(see table 3), the expression of inflammatory cytokines IL-17, IL-23 and HS-CRP was significantly 
elevated in children with OSA (p=0.002, p=0.024, p=0.047 respectively). Plasma levels of TNF-α, IL-
1, IL-6 and IL-10 showed a non-significant elevation comparing with normal control. Results of CPT 
and WCST tests (see table 4) indicated significant difference between OSA and control in “Hit- RT- 
Std.- Error “(p=0.006) and “Hit-RT-ISI-Change”(p=0.004). 
A Standardized Regression Test was performed to demonstrate the relationship of cytokines levels 
with PSG and neurocognitive outcomes after controlling the factors of “asthma, allergy, BMI, gender, 
tonsil hypertrophy, adenoid hypertrophy, turbinate hypertrophy, and naso-septal deviation” (see 
Appendix2). It revealed significant relationship between pro-inflammatory cytokines and PSG scores 
with higher AHI score and OSA severity, such as HS-CRP (β=0.390, P<0.05) and IL-17(β=0. 329, 
P<0.05 ( see Appendix 2). Higher AI “influenced” serum levels of HS-CRP suggesting an impact of 
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inflammatory cytokines on soft tissues hypertrophy. Similarly, higher serum levels of IL-23 (β=0.403, 
P<0.05) was “influenced” by higher AI. Also lower mean SaO2 “influenced” IL-10 level (β= -0.567, 
P<0.01), and higher serum levels of TNF-α and IL-1β were “influenced” by higher diastolic pressure 
(β=0.469 and 0.659, P<0.01). 
There was a significant relationship between lower performances of CPT test and pro-
inflammatory cytokines as shown in table 5. The Standardized-Regression-Test indicated significant 
findings between pro-inflammatory cytokines and neurocognitive-function tests. The elevated cytokines 
are related to domains of inattention, vigilance, such as “Hit-RT-ISI-Change T- score” and HS-CRP (β= 
-0.426, P<0.05); “Response-Style T-score” and TNF-α (β= -0.432, P<0.05); “Hit RT ISI Change T score” 
and “Hit SE ISI Change T score” with IL23 (β= -0.545, -0.526, P<0.01); and higher “Confidence-Index” 
with IL17 (β= 0.424, P<0.05). When looking at the influence between inflammatory cytokines and 
WCST, the results indicate that elevated cytokines, such as TNF-α and IL6 are related to decrease of 
executive functions: such as “non-Perseverative- Errors T-scores” (β= -0.553, P<0.05) ; “Learning-to-
Learn” (β= -0.838, P<0.05) ; and “Percent-Conceptual-Level-Response- T-scores” (β= 0.476, P<0.05); 
especially IL-23 with significant poor performance of “non-Perseverative-Errors T- scores” (β= -0.729, 
P<0.01).  
Our data shows the significant Spearman’s correlation factors between pro-inflammatory 
cytokines and clinical findings such as asthma and IL-6 (ρ= 0.261, P=0.026 ); allergic rhinitis and HS-
CRP(ρ= 0.280, P=0.022*), IL-6(ρ= 0.299, P=0.01*) and IL-10(ρ= -0.265, P=0.023*) ; Tonsil 
hypertrophy and HS-CRP(ρ= 0.244, P=0.046 ) ; Adenoid hypertrophy and IL-6 (ρ=0.232, 
P=0.048*)(Appendix 3). 
  
Discussion  
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Plasma levels of pro-inflammatory cytokines such as HS-CRP, TNF-α, IL-1β and IL-6 have been 
previously reported as elevated in children with OSA; and the expression ratio of the IL-10 and IL-6 was 
elevated in OSA children with recovery after adenotonsillectomy surgery [17]. This last finding 
supported the concept that OSA induces a systemic inflammatory response activating the signal 
transduction pathway leading to up-regulation of inflammatory cytokines and down regulation of anti-
inflammatory cytokines. 
 But the interaction between the different cytokines may not be as clear-cut as thought, the 
advances in the recognition of the activation of a chain of inflammatory factors allows further 
understanding. We found a non- significant trend toward elevation of IL-10 in our subjects: as this 
cytokine is involved in both pro and anti-inflammatory processes, further investigations will be needed.  
Also, although IL-6 did not appear to have a significantly high expression level in our OSA 
children, we cannot exclude a role for IL-6 in OSA-related inflammation, as IL-6 is a crucial cytokine 
signal in guiding the differentiation of naïve T cells into TH 17cells that release IL-17, and, in our 
subjects, we clearly found that IL-17 is elevated with pediatric OSA. But one may not necessarily have 
to call-upon IL-6 for stimulation, as IL-23 has been considered as a key-cytokine directing the 
differentiation of naïve T cells into IL-17-producing TH17 cells. This issue however is still under debate 
as some studies support the concept that the production of IL-17 is dependent on IL-23[31]; while other 
studies may indicate that IL-17 could be produced without the presence of IL-23[37-39]. IL-17 may act 
synergistically with TNF-α to trigger the signaling pathway that upregulates the downstream cytokines, 
IL-6 and IL-8.  IL-17 itself acted as a downstream of IL-1 in animal model of autoimmune arthritis 
[40,41]. IL-17, in turn, stimulates cell production of IL-1, TNF-α and ultimately leads to recruitment of 
inflammatory cells such as neutrophils and other leukocytes [42]. All of the studies above confirmed that 
IL-17, primarily secreted by Th17, a subset of T helper cells, is a pro-inflammatory cytokine that act, 
with the company of other cytokines such as IL-1, TNF-α and IL-6, to induce systemic inflammatory 
diseases and plays an important role in the development of auto-immunity. Our study indicates that both 
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IL-17 and IL-23 are elevated in pediatric OSA and could be used as biomarkers of pediatric OSA. They 
can play a role in the development of secondary health problems noted with OSA.   
OSA not only affects cardiovascular functions and growth problem but also causes 
behavioral and cognitive dysfunction in children [43] and these co-morbidities are more 
common than cardiovascular dysfunction in non-obese pediatric OSA. But the mechanisms 
involved are still unknown. Evidence suggests that some peripheral pro-inflammatory 
cytokines such as IL-1 and IL-6 can pass blood-brain barrier [15,44] The new finding in 
rodent of a direct connection between cerebro-spinal- fluid and deep neck lymph nodes is also 
a very important clue [19]. These cytokines activate and regulate the vagus nerve system, and 
it affects the function of central nervous system (CNS) [44,45]. Moreover, chronically rising 
level of pro-inflammatory cytokines might also induce neuro-inflammation or 
neurodegeneration and cause impairment of neurocognitive functions[46,47].Other research 
shows reduction of cognitive function as related to increase level of peripheral IL-6 even in 
the normal aging Americans [48,49] .Our study shows that higher level of TNF-α and IL-23 
are significantly related to some neurocognitive deficits in pediatric OSA. New studies should 
further address this issue. 
Our study has limitations: despite the fact that we looked at 79 children- even if a high number for 
this type of study- this is still an overall low number. Also our controls were somewhat “hyper-normal”: 
we eliminated from the study any child that had an indication of abnormal levels of inflammatory 
cytokines. One important point our children were not all with “severe” OSA (only 17% had AHI>10), 
all however presented abnormal PSG findings: And our findings are in line with data showing that even 
children with low but abnormal AHI have often memory, attention problems and school difficulties [3-
6] 
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OSA in children impacts brain functioning: cognitive, memory, attention disorders as well as  
behavioral and mood problems are much more common than any other listed complications. The impact 
of inflammatory factors , neuroinflammation and dysfunction of the neuronal net-work has been 
mentioned by many; our study indicates some interleukin abnormalities ( IL 17 and IL 23) not reported 
before may be present very early with SDB, and should be investigated: these pro-inflammatory 
cytokines might be potential markers helping in diagnosis and post-treatment follow-up of pediatric OSA.   
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Table 1 Demographic characteristics of OSA and healthy children 
 Control 
(n=32) 
OSA 
(n=47) 
p value 
Number of males (%) 21 (65.6%) 30 (63.8%) 0.428 
Age (years) 7.02±0.65 7.84±0.56 0.366 
BMI (kg/m2) 16.55±0.58 16.95±0.47 0.601 
BMI z score a -0.12±0.27 0.15±0.21 0.442 
AHI(events/h) 0.37±0.06 9.13±1.67 <0.001*** 
PLMI (events/h) 0.13±0.10 0.93±0.41 0.067† 
PLM disorder (%) 0(0%) 3(6.4%) 0.083† 
Learning disorder(%)b 0(0%) 1(2.1%) 0.461 
ADHD(%)b 2(6.2%) 18(38.3%) 0.001** 
Enuresis(%)b 4(12.5%) 15(31.9%) 0.036* 
Other Physical Comorbidity History 
 Asthma(%) c 4(12.5%) 6(12.8%) 0.561 
 Allergic rhinitis(%) c 4(12.5%) 23(48.9%) <0.001*** 
Findings of ENT examination  
 Tonsil hypertrophy (more than Gr. 2) (%) c 4(12.5%) 32(68.1%) <0.001*** 
 Adenoid hypertrophy (%)c 3(9.3%) 24(51.1%) <0.001*** 
 Turbinate hypertrophy(%) c 1(3.1%) 6(12.8%) 0.158 
 Nasoseptal deviation(%) c 0(0%) 1(2.1%) 0.461 
†0.05≦P0.1. *P<0.05. **P<0.01. ***P<0.001. BMI, body mass index; ENT, ear, nose and throat; 
ADHD, attention deficient hyperactivity disorder; PLM, periodic limb movement. aCorrected BMI 
z score based on the Center for Disease Control (CDC) growth charts. bDiagnosed according to the 
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criteria of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision. 
cDiagnosed by pediatricians.  
 
Table 2 Comparison of polysomonogram findings in OSA and healthy children 
 
 
Control 
(n=32) 
OSA 
(n=47) 
p value 
BMI (kg/m2) 16.55±0.58 16.95±0.47 0.601 
BMI z score -0.12±0.27 0.15±0.21 0.442 
Polysomonograhic findings 
AHI(events/h) 0.37±0.06 9.13±1.67 <0.001*** 
AHI/REM (events/h) 0.65±0.18 16.25±3.68 <0.001*** 
AI(events/h) 0.18±0.05 2.12±0.51 0.001** 
Desaturation Index(events/h) 0.41±0.06 7.27±1.59 <0.001*** 
Sleep efficiency (%) 89.70±1.32 83.65±2.28 0.131 
Awake (%) 6.74±1.42 10.90±2.36 0.305 
REM (%) 18.62±1.406 19.11±1.16 0.820 
Stage N1 (%) 10.46±1.70 10.24±1.44 0.935 
Stage N2 (%) 41.65±2.67 42.56±2.74 0.853 
 Stage N3 (%) 28.28±2.71 30.40±1.28 0.434 
 TST (mins) 405.26±10.96 383.34±11.15 0.274 
 Sleep latency(mins) 17.67±3.84 20.86±3.74 0.629 
 PLM Index(events/h) 0.13±0.10 0.93±0.41 0.067† 
 Snore Index(events/h) 30.41±15.28 156.02±35.62 0.002** 
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Mean SaO2 (%) 
Systolic pressure 
Diastolic pressure 
95.97±1.12 
100.80±17.20 
60.00±22.36 
90.12±3.61 
106.76±19.40 
66.79±11.86 
0.332 
0.387 
0.141 
†0.05≦P0.1. *P<0.05. **P<0.01. ***P<0.001. BMI, body mass index; AHI, apnea-hypopnea index; 
AHI/REM, AHI during REM; AI, apnea index; REM, rapid eye movement; TIB,Time in Bed; SPT, 
Sleep Period Time; TST, Total Sleep Time; WASO, Wake time after sleep onset; PLM, Periodic 
Limb Movement; Mean SaO2, mean oxygen saturation; Lowest SaO2, lowest oxygen saturation.  
 
Table 3  Comparison of inflammatory cytokines in healthy and OSA children 
 
 
Control(n=32) 
mean±SD 
OSA(n=47) 
mean±SD 
 
p value 
HS-CRP mg/l 0.41±0.48 1.90±0.44 0.002** 
TNF-αug/dl 12.62± 0.94 12.58± 0.83 0.974 
IL-1βpg/ml 0.42±0.27 0.36±0.16 0.857 
IL-6 pg/ml 1.10±0.18 1.66±0.23 0.104 
IL-10 pg/ ml 2.10±0.28 2.62±0.39 0.332 
IL-17 pg/ml 10.20± 1.25 15.12± 1.38 0.024 * 
IL-23 pg/ml 12.29± 0.73 14.58±0.75 0.047* 
*P<0.05.**P<0.01. 
HS-CRP, high sensitivity-C reactive protein;TNF-α, tumor necrosis factor alpha; IL-1β, 
Interleukins 1 beta; IL-6, Interleukins 6; IL-10,Interleukins 10;IL-17, Interleukins 17; IL-23, 
Interleukins 23. 
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Table 4 Comparison of CPT and WCST findings in OSA children 
 
 
Control 
total(n=32) 
OSA 
total(n=47) 
p value 
CPT    
 Clinical, Confidence Index 39.34±15.91 49.51±24.46 0.142 
Omissions T score 46.57±5.36 52.33±17.93 0.074† 
Commissions T score 40.50±10.93 45.03±13.02 0.237 
Hit RT T score 49.94±8.86 57.08±13.03 0.056† 
Hit RT Std. Error T score 45.79±6.26 52.96±12.23 0.006** 
Variability T score 46.43±7.31 51.42±10.57 0.099† 
Detectability T score 40.87±12.39 54.62±15.72 0.316 
Response Style T score 51.57±14.97 53.12±14.69 0.732 
Perseverations T score 49.69±7.91 55.34±12.25 0.104 
Hit RT Block Change T score 48.99±6.54 50.43±6.73 0.479 
Hit SE Block Change T score 49.40±7.71 50.07±11.00 0.831 
Hit RT ISI Change T score 47.88±5.25 54.53±10.83 0.004** 
Hit SE ISI Change T score 46.80±8.80 51.70±9.06 0.077† 
WCST    
Total Errors Standard scores 107.20±20.97 99.67±24.26 0.392 
Total Errors T scores 54.80±13.97 49.81±16.19 0.395 
Perseverative Responses T scores 55.10±14.77 50.56±16.57 0.452 
Perseverative Errors T scores 56.30±15.10 50.74±16.42 0.357 
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nonPerseverative Errors T scores 55.60±14.37 52.78±16.66 0.639 
% Conceptual Level Response T scores 54.50±4.60 50.19±3.31 0.487 
Learning to Learn -3.49±11.66 -3.90±9.78 0.712 
CPT, Continuous performance task. The result of CPT score is presented in T-
scores. According to the Conners’ CPT Computer Program User’s Manual, 
high T-scores are designed to indicate an attention problem. Any T-score above 
60 is considered abnormal. The Confidence Index presents the summary of the 
CPT. The Omissions reveals the number of targets which the person did not 
respond to. The Commission reveals the number of times when the person 
responds to a non-target. Hit RT, Hit reaction time; which reflects the mean 
response time. Hit RT std. Error, Hit reaction time standard error; which 
measures the speed consistency. The variability, also a measure of response 
time consistency, which calculates the standard deviation of the 18 standard 
error values calculated for each sub-block. The detectability is a measure of 
discriminative power. The higher response style T score indicates that the 
person act more cautiously to avoid commission error, and the lower score 
indicates that the person respond more freely to make sure they answer most 
of the target. The perseverations T score shows the frequency when responding 
time is lower than 100ms. Hit RT block change, Hit reaction time block change. 
The Hit RT block change shows the change in reaction time over the 6 time 
blocks; the higher Hit RT block change T scores indicates a slowing of reaction 
time as the test progress. Hit SE block change, Hit standard error block change, 
which indicates the consistency the person react to the targets as test progress. 
Hit RT ISI Change, Hit reaction time inter-stimulus interval change, reflects 
the change in reaction time over three inter-stimulus intervals (1,2 and 4 
seconds.) Higher score reflects slowing of reaction time as the intervals 
between targets increased. Hit SE ISI Change, Hit reaction time inter-stimulus 
interval change. Higher score reflects the person became more erratic as the 
time between targets increased.  
WCST, Wisconsin Card Sorting Test. The total errors scores is an overall score 
of WCST test, and the higher score indicates worse performance. The 
perseverative response and error T score are higher in the person with worse 
performance of mental flexibility and insight. The non-perseverative error 
reflects difficulty to forming concepts and insight even in flexible answer. The 
conceptual level response score indicates the insights in correct principle of 
the card combination. Learning to learn depicts the average tendency over 
successive categories for efficiency to change.  
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Table 5 Relationships between inflammatory cytokines and neurocognitive function tests 
 HSCRP TNF-
α 
IL-1β IL-6 IL-10 IL-17 IL-23 
CPT 
Clinical, Confidence Index a 
-0.185 -
0.177 
-0.040 -0.027 0.181 0.424* -0.317 
Omissions T score a -0.256 -
0.154 
-0.067 -0.109 0.002 0.112 -
0.336† 
Commissions T score a 0.037 0.075 0.170 0.030 0.250 -
0.056 
0.045 
Hit RT T score a -0.071 -
0.127 
0.006 -0.106 0.065 0.267 -0.249 
Hit RT Std.Error T score a -0.207 -0.216 
0.083 -0.103 0.182 0.294† -
0.322† 
Variability T score a -0.247 -0.098 
0.160 -0.009 0.354† 0.274 -0.291 
Detectability T score a -0.116 0.032 0.136 -0.004 -0.050 
-
0.186 
0.034 
Response Style T score a -0.044 -0.432* 
-0.101 -0.039 0.136 0.309† -0.129 
Perseverations T score a -0.253 0.109 -0.013 -0.112 0.155 0.184 -0.203 
Hit RT Block Change T score a -0.146 -0.328† 
-0.066 -0.017 0.105 -
0.102 
-0.051 
Hit SE Block Change T score a -0.100 -0.121 
0.131 -0.029 0.201 -
0.184 
-0.051 
Hit RT ISI Change T score a 
-0.426* -
0.155 
0.003 -0.168 -
0.012 
-
0.036 
-
0.545** 
Hit SE ISI Change T score a 
-0.389† -
0.192 
0.174 -0.159 0.049 0.114 -
0.526** 
WCST 
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Total Errors Standard scores a 
-0.123 -
0.335 
0.089 0.436† 0.065 -
0.086 
-
0.443† 
Total Errors T scores a 
-0.124 -
0.345 
0.082 0.433† 0.068 -
0.083 
-
0.446† 
Perseverative Responses T scores a -0.276 -
0.093 
0.186 0.324 -
0.016 
0.027 -0.179 
Perseverative Errors T scores a -0.262 -
0.117 
0.175 0.324 -
0.021 
0.012 -0.197 
nonPerseverative Errors T scores a 0.047 -
0.553* 
-0.058 0.255 0.106 -
0.250 
-
0.729** 
% Conceptual Level Response T 
scores a 
-0.131 -
0.315 
0.067 0.476* 0.081 -
0.079 
-
0.404† 
Learning to Learn a 0.336 -0.838* 
0.019 0.221 0.119 0.330 0.295 
aStandardized regression coefficient. Control factors: Asthma, allergy, BMI, gender, Tonsil 
hypertrophy, Adenoid hypertrophy, Turbinate hypertrophy, Nasoseptal deviation., †0.05P0.1. 
*P<0.05. **P<0.01. WCST, Wisconsin Card Sorting Test; CPT, Continuous performance task 
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FINAL CONCLUSION: 
Our work is a work in progress. We are following our premature cohort, and despite the 
attrition that we expected, we see a persistence of abnormal breathing during sleep, with apnea 
and hypopnea in 77% of our group. Premature infants have more learning and attention 
problems but the children with sleep-disordered-breathing –SDB-have more dysfunctions than 
those without SDB. 
Some of the premature as full term infants have short lingual frenulum [1], an anatomical 
presentation not checked in premature infants and often difficult to recognize in early 
premature, but that should be systematically checked with further growth. “Clipping” of the 
lingual frenulum may not be possible but dis-insertion of this vestigial abnormally placed 
fibrous tissue can be done.  
Prematurity independently of short frenulum or not, is associated with abnormal oral facial 
functions such as sucking, swallowing, nasal breathing and sound emission (speech). 
Myofunctional therapy [MFT] [2-4] has received a large amount of attention in the recent past, 
despite the fact that it has been practiced for many years, particularly in Europe and Brazil. 
Usage of MFT should be much more applied to any child with regular mouth breathing during 
sleep as it leads to oral facial abnormal development and growth and SDB, with increasing the 
risk of collapsibility of the upper-airway during sleep. And such dysfunction will impact 
further sleep and cognition. But MFT is difficult to perform in young individuals and 
compliance is limited even with the most dedicated parents. The beginning investigations of 
the potential role of “passive reeducation” using orthodontic simple devices during sleep 
versus “active reeducation” with parental involvement and exercise during wakefulness have 
to be pursued, as these investigations are mostly in the stage of feasibility studies [5]. 
The involvement of inflammatory cytokines with SDB is also clear but much more work needs 
to be done in this area. Further work may help indicating if a treatment is successful 
performing a blood test and not having to perform systematic PSG. But the field of cytokines 
is getting always more complex and the selection of the cytokine(s) to systematically follow is 
still uncertain, and much more work is needed in this area [6] 
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Sleep is always affected in children with health problems, but sleep and investigation of vital 
variables during sleep is an important test to perform to understand the development and 
worsening of SDB, and despite its challenges, it should be a test used much more in clinical 
practice when daytime problems cannot be easily resolved 
References 
1. Guilleminault C, Huseni S, Lo L A frequent phenotype for paediatrics obstructive sleep 
apnea: short lingual frenulum ERJ (Open Research) 2016 2:43-47; DOI: 
10.1183/23120541.00043-2016. 
2. Guilleminault C, Huang YS, Monteyrol PJ, Sato R, Quo S, Lin CH.: Critical role of 
myofascial reeducation in sleep-disordered breathing Sleep Med. 2013;14: 518-525 . 
3. Camacho C, Certal V, Abdullatif J, Zaghi S, Ruoff CM, Capasso R  et al. Myofunctional 
therapy to  treat obstructive sleep apnea: a systematic review and meta-analysis, 
Sleep.2015; 38: 669-75. 
4. de Felício C M.  da Silva Dias V, Folha GA, Azevedo de Almeida L,  Freitas de Souza,J. 
Anselmo-Lima WT,Trawitzki LVV, . Valera FCP, Orofacial motor functions in pediatric 
obstructive sleep apnea and implications for myofunctional therapy, International Journal 
of Pediatric Otorhinolaryngology  (2016), doi: 10.1016/j.ijporl.2016.08.019. 
5. Chuang LC, Lian YC, Hervy M, Guilleminault C, Huang YS*.Passive myofunctional 
therapy applied on children with obstructive sleep apnea: A 6-month follow-up. J Formos 
Med Assoc. 2016 Oct 3. pii: S0929-6646(16)30184-X. doi: 10.1016/j.jfma.2016.08.002. 
[Epub ahead of print] 
6. Huang YS, Guilleminault C*, Hwang FM, Cheng C, Lin CH, Li HY, Lee LA. 
Inflammatory Cytokines in Pediatric Obstructive Sleep Apnea. Medicine (2016) 95:40-49. 
 
 
